Sentence,class,file
"http://dx.doi.org/10.1085/jgp   .20070987 1 Keramidas, A., and N.L.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"135:59– 75. http://dx.doi.org/10.1085/jgp.20091031 7 Kloda, J.H., and C. Czajkowski.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi   .org/10.1097/00000542-200410000-0001 8 Bergmann, R., K. Kongsbak, P.L.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/10.1371/journal.pone.005232 3 Boileau, A.J., and C. Czajkowski.",Non-OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/10.1038/sj.bjp.070679 6 Chowdhury, S., and B. Chanda.",Non-OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
http://dx.doi   .org/10.1073/pnas.100360910 7,Non-OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/10   .1021/bi00865a04 7 Lavoie, A.M., and R.E.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/10.1146/annurev   .ne.17.030194.00303 3 Maksay, G. 1994.",Non-OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
http://dx.doi   .org/10.1111/j.1469-7793.1997.353bh.,Non-OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/10.1016/S0022-2836(65)80285- 6 Mozrzymas, J.W., A. Barberis, K. Mercik, and E.D.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/10.1016/S0006-8993(99)02151- 4 Perrais, D., and N. Ropert.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/10.1038/338582a 0Rogers, C.J., R.E.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/10.1038/nrd350 2 Rüsch, D., and S.A. Forman.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/   10.1097/00000542-200504000-0001 4 Rüsch, D., H. Zhong, and S.A. Forman.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/10.1074/jbc.M40047220 0 Sharkey, L.M., and C. Czajkowski.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/10.1124/mol.108.04489 1 Sieghart, W. 1995.",Non-OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi   .org/10.1085/jgp.20121085 9 Topf, N., A. Jenkins, N. Baron, and N.L.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi.org/   10.1002/ana.41025030 2 Vicini, S., J.M.",Non-OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.4316-03.200 4 Wieland, H.A., H. Lüddens, and P.H.",OADS,/arxiv_data1/oa_pdf/db/cb/JGP_201411183.PMC4076519.pdf
This article is distributed under the terms of an Attribution–Noncommercial–  Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2188­06.2006 Beurg, M., R. Fettiplace, J.H.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10 .1038/nn.2295 Beurg, M., X. Tan, and R. Fettiplace.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1016/j .neuron.2013.05.018 Brelidze, T.I., X. Niu, and K.L.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.3390/toxins5020456 Coste, B., J. Mathur, M. Schmidt, T.J. Earley, S. Ranade, M.J. Petrus,  A.E.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1126/science .1193270 Crawford, A.C., and R. Fettiplace.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1371/journal.pone.0000515 Farris, H.E., C.L.",Non-OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1113/jphysiol .2004.061267 Fettiplace, R. 2009.",Non-OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1098/rspb.1997.0087 Glowatzki, E., J.P. Ruppersberg, H.­P.",Non-OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1016/ S0028­3908(97)00108­1 Johnson, S.L., M. Beurg, W. Marcotti, and R. Fettiplace.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
http://dx.doi.org/10.1021/bi200770q,Non-OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"47:139– 165. http://dx.doi.org/10.1146/annurev­genet­111212­133424 Reynolds, C.D., R.A. Palmer, B.A.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1016/ 0304­4165(75)90342­6 Ricci, A.J., A.C. Crawford, and R. Fettiplace.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1016/S0896­6273 (03)00721­9 Rüsch, A., C.J.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1093/bioinformatics/14.5.384 Strecker, G.J., and M.B.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1016/ S0006­3495(89)82726­2 Suchyna, T.M., and F. Sachs.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1113/jphysiol.2006 .125021 Suchyna, T.M., J.H.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1085/jgp.115.5.583 Suchyna, T.M., S.E.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1038/nature02743 Swartz, K.J.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/ 10.1016/j.toxicon.2006.09.024 van Netten, S.M., and C.J.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10 .1016/S1063­5823(06)59013­1 Vreugde, S., A. Erven, C.J.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1038/ ng848 Xiong, W., N. Grillet, H.M. Elledge, T.F.",Non-OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10 .1016/j.cell.2012.10.041Kawashima, Y., G.S.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1172/JCI60405 Kazmierczak, P., and U. Müller.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1016/j.tins.2011.10.007 Kim, K.X., and R. Fettiplace.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1085/jgp.201210913 Kim, K.X., M. Beurg, C.M.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1085/jgp .201311068 Kroese, A.B., A. Das, and A.J.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi .org/10.1016/0378­5955(89)90023­3 Kurima, K., L.M.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1038/ng842 Kurima, K., Y. Yang, K. Sorber, and A.J.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1016/S0888­ 7543(03)00154­X Marcotti, W., S.M.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1113/jphysiol .2005.085951 Marcotti, W., L.F. Corns, T. Desmonds, N.K.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10 .1523/JNEUROSCI.4086­13.2014 Mutai, H., S. Mann, and S. Heller.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi .org/10.1016/j.neuroscience.2005.01.046 Nishizawa, M., and K. Nishizawa.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
"http://dx.doi.org/10.1152/jn.01178.2011 Pan, B., G.S.",OADS,/arxiv_data1/oa_pdf/48/92/JGP_201411173.PMC4076520.pdf
This article is distributed under the terms of an Attribution–Noncommer- cial–Share Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"After six months it is available under a Creative Com- mons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
The online supple - mental material is available at http://www.jgp.org/cgi/content/full/jgp.201411169/DC1.,Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1165/ajrcmb.25.3.4493 Giraldez, T., T.E.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1085/ jgp.200509368 Gonzales, E.B., T. Kawate, and E. Gouaux.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/nature08218 Graeber, M.B.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"330:783– 788. http://dx.doi.org/10.1126/science.1190929 Haller, T., J. Ortmayr, F. Friedrich, H. Völkl, and P. Dietl.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1073/ pnas.95.4.1579 Hattori, M., and E. Gouaux.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/nature11010 Huh, D., B.D.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/ 10.1126/science.1188302 Inoue, K. 2008.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1007/s00018-008-8210-3 Jarvis, M.F.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/ 10.1016/j.tins.2009.10.003 Jarvis, M.F., and B.S.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1016/j.neuropharm.2008.06.067 Jelínkova, I., V. Vávra, M. Jindrichova, T. Obsil, H.W.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1016/j.tibs.2012.10.006 Jones, C.A., I.P.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/sj.bjp.0703059 Kaczmarek-Hájek, K., E. Lörinczi, R. Hausmann, and A. Nicke.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"8:375– 417. http://dx.doi.org/10.1007/s11302-012-9314-7 Kawate, T., J.C. Michel, W.T.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/nature08198 Khakh, B.S., and G. Burnstock.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1074/jbc.M411324200 Khakh, B.S., and R.A. North.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1016/j.sbi.2013.04.005 Bobanovic, L.K., S.J.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1017/S1461145712000909 Bowler, J.W., R.J. Bailey, R.A. North, and A. Surprenant.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/sj.bjp.0705459 Browne, L.E., L.H.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1016/j.tips.2010.02.004 Browne, L.E., J.P. Nunes, J.A.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"7:273.  http://dx.doi.org/10.3389/fncel.2013.00273 Chaumont, S., and B.S.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/ 10.1073/pnas.0803008105 Chaumont, S., V. Compan, E. Toulme, E. Richler, G.D. Housley, F.  Rassendren, and B.S.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1515/rns.2011.014 Coddou, C., Z. Yan, T. Obsil, J.P. Huidobro-Toro, and S.S.  Stojilkovic.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/ 10.1124/pr.110.003129 Coull, J.A., S. Beggs, D. Boudreau, D. Boivin, M. Tsuda, K. Inoue, C.  Gravel, M.W.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/ nature04223 Dobbs, L.G., R. Gonzalez, and M.C.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.3250-04.2004 Frick, M., S. Eschertzhuber, T. Haller, N. Mair, and P. Dietl.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1124/jpet.110.176990 Parkinson, K., A.E.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/ ncb2887 Priel, A., and S.D.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"123:281– 293. http://dx.doi.org/10.1085/jgp.200308986 Qureshi, O.S., A. Paramasivam, J.C. Yu, and R.D.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10 .1038/nmeth1144 Richler, E., E. Shigetomi, and B.S.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10 .1523/JNEUROSCI.3362-11.2011 Robinson, L.E., and R.D.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1002/bies.10200 Royle, S.J., L.K.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10 .1242/jcs.02451 Samways, D.S., and T.M.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/ 10.1074/jbc.M111.322461 Samways, D.S., Z. Li, and T.M.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/ 10.1016/S0006-3495(00)76468-X Schneggenburger, R., Z. Zhou, A. Konnerth, and E. Neher.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi .org/10.1016/0896-6273(93)90277-X Sekine-Aizawa, Y., and R.L.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1073/ pnas.081089198 Khakh, B.S., J.A.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/nn.3126 Lörinczi, É., Y. Bhargava, S.F.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1016/S0091-679X(08)85002-9 Miesenböck, G. 2012.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1101/pdb.ip067827 Miesenböck, G., D.A.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/28190 Migita, K., W.R. Haines, M.M.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1074/jbc.M103366200 Miklavc, P., O.H.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1111/j.1749-6632.2008.03989.x Miklavc, P., N. Mair, O.H.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"7:171. http://dx.doi.org/10.3389/fncel.2013.00171 Milligan, E.D., and L.R.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1113/ jphysiol.2009.174961 Murrell-Lagnado, R.D., and O.S.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1080/09687680802050385 Nicke, A., H.G.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1093/ emboj/17.11.3016 North, R.A. 2002.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
http://dx.doi.org/10.1124/mol.,OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10 .1073/pnas.0407563101 Sheridan, D.L., C.H.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.03.020 Srinivasan, R., C.I.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1124/mol.112.077792 Stokes, L., and A. Surprenant.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/ 10.1002/eji.200838818 Thompson, K.E., J.P. Korbmacher, E. Hecht, N. Hobi, O.H.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1074/jbc.M111 .329334 Toulmé, E., F. Soto, M. Garret, and E. Boué-Grabot.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10 .1124/mol.105.018812Toulme, E., A. Garcia, D. Samways, T.M.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/nature01786 Ulmann, L., J.P. Hatcher, J.P. Hughes, S. Chaumont, P.J.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.2308-08.2008 Ulmann, L., H. Hirbec, and F. Rassendren.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/ 10.1038/emboj.2010.126 Ulmann, L., F. Levavasseur, E. Avignone, R. Peyroutou, H. Hirbec,  E. Audinat, and F. Rassendren.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1002/glia.22516 Wyatt, L.R., S.C. Godar, S. Khoja, M.W.",Non-OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1038/ npp.2013.98 Yang, A., D. Sonin, L. Jones, W.H.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1016/j .neuropharm.2012.03.014 Young, M.T., J.A.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
"http://dx.doi.org/10.1074/jbc.M804458200 Zinchuk, V., and O. Zinchuk.",OADS,/arxiv_data1/oa_pdf/73/46/JGP_201411169.PMC4076521.pdf
This article is distributed under the terms of an Attribution–Noncommercial–  Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10 .1126/science.266.5189.1348 Malvezzi, M., M. Chalat, R. Janjusevic, A. Picollo, H. Terashima,  A.K.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"4:2367. http://dx.doi.org/10.1038/ncomms3367 Ni, Y.L., A.S. Kuan, and T.Y.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1371/journal.pone.0086734 Park, H.W., and M.G.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1101/cshperspect.a009571 Qu, Z., and H.C. Hartzell.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10 .1085/jgp.116.6.825 Qu, Z., and H.C. Hartzell.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1074/jbc.M101264200 Quinton, P.M. 2007.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1152/physiol.00041.2006 Richman, D.P., Y. Yu, T.T.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1007/s12017-012-8190-1 Sakmann, B., and E. Neher.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1146/annurev.ph.46 .030184.002323 Scheele, G.A., S.I.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1097/00006676-199601000-00001 Schroeder, B.C., T. Cheng, Y.N.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1016/j.cell .2008.09.003 Scudieri, P., E. Sondo, L. Ferrera, and L.J.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/ 10.1113/expphysiol.2011.058198 Sigworth, F.J. 1983.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1113/jphysiol.2013.251660 Boucher, R.C.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1161/ CIRCRESAHA.112.277145 Caputo, A., E. Caci, L. Ferrera, N. Pedemonte, C. Barsanti, E. Sondo,  U. Pfeffer, R. Ravazzolo, O. Zegarra-Moran, and L.J.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1038/ 368545a0 Chen, T.Y., M. Illing, L.L.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1111/ j.1476-5381.2010.01137.x Dhallan, R.S., K.W.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"347:184– 187. http://dx.doi.org/10.1038/347184a0 Hartzell, H.C. 2008.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10 .1146/annurev.physiol.67.032003.154341 Hengl, T., H. Kaneko, K. Dauner, K. Vocke, S. Frings, and F.  Möhrlen.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10 .1124/pr.111.005009 Huang, F., H. Zhang, M. Wu, H. Yang, M. Kudo, C.J.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1016/j.neuron.2012 .01.033 Hwang, S.J., P.J.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
http://dx.doi.org/10.1113/ jphysiol.2009.176198,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1073/ pnas.0903304106 Stöhr, H., J.B. Heisig, P.M. Benz, S. Schöberl, V.M.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5546-08.2009 Suzuki, J., M. Umeda, P.J.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1038/nature09583 Suzuki, J., T. Fujii, T. Imao, K. Ishihara, H. Kuba, and S. Nagata.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"288:13305– 13316. http://dx.doi.org/10.1074/jbc.M113.457937 Tarran, R., M.E.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/ 10.1085/jgp.20028599 Terashima, H., A. Picollo, and A. Accardi.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1073/ pnas.1312014110 Tian, Y., P. Kongsuphol, M. Hug, J. Ousingsawat, R. Witzgall, R.  Schreiber, and K. Kunzelmann.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1096/ fj.10-166884 Vocke, K., K. Dauner, A. Hahn, A. Ulbrich, J. Broecker, S. Keller,  S. Frings, and F. Möhrlen.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1085/ jgp.201311015 Xiao, Q., K. Yu, P .",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1016/j.cell.2012.07.036 Yang, Y.D., H. Cho, J.Y.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/10.1038/nature07313 Yu, K., J. Zhu, Z. Qu, Y.Y.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
"http://dx.doi.org/ 10.1085/jgp.201311047 Zhang, X.D., P.Y.",OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
http://dx.doi.org/10.1085/jgp.200810004,OADS,/arxiv_data1/oa_pdf/b4/a2/JGP_201411179.PMC4076522.pdf
An analysis of records posted on the  website of the Association of Chairs of Departments of  Physiology (http://www.acdponline.org/Surveys.htm)  indicates that physiology’s lack of gender parity is typical  of that observed pan-NIH.,Non-OADS,/arxiv_data1/oa_pdf/e8/d6/JGP_201411240.PMC4076523.pdf
"In each year, the total num- ber of faculty (men plus women) exceeded 800.Getting nowhere fast: The lack of gender equity in the   physiology community Sharona E. Gordon Editor, The Journal of General Physiology © 2014 Gordon  This article is distributed under the terms of an Attribution–Noncommercial–  Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/e8/d6/JGP_201411240.PMC4076523.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/e8/d6/JGP_201411240.PMC4076523.pdf
"Women who apply for tenure-track faculty positions  in the natural sciences at Research Universities with  Very High Research Activity (formerly known as R1   Research Universities; Carnegie Classification of 2005  and 2010, http://classifications.carnegiefoundation.org/)   are hired at rates at least as high as men (Ceci and Williams, 2011; Kaminski and Geisler, 2012).",Non-OADS,/arxiv_data1/oa_pdf/e8/d6/JGP_201411240.PMC4076523.pdf
"335:864– 866. http://dx.doi.org/10.1126/science.1214844 Moss-Racusin, C.A., J.F.",OADS,/arxiv_data1/oa_pdf/e8/d6/JGP_201411240.PMC4076523.pdf
"2013. http://report.nih  .gov/nihdatabook/index.aspx (accessed June 17, 2014).",OADS,/arxiv_data1/oa_pdf/e8/d6/JGP_201411240.PMC4076523.pdf
"Women,   Minorities, and Persons with Disabilities in Science and Engineering:  2013. http://www.nsf.gov/statistics/wmpd/2013/start.cfm (ac- cessed June 17, 2014).",OADS,/arxiv_data1/oa_pdf/e8/d6/JGP_201411240.PMC4076523.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
The online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201311145/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1093/nar/gkt099 Huang, G.Y., J.J. Kim, A.S. Reger, R. Lorenz, E.W.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi .org/10.1016/j.str.2013.09.021 Jorgensen, W.L., J. Chandrasekhar, J.D.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi .org/10.1063/1.445869 Kabsch, W. 2010.",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"66:125– 132. http://dx.doi.org/10.1107/S0907444909047337 MacKerell, A.D., D. Bashford, M. Bellott, R.L.",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1063/1.467468 McCoy, A.J., R.W.",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1107/ S0021889807021206 Miyamoto, S., and P.A.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1002/jcc.540130805 Nimigean, C.M.",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1038/nprot.2006.166 Nimigean, C.M., and M.D.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1016/j.jmb.2007.06.030 Nimigean, C.M., T. Shane, and C. Miller.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1085/jgp.200409133 Peuker, S., A. Cukkemane, M. Held, F. Noé, U.B.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1016/j.bpj.2012 .11.3816 Phillips, J.C., R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid, E.  Villa, C. Chipot, R.D.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1002/jcc.20289 Pifferi, S., A. Menini, and T. Kurahashi.",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/ 10.1016/S0896-6273(00)80030-6R E F E R E N C E S Afonine, P .V., R.W.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1107/S0907444912001308 Altenhofen, W., J. Ludwig, E. Eismann, W. Kraus, W. Bönigk, and  U.B.",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi .org/10.1073/pnas.88.21.9868 Altieri, S.L., G.M.",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1016/j .jmb.2008.06.011 Baker, N.A., D. Sept, S. Joseph, M.J. Holst, and J.A.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1016/0092-8674(84)90278-2 Chiu, P.L., M.D.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/ 10.1016/j.str.2007.06.020 Clayton, G.M., W.R. Silverman, L. Heginbotham, and J.H.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi .org/10.1146/annurev.physiol.68.040104.134728 Cukkemane, A., B. Grüter, K. Novak, T. Gensch, W. Bönigk, T.  Gerharz, U.B.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1038/sj.embor.7401025 Cukkemane, A., R. Seifert, and U.B.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1016/j.tibs.2010.07.004 Emsley, P., B. Lohkamp, W.G.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1107/S0907444910007493 Essmann, U., L. Perera, M.L.",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1063/1.470117 Evans, P. 2006.",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1107/ S0907444905036693 Feller, S.E., Y.H.",Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
http://dx.doi .org/10.1016/j.str.2007.04.008,OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1038/nrm2082 Schreiber, G., and A.R.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1016/S0022-2836(95)80064-6 Schünke, S., M. Stoldt, K. Novak, U.B.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1038/embor.2009.68 Schünke, S., M. Stoldt, J. Lecher, U.B.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/ 10.1073/pnas.1015890108 Varnum, M.D., K.D.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1016/0896-6273(95)90150-7 Yifrach, O., N. Zandany, and T. Shem-Ad.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi.org/10.1016/S0076-6879 (09)66008-0 Zhang, X., and R.H. Cote.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
"http://dx.doi .org/10.1016/j.str.2007.04.012 Zhou, L., and S.A. Siegelbaum.",OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
http://dx.doi.org/10.1529/ biophysj.108.130872,Non-OADS,/arxiv_data1/oa_pdf/b6/f6/JGP_201311145.PMC4076524.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
Online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201311159/DC1.,Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi .org/10.1038/4931 Buchanan, S.K., P. Lukacik, S. Grizot, R. Ghirlando, M.M.",Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi .org/10.1038/sj.emboj.7601693 Cadieux, N., C. Bradbeer, and R.J. Kadner.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi .org/10.1046/j.1365­2958.2000.02093.x Cao, Z., P .",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1074/jbc.M210360200 Chimento, D.P., A.K.",Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/ 10.1038/nsb914 Cobessi, D., A. Meksem, and K. Brillet.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1002/prot.22539 Cox, G.B., F. Gibson, R.K. Luke, N.A.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"282:2215– 2220. http://dx.doi.org/10.1126/science.282.5397.2215 Ferguson, A.D., R. Chakraborty, B.S.",Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1126/science.1067313 Hashimoto­Gotoh, T., A. Kume, W. Masahashi, S. Takeshita, and  A. Fukuda.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1016/0378­1119(86)90275­1 Higgs, P.I., R.A. Larsen, and K. Postle.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"44:271– 281. http://dx.doi.org/10.1046/j.1365­2958.2002.02880.x James, K.J., M.A.",Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1110/ps.036244.108 Jiang, X., M.A.",Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"276:1261– 1264. http://dx.doi.org/10.1126/science.276.5316.1261 Jordan, L.D., Y. Zhou, C.R.",Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
http://dx.doi.org/ 10.1073/pnas.1304243110in the vestibule.,Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
186:3578– 3589. http://dx.doi.org/10.1128/JB.186.11.3578­3589.2004,Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.2741/1233 Klebba, P.E., M.A.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi .org/10.1038/nsb997 Liu, J., J.M.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"33:13274– 13283. http://dx.doi.org/10.1021/bi00249a014 Locher, K.P., B. Rees, R. Koebnik, A. Mitschler, L. Moulinier,  J.P. Rosenbusch, and D. Moras.",Non-OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1016/S0092 ­8674(00) 81700 ­6 Ma, L., W. Kaserer, R. Annamalai, D.C. Scott, B. Jin, X. Jiang,   Q. Xiao, H. Maymani, L.M.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1074/jbc .M605333200 Miller, J.H.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1074/jbc.270.45.26723 Newton, S.M., J.S.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi .org/10.1046/j.1365­2958.1999.01424.x Newton, S.M., V. Trinh, H. Pi, and P.E.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1074/jbc.M109.100206 Nikaido, H., and M. Vaara.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1126/science .1128057 Payne, M.A., J.D.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1074/ jbc.272.35.21950 Pollack, J.R., and J.B. Neilands.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1016/0006 ­ 291X(70)90819­3 Rutz, J.M., J. Liu, J.A.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1126/ science.1411544 Schauer, K., D.A.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi .org/10.1016/j.tibs.2008.04.012 Scott, D.C. 2000.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10 .1128/JB.184.17.4906­4911.2002 Shultis, D.D., M.D.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10.1126/ science.1127694 Smallwood, C.R., A.G. Marco, Q. Xiao, V. Trinh, S.M.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"72:1171– 1180. http://dx.doi.org/10.1111/j.1365­2958.2009.06715.x Smirnova, I., V. Kasho, J. Sugihara, and H.R.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"http://dx.doi.org/10 .1073/pnas.0911434106 Smit, J., Y. Kamio, and H. Nikaido.",OADS,/arxiv_data1/oa_pdf/69/49/JGP_201311159.PMC4076525.pdf
"@ERSpublications Multiple cohort studies do not support job strain being a major independent risk factor for severe COPD exacerbations http://ow.ly/tAyq2 Katriina Heikkila ¨1, Ida E.H. Madsen2, Solja T. Nyberg1, Eleonor I. Fransson3,4,5, Kirsi Ahola1, Lars Alfredsson3,6, Jakob B. Bjorner2, Marianne Borritz7, Hermann Burr8, Anders Knutsson9, Markku Koskenvuo10, Aki Koskinen1, Martin L. Nielsen7, Maria Nordin11, Krista Pahkin1, Jaana Pentti12, Reiner Rugulies2,13, Paula Salo12,14, Martin J. Shipley15, Sakari B. Suominen16,17,18,T o¨res Theorell5, Ari Va ¨a¨na¨nen1, Jussi Vahtera12,17, Marianna Virtanen1, Peter J.M.",Non-OADS,/arxiv_data1/oa_pdf/34/3e/erj-44-01-247.PMC4076526.pdf
@ERSpublications Airflow obstruction is prevalent in Chinese never-smokers and particularly associated with low socioeconomic status http://ow.ly/sG481 Received: Sept 02 2013 |Accepted after revision: Dec 31 2013 |First published online: March 06 2014 Conflict of interest: None declared.,Non-OADS,/arxiv_data1/oa_pdf/41/49/erj-44-01-066.PMC4076527.pdf
@ERSpublications Telomerase mutation carriers with IPF may be prone to complications from their underlying telomere syndrome after LTx http://ow.ly/wmy6P This article has supplementary material available from www.erj.ersjournals.com Received: Feb 05 2014 |Accepted after revision: April 25 2014 |First published online: May 15 2014 Support statement: This work was supported by funding from the United States National Institutes of Health P30 CA006973 and the Flight Attendants Medical Research Institute (FAMRI).,Non-OADS,/arxiv_data1/oa_pdf/c7/ca/erj-44-01-178.PMC4076528.pdf
@ERSpublications TBNET consensus statement on the management of patients with MDR/XDR-TB has been released in the Eur Respir J http://ow.ly/uizRD Received: Oct 30 2013 |Accepted after revision: March 03 2014 |First published online: March 23 2014 Copyright /C223ERS 2014.,Non-OADS,/arxiv_data1/oa_pdf/d2/0a/erj-44-01-023.PMC4076529.pdf
"http://apps.who.int/iris/handle/10665/44163?locale 5esDate last accessed: December 13, 2012.",Non-OADS,/arxiv_data1/oa_pdf/d2/0a/erj-44-01-023.PMC4076529.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1038/nrm73 2 Brugnera, E., L. Haney, C. Grimsley, M. Lu, S.F.",Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1016/S1074-5521(00)00025- 9 Cohen, P., and S. Frame.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1038/3509607 5 Côté, J.F., and K. Vuori.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/   10.1242/jcs.0021 9 Côté, J.F., and K. Vuori.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"406:41– 57. http://dx.doi.org/10.1016/S0076-6879(06)06004- 6 Dráber, P ., V .",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"3:130. http://dx.doi.org/10.3389/fimmu   .2012.0013 0 Duttlinger, R., K. Manova, T.Y.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1038/nature0114 8 Fukui, Y., O. Hashimoto, T. Sanui, T. Oono, H. Koga, M. Abe, A. Inayoshi,  M. Noda, M. Oike, T. Shirai, and T. Sasazuki.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1038/3509059 1 Gilfillan, A.M., and J. Rivera.",Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
http://dx.doi.org/   10.1111/j.1600-065X.2008.00742.,Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1084/jem.2009177 6 Grimbaldeston, M.A., C.C.",Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)62055- X Gu, H., K. Saito, L.D.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1038/3508407 6 Kambayashi, T., D.F.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
http://dx.doi.org/10   .1111/j.1600-065X.2009.00825.,Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1084/jem.2003065 2 Kim, Y.T., E.M. Hur, W.D.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1101/gad.12.21.333 1 Klein, P.S., and D.A.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
Online supplemental material is available at http://www.jem.org/   cgi/content/full/jem.20131926/DC1.,Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1093/intimm/dxg14 8 Rådinger, M., H.S.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.4049/jimmunol.090293 1 Rådinger, M., D. Smrž, D.D.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10   .4049/jimmunol.110125 7 Sampson, H.A., A. Muñoz-Furlong, S.A. Bock, C. Schmitt, R. Bass, B.A.",Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10   .1016/j.jaci.2005.01.00 9 Sanematsu, F., A. Nishikimi, M. Watanabe, T. Hongu, Y. Tanaka, Y.  Kanaho, J.F.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/   10.1074/jbc.M112.41042 3 Sanui, T., A. Inayoshi, M. Noda, E. Iwata, M. Oike, T. Sasazuki, and Y.  Fukui.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1016/S1074-7613(03)00169- 9 Schmidt, A., and A.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1034/j.1600- 0854.2003.00084. x Vives, V., M. Laurin, G. Cres, P. Larrousse, Z. Morichaud, D. Noel, J.F.",Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1002/jbmr.28 2 Wolters, P.J., J. Mallen-St Clair, C.C.",Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
http://dx.doi.org/10.1111/ j.1365-2222.2005.02136.,Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1016/j.cell   .2004.11.01 2 Zhou, F .Q., and W .D.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1126/   science.111030 1 Zhou, F .Q., J. Zhou, S. Dedhar, Y .H.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"42:897– 912. http://dx.doi.org/10.1016/j.neuron.2004.05.01 1Kraft, S., and J.P. Kinet.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/   10.1038/nri207 2 Kulkarni, K., J. Yang, Z. Zhang, and D. Barford.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"286:25341– 25351. http://dx.doi.org/10.1074/jbc.M111.23645 5 Kunisaki, Y ., A. Nishikimi, Y .",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1083/jcb.20060214 2 Laurin, M., N. Fradet, A. Blangy, A.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10   .1073/pnas.080554610 5 Li, W., J.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"20:6403– 6417. http://dx.doi.org/10.1038/sj.onc.120478 2 Lundequist, A., and G. Pejler.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/   10.1007/s00018-010-0587- 0 Lyon, M.F., and P.H.",Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1017/S001667230002098 X Martin-Verdeaux, S., I. Pombo, B. Iannascoli, M. Roa, N. Varin-Blank,  J. Rivera, and U. Blank.",Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1242/jcs.0021 6 Meller, N., M. Irani-Tehrani, W.B.",Non-OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/   10.1038/ncb83 5 Mimori-Kiyosue, Y., N. Shiina, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1083/jcb.20050111 1 Nishida, K., S. Yamasaki, A. Hasegawa, A. Iwamatsu, H. Koseki, and T.  Hirano.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"187:932– 941. http://dx.doi.org/10.4049/jimmunol.110036 0 Nishikimi, A., T. Uruno, X. Duan, Q. Cao, Y .",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
"http://dx.doi.org/10.1016/j.chembiol.2012.03.00 8 Parravicini, V., M. Gadina, M. Kovarova, S. Odom, C. Gonzalez-Espinosa,  Y. Furumoto, S. Saitoh, L.E.",OADS,/arxiv_data1/oa_pdf/07/31/JEM_20131926.PMC4076576.pdf
© 2014 Finsterbusch  This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).Abbreviations used: SMA,   -smooth muscle actin; BM,  basement membrane; EC,  endothelial cells; HBP, heparin- binding protein; LTB4, leukotriene  B4; PECAM, platelet endothelial  cell adhesion molecule; ROI,  region of interest; TEM,  transendothelial cell migration;  VEGF, vascular endothelial cell  growth factor.The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
http://dx.doi.org/10.1007/BF0091624 3as mean per mouse.,OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1084/jem.2006092 5 Proebstl, D., M.B.",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1084/jem.2011162 2 Schulte, D., V .",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi   .org/10.1038/emboj.2011.30 4 Smedman, C., B. Gårdlund, K. Nihlmark, P. Gille ­Johnson, J. Andersson, and  S.Paulie.",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1016/j.jim.2009.04.00 1 T okita, K., and T .",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1038/labinvest.370013 3 Voisin, M.B., A. Woodfin, and S. Nourshargh.",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"29:1193– 1199. http://dx.doi.org/10.1161/ATVBAHA.109.18745 0 V oisin, M.B., D. Pröbstl, and S. Nourshargh.",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.2353/ajpath.2010.09051 0 Wang, S., M.B.",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1084/jem.2005121 0 Wedmore, C.V ., and T.J. Williams.",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1038/289646a 0 Williams, T.J., and P .J.",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1084/   jem.153.1.13 6 Williamson, L.M., K. Sheppard, J.M.",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
http://dx.doi.org/   10.1111/j.1365­2141.1986.tb04131.,Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1182/blood ­  2008­11­18837 5 Woodfin, A., M.B.",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/   10.1038/ni.206 2 Yancey, K.B., L. Bielory, R. Wright, N. Y oung, M.M.",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1016/   S1537­1891(03)00010­ 7Brett, J., H. Gerlach, P .",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1084/jem.169.6.197 7 Cain, R.J., B. Vanhaesebroeck, and A.J.",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1083/jcb.20090713 5 Colom, B., Y .",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi   .org/10.1096/fj.11­19622 0 Di Gennaro, A., E. Kenne, M. Wan, O. Soehnlein, L. Lindbom, and J.Z.",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"30:547– 556. http://dx.doi.org/10.1016/j.it.2009.07.01 2 Faust, N., F. Varas, L.M.",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1084/   jem.191.11.182 9 Gautam, N., A.M. Olofsson, H. Herwald, L.F .",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10   .1038/nm1001­112 3 Halai, K., J. Whiteford, B. Ma, S. Nourshargh, and A. W oodfin.",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1242/jcs.13746 3 Huber, A.R., and S.J.",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10   .1172/JCI11399 2 Hurley, J.V .",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1038/nri215 6 Majno, G., and G.E.",OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10.1083/   jcb.11.3.57 1 Naikawadi, R.P ., N. Cheng, S.M.",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
"http://dx.doi.org/10   .1161/CIRCRESAHA.112.27307 8 Needham, L., P .G.",Non-OADS,/arxiv_data1/oa_pdf/50/7c/JEM_20132413.PMC4076577.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"Therapeutic studies on indolent FLs  are limited by lack of tractable models; notably, all FL cell lines CDK4/6 and is currently in clinical trials against several cancers,  including mantle cell lymphoma, but patients with indolent FL  have been specifically excluded (e.g., http://clinicaltrials.gov/   show/NCT01111188; Fry et al., 2004; Flaherty et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"T o identify significantly amplified and deleted re - gions, we used the GISTIC algorithm (Beroukhim et al., 2010) through the  GenePattern web service (http://genepattern.broadinstitute.org).",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1182/blood-2002-07-229 8 Hsi, E.D., I. Mirza, G. Lozanski, J. Hill, B. Pohlman, M.T.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1073/   pnas.080429510 5 Llanos, M., H. Alvarez-Argüelles, R. Alemán, J. Oramas, L. Diaz-Flores, and  N. Batista.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10   .1385/MO:18:1:1 5 Martin, A.R., D.D.",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1016/0092-8674(92)90360- O Mermel, C.H., S.E.",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1186/gb-2011-12-4-r4 1 Michaud, K., D.A.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1038/nature1035 1 Musgrove, E.A., C.E.",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1038/nrc309 0 Naderi, S., K.B.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/   10.1038/ng.285 6 Olshen, A.B., E.S.",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1093/biostatistics/   kxh00 8Author contributions: E. Oricchio, G. Ciriello, and J.H.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1038/   nature1163 2 Beroukhim, R., C.H.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1038/nature0882 2 Bödör, C., V .",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1182/blood-2013-04-49689 3 Bouska, A., T.W .",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1182/blood-2013-05-50059 5 Ciriello, G., E. Cerami, C. Sander, and N. Schultz.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1101/gr.125567.11 1 Egle, A., A.W .",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1182/blood-   2003-07-246 9 Elenitoba-Johnson, K.S., R.D.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1038/nchembio81 7 Flaherty, K.T., P .M.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/   10.1158/1078-0432.CCR-11-050 9 Fry, D.W ., P .J.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1038/nrc129 9 Green, M.R., A.J.",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1182/   blood-2012-09-45728 3 Grønbaek, K., P .",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1038/   nature0357 9 Oricchio, E., G. Nanjangud, A.L.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1016/j.cell.2011.09.03 5 Pasqualucci, L., V .",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1038/ni124 5 Pinyol, M., F .",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1200/JCO.2009.26.169 3Rozen, S., and H.J.",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/   10.1126/science.274.5293.167 2 Solal-Céligny, P., P. Roy, P. Colombat, J.",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"104:1258– 1265. http://dx.doi.org/10.1182/blood-2003-12-443 4 Staudt, L.M.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1056/NEJMcibr06715 5 Vairo, G., K.M.",OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
"http://dx.doi.org/10.1128/MCB.20.13.4745-   4753.200 0 Wendel, H.G., E. De Stanchina, J.S.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
http://dx.doi.org/10.1038/nature0236 9,Non-OADS,/arxiv_data1/oa_pdf/27/e4/JEM_20132120.PMC4076578.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after   the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/   10.1084/jem.187.7.100 9 Guo, X., J. Qiu, T. Tu, X. Yang, L. Deng, R.A. Anders, L. Zhou, and  Y.X.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1016/   j.immuni.2013.10.02 1 Iizuka, K., D.D.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/   10.1038/ni79 6 Kondo, M., I.L.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80453- 5 Lian, R.H., and V. Kumar.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1016/S104453230200080 5 Lian, R.H., R.K. Chin, H.E.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi   .org/10.1002/eji.20042539 4 Mebius, R.E., T. Miyamoto, J. Christensen, J. Domen, T. Cupedo, I.L.",Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"166:6593– 6601. http://dx.doi.org/10.4049/jimmunol.166.11.659 3 Mjösberg, J., J. Bernink, C. Peters, and H. Spits.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1038/sj.cdd.440037 4 Pandiyan, P., X.P.",Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.4049/jimmunol.120147 6 Ramirez, K., and B.L.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/   10.1016/j.coi.2010.02.00 2 Rosmaraki, E.E., I. Douagi, C. Roth, F .",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1002/   1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2- M Sawa, S., M. Cherrier, M. Lochner, N. Satoh-Takayama, H.J.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi   .org/10.1126/science.119459 7 Smyth, M.J., J.M.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
30:647– 675. http://dx.doi.org/10.1146/annurev-immunol-020711-07505 3DNase I (Sigma-Aldrich) and 0.1 mg/ml Liberase (Roche) at 37°C for 20 min.,Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1084/jem.2011138 6 Biron, C.A., K.B.",Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/   10.1146/annurev.immunol.17.1.18 9 Cerwenka, A., J.L.",Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1016/j.coi.2012.02.00 3 Chiang, E.Y., G.A.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1038/nm.198 4 Chiossone, L., J. Chaix, N. Fuseri, C. Roth, E. Vivier, and T. Walzer.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1182/blood-2008-10-18717 9 Di Santo, J.P. 2006.",Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.24.021605.09070 0 Dong, Z., M.E.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1038/ni.176 3 Eberl, G., and D.R.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1016/j.coi.2005.01.00 6 Fu, Y.X., and D.D.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
http://dx.doi   .org/10.1146/annurev.immunol.17.1.39 9,Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
http://dx.doi.org/10.1034/j.1600-   065X.2003.00071.,Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1016/   j.chom.2011.06.00 2 Upadhyay, V., and Y.X.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1038/nri340 6 van den Broek, M.F ., D. Kägi, R.M.",Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1002/eji   .183025124 6 Vivier, E., S. Ugolini, D. Blaise, C. Chabannon, and L. Brossay .",Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1038/nri317 4Vosshenrich, C.A., and J.P. Di Santo.",Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1016/j.coi.2013.02.00 2 Vosshenrich, C.A., S.I.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.1016/j.coi.2005.01.00 5 Wang, Y., E.P.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/   10.1016/j.immuni.2010.02.01 1 Ware, C.F., T.L.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
"http://dx.doi.org/10.4049/jimmunol   .166.3.168 4 Y oshida, H., H. Kawamoto, S.M.",OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
http://dx.doi.org/10.4049/jimmunol   .167.5.251 1,Non-OADS,/arxiv_data1/oa_pdf/50/16/JEM_20131501.PMC4076579.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
4 c. Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20132486/DC1.,Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/ni.163 1 Ikeda, F ., Y .L.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/nature0981 4 Inn, K.-S., M.U.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"41:354– 365. http://dx.doi.org/10.1016/j.molcel.2010.12.02 9 Iwai, K., and F .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10   .1038/embor.2009.14 4 Iyer, S.S., Q.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/j.immuni.2013.08.00 1 Joosten, L.A.B., F .L.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
http://dx.doi.org/10.1111/j.1600-0463.2010.02684.,Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi   .org/10.1074/jbc.M112.40713 0 Kayagaki, N., M.T.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10   .1126/science.124024 8 Keusekotten, K., P .R.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/   10.1016/j.cell.2013.05.01 4 Kirisako, T., K. Kamei, S. Murata, M. Kato, H. Fukumoto, M. Kanie, S. Sano,  F .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/embor.2009.5 5 Kovarova, M., P .R.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.4049/   jimmunol.120106 5 Lee, S.H., Z. T oth, L.Y .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1128/mBio.00411-1 2 Liang, Y .",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1371/ journal.pone.002169 6 Liang, Y ., R.E.",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/jid.2010.25 9 Lopez-Castejon, G., N.M. Luheshi, V .",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1074/jbc.M112.42223 8 Mariathasan, S., K. Newton, D.M.",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"13:1178– 1186. http://dx.doi.org/10.1038/ni.245 7 Broz, P ., J. von Moltke, J.W .",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/j.chom.2010.11.00 7 Bruey, J.M., N. Bruey-Sedano, F .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/j.cell.2007.01.04 5 Bryan, N.B., A. Dorfleutner, Y .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.4049/jimmunol.080236 7 Damgaard, R.B., U. Nachbur, M. Yabal, W .W .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/   j.molcel.2012.04.01 4 Damgaard, R.B., B.K.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1002/   emmm.20130309 0 Dostert, C., V .",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10   .1126/science.115699 5 Emmerich, C.H., A. Ordureau, S. Strickson, J.S.",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/nature0771 0 Franchi, L., R. Muñoz-Planillo, and G. Núñez.",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/ni.223 1 Gerlach, B., S.M.",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/nature0981 6 Haas, T .L., C.H.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.10.01 3 Hara, H., K. Tsuchiya, I. Kawamura, R. Fang, E. Hernandez-Cuellar, Y .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
http://dx.doi.org/10.1038/ni.274 9,Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"430:213– 218. http://dx.doi.org/10.1038/nature0266 4 Mariathasan, S., D.S.",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/nature0451 5 Marim, F .M., T.N.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/   10.1371/journal.pone.001526 3 Martinon, F ., K. Burns, and J. Tschopp.",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10   .1016/S1097-2765(02)00599- 3 Matsumoto, M.L., K.C.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/   j.jmb.2011.12.05 3 McNamara, M.J., J.A.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/ni.198 0 Nakamura, M., F .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/j.bbrc   .2006.09.16 3 Pan, Q., J. Mathison, C. Fearns, V .V .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1189/jlb   .100662 7 Proell, M., M. Gerlic, P .D.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1042/BJ2012119 8 Py, B.F ., M.S.",Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/j.molcel.2012   .11.00 9 Rahighi, S., F .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/j.cell.2009.03.00 7 Rathinam, V .A.K., Z. Jiang, S.N.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/ni.186 4 Rivkin, E., S.M.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/nature1229 6 Sato, Y ., H. Fujita, A. Y oshikawa, M. Yamashita, A. Yamagata, S.E.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/j.cell.2010.01.04 0Seok, J., H.S.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/   10.1126/science.121714 1 Shi, C.S., K. Shenderov, N.N.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/   10.1038/ni.221 5 Shimada, K., T.R.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1016/j.immuni   .2012.01.00 9 Stieglitz, B., A.C. Morris-Davies, M.G.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10   .1038/embor.2012.10 5 Tatematsu, K., C. T okunaga, N. Nakagawa, K. Tanizawa, S. Kuroda, and U.  Kikkawa.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1006/bbrc.1998.879 5 T okunaga, F ., and K. Iwai.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10   .1006/bbrc.1998.827 0 T okunaga, F ., S.-i.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/ncb182 1 T okunaga, F ., T. Nakagawa, M. Nakahara, Y .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/nature0981 5 T okunaga, F ., H. Nishimasu, R. Ishitani, E. Goto, T. Noguchi, K. Mio, K.  Kamei, A. Ma, K. Iwai, and O. Nureki.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/emboj.2012.24 1 Verhelst, K., I. Carpentier, M. Kreike, L. Meloni, L. Verstrepen, T. Kensche,  I. Dikic, and R. Beyaert.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/emboj.2012.24 0 W ertz, I.E., K.M.",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
"http://dx.doi.org/10.1038/nature0279 4 Zak, D.E., F .",OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
http://dx.doi.org/10   .1038/nature1051 0,Non-OADS,/arxiv_data1/oa_pdf/0d/6d/JEM_20132486.PMC4076580.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1038/ni.187 7 Green, J.A., and J.G.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
http://dx.doi.org/10   .1111/j.1600-065X.2012.01114.,Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1038/ni.204 7 Harada, Y., S. Tanaka, Y. Motomura, Y. Harada, S. Ohno, S. Ohno, Y.  Yanagi, H. Inoue, and M. Kubo.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1016/j.immuni   .2012.02.00 2 Haynes, N.M., C.D.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.4049/jimmunol.179.8.509 9 Junt, T., K. Fink, R. Förster, B. Senn, M. Lipp, M. Muramatsu, R.M.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.4049/jimmunol.175   .11.710 9 Kitano, M., S. Moriyama, Y .",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"34:961– 972. http://dx.doi.org/10.1016/j.immuni.2011.03.02 5 Linterman, M.A., R.J. Rigby, R.K. Wong, D. Yu, R. Brink, J.L.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1084/jem   .2008188 6 Linterman, M.A., A. Liston, and C.G.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
http://dx.doi.org/10.1111/j.1600- 065X.2012.01121.,Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1084/jem.2004150 9 Lüthje, K., A. Kallies, Y. Shimohakamada, G.T.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1038/ni.226 1 MacLennan, A.J., P.R.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
http://dx.doi   .org/10.1046/j.0953-816x.2001.01634.,Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1038/nature0228 4 McHeyzer-Williams, M., S. Okitsu, N. Wang, and L. McHeyzer-Williams.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10   .1016/j.immuni.2011.12.01 2 Mombaerts, P., A.R.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
http://dx.doi.org/   10.1038/360225a 0sera and anti-NP monoclonal antibody standard (C6) were applied to the  plates for 2 h at room temperature.,Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
Online supplemental materials are available  at http://www.jem.org/cgi/content/full/jem.20131666/DC1.,Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1126/science.113673 6 Ansel, K.M., L.J.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1084/jem.190   .8.112 3 Arnold, C.N., D.J.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1002/eji   .20063648 6 Cattoretti, G., J. Mandelbaum, N. Lee, A.H. Chaves, A.M. Mahler, A.  Chadburn, R. Dalla-Favera, L. Pasqualucci, and A.J.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"69:8686– 8692. http://dx.doi.org/10.1158/0008-5472.CAN-09-111 0 Du, W ., N. Takuwa, K. Y oshioka, Y .",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-09-272 2 Good-Jacobson, K.L., C.G.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1038/nature0734 5 Ramiscal, R.R., and C.G.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1111/imr.1203 1 Reinhardt, R.L., H.E.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"10:385– 393. http://dx.doi.org/10.1038/ni.171 5 Shulman, Z., A.D. Gitlin, S. Targ, M. Jankovic, G. Pasqual, M.C.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
"http://dx.doi.org/10.1126/science.124168 0Skoura, A., and T. Hla.",OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
http://dx.doi.org/10.1111/ j.1600-065X.2010.00937.,Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
http://dx.doi.org/10.1084/jem.2011144 9,Non-OADS,/arxiv_data1/oa_pdf/47/fa/JEM_20131666.PMC4076581.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi   .org/10.1016/S0968-0004(01)01995- 8 Bossen, C., K. Ingold, A. Tardivel, J.L.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1074/jbc   .M60155320 0 Bulliard, Y ., R. Jolicoeur, M. Windman, S.M.",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi   .org/10.1084/jem.2013057 3 Chan, F .K.",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi   .org/10.1126/science.288.5475.235 1 Chattopadhyay, K., U.A.",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
http://dx.doi.org/10   .1111/j.1600-065X.2009.00778.,Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1016/j.cyto.2006.04.00 8 Chou, F .C., S.J.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1093/glycob/cwq14 4 Foell, J., S. Strahotin, S.P .",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1074/jbc.M109.03750 7 Golden-Mason, L., R.H. McMahan, M. Strong, R. Reisdorph, S. Mahaffey,  B.E.",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1128/JVI.01085-1 2 Grigorian, A., S. T orossian, and M. Demetriou.",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
http://dx.doi.org/10.1111/j.1600-065X.2009.00796.,Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20132687/DC1.,Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/   10.1016/j.clim.2009.09.00 4 Ascierto, P .A., E. Simeone, M. Sznol, Y .X.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
http://dx.doi.org/10.1053/j.seminoncol.2010.09.00 8,Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1074/jbc.M50688120 0 Salek-Ardakani, S., and M. Croft.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1089/jir.2010.002 6 Sato, M., N. Nishi, H. Shoji, M. Seki, T. Hashidate, J. Hirabayashi, K. Kasai  Ki, Y .",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"12:191– 197. http://dx.doi.org/10.1093/glycob/12.3.19 1 Schabowsky, R.H., K.G.",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1016/j.vaccine.2009.09.12 7 Seki, M., K.M.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1002/art.2307 6 Seki, M., S. Oomizu, K.M.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1016/j.clim.2008.01.00 6 Seo, S.K., J.H.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1038/nm110 7 Shuford, W .W ., K. Klussman, D.D.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1084/jem.186.1.4 7 Siegel, R.M., J.K. Frederiksen, D.A.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1126/science.288.5475.235 4 Snell, L.M., G.H.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
http://dx.doi.org/10   .1111/j.1600-065X.2011.01063.,Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"19:253– 262. http://dx.doi.org/10.1016/j.cytogfr.2008.04.00 3 Su, E.W ., S. Bi, and L.P .",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi   .org/10.1093/glycob/cwq21 4 Sun, Y ., X. Lin, H.M. Chen, Q. Wu, S.K.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.4049/jimmunol.168.3.145 7 Türeci, O., H. Schmitt, N. Fadle, M. Pfreundschuh, and U. Sahin.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1371/journal.pone.003870 8 Vinay, D.S., and B.S.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
http://dx.doi.org/10.1158/1535-7163.,Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.23.021704.11583 9 Wiersma, V .R., M. de Bruyn, W .",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1002/med.2024 9Hirabayashi, J., T. Hashidate, Y .",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1016/S0304-   4165(02)00311- 2 Katoh, S., N. Ishii, A. Nobumoto, K. Takeshita, S.Y .",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"187:1120– 1128. http://dx.doi.org/10.4049/jimmunol.100268 1 Kwon, B.S., and S.M.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1073/   pnas.86.6.196 3 Kwon, B.S., C.A.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1007/   978-0-387-89520-8_ 8 Lee, S.W ., Y .",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.4049/jimmunol.120124 8 Loo, D.T., N.J. Chalupny, J. Bajorath, W .W .",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1074/   jbc.273.27.1697 6 Nagae, M., N. Nishi, T. Murata, T. Usui, T. Nakamura, S. Wakatsuki, and R.  Kato.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1016/S0968-   0004(97)01164- X Nonaka, Y ., T. Ogawa, S. Oomizu, S. Nakakita, N. Nishi, S. Kamitori, M.  Hirashima, and T. Nakamura.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1093/jb/mvt00 9 Ohtsubo, K., S. Takamatsu, M.T.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1016/j.cell.2005.09.04 1 Oomizu, S., T. Arikawa, T. Niki, T. Kadowaki, M. Ueno, N. Nishi, A. Yamauchi,  and M. Hirashima.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1016/j.clim.2012.01.00 4 Pace, K.E., C. Lee, P .L.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1172/JCI2379 2 Rabinovich, G.A., and M.A.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1038/nri253 6 Rabinovich, G.A., M.A.",Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
http://dx.doi.org/10.1016/j.sbi.2007.09.00 2,OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10.1016/j.ccr.2010.11.01 2 Won, E.Y ., K. Cha, J.S.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi   .org/10.1074/jbc.M109.08444 2Zhou, Z., X.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
"http://dx.doi.org/10   .1073/pnas.071135010 5 Zhu, C., A.C. Anderson, A. Schubart, H. Xiong, J. Imitola, S.J.",OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
6:1245– 1252. http://dx.doi.org/10.1038/ni127 1,Non-OADS,/arxiv_data1/oa_pdf/13/34/JEM_20132687.PMC4076583.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after   the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1016/j.stem.2007.10.00 3 Chambers, S.M., C.A.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1161/CIRCULATIONAHA.111.06403 0 Christensen, J.L., and I.L.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1073/pnas.26156279 8 Colonna, M., J. Samaridis, and L. Angman.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1002/immu.20031000 5 Dzierzak, E., and N.A.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1038/ni156 0 Essers, M.A., S. Offner, W.E.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1038/nature0781 5 Forsberg, E.C., S.S. Prohaska, S. Katzman, G.C.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/   10.1371/journal.pgen.001002 8 Foudi, A., K. Hochedlinger, D. Van Buren, J.W.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1038/nbt.151 7 Gazit, R., R. Gruda, M. Elboim, T.I.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1038/ni132 2 Gazit, R., B.S.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1016/j.stemcr.2013.07.00 4 Goodell, M.A., K. Brose, G. Paradis, A.S. Conner, and R.C.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1016/j.stem.2008.06.00 2 Hildebrandt, M., A. Adjei, R. Weinshilboum, J.A.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1097/FPC.0b013e32832e042 e Hosen, N., T. Yamane, M. Muijtjens, K. Pham, M.F.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
Online supplemental materials  are available at http://www.jem.org/cgi/content/full/jem.20130428/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1182/blood-2005-06-224 9 Baldridge, M.T., K.Y .",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/   10.1038/nature0913 5 Barker, N., J.H.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1038/nature0619 6 Becker, A.J., E.A.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1038/   197452a 0 Beerman, I., D. Bhattacharya, S. Zandi, M. Sigvardsson, I.L.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1084/jem.2005171 4 Bryder, D., D.J.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.2353/ajpath.2006.06031 2 Chambers, S.M., N.C. Boles, K.Y.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1634/stemcells.2008-082 4 Osawa, M., K. Hanada, H. Hamada, and H. Nakauchi.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1126/science.273.5272.24 2 Park, I.K., Y.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"99:488– 498. http://dx.doi.org/10.1182/blood.V99.2.48 8 Park, I.K., D. Qian, M. Kiel, M.W.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1038/nature0158 7 Pászty, C., N. Mohandas, M.E.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1038/ng0995-3 3 Pineault, N., C.D.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1016/S0301-472X(01)00757- 3 Raftogianis, R.B., T.C.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1006/bbrc.1997.746 6 Rossi, D.J., D. Bryder, J.M.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1371/journal   .pone.004032 1 Shojaei, F., J. Trowbridge, L. Gallacher, L. Yuefei, D. Goodale, F. Karanu, K.  Levac, and M. Bhatia.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1016/j.devcel.2005.03.00 4 Siminovitch, L., E.A.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"62:327– 336. http://dx.doi.org/10.1002/jcp.103062031 3 Sobanov, Y., A. Bernreiter, S. Derdak, D. Mechtcheriakova, B. Schweighofer,  M. Düchler, F. Kalthoff, and E. Hofer.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1002/1521- 4141(200112)31:12<3493::AID-IMMU3493>3.0.CO;2- 9 Spangrude, G.J., S. Heimfeld, and I.L.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1126/science.289881 0 Suzuki, N., O. Ohneda, N. Minegishi, M. Nishikawa, T. Ohta, S. Takahashi,  J.D.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1073/   pnas.050892810 3 Tadjali, M., S. Zhou, J. Rehg, and B.P.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1634/   stemcells.2005-056 2 Taoudi, S., C. Gonneau, K. Moore, J.M.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
http://dx.doi.org/10   .1016/j.stem.2008.06.00 4reveal the dynamic regulation of bmi-1 expression in normal and leuke - mic hematopoietic cells.,OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1634/stemcells.2006-022 9 Ivanova, N.B., J.T.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1126/science.107382 3 Kataoka, K., T. Sato, A. Yoshimi, S. Goyama, T. Tsuruta, H. Kobayashi, M.  Shimabe, S. Arai, M. Nakagawa, Y. Imai, et al.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1084/jem.2011044 7 Kiel, M.J., O.H.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1016/j.cell.2005.05.02 6 Kiel, M.J., O.H.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1016/j.cell.2005.05.02 6 Kubota, Y., M. Osawa, L.M.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1182/blood-2009-07-23029 2 Kühn, R., F. Schwenk, M. Aguet, and K. Rajewsky.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1126/science.766012 5 Kurogane, Y., M. Miyata, Y. Kubo, Y. Nagamatsu, R.K. Kundu, A. Uemura,  T. Ishida, T. Quertermous, K.I.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"32:988– 996. http://dx.doi.org/10.1161/ATVBAHA.111.24400 4 Laugwitz, K.L., A. Moretti, J. Lam, P. Gruber, Y. Chen, S. Woodard, L.Z.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"433:647– 653. http://dx.doi.org/10.1038/nature0321 5 Luckey, C.J., D. Bhattacharya, A.W.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1073/pnas.051113710 3 Matsumoto, A., S. Takeishi, T. Kanie, E. Susaki, I. Onoyama, Y. Tateishi,  K. Nakayama, and K.I.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1016/j.stem.2011.06.01 4 Medvinsky, A., and E. Dzierzak.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)80165- 8 Montgomery, R.K., D.L.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1073/   pnas.101300410 8 Morita, Y., H. Ema, S. Yamazaki, and H. Nakauchi.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1182/blood-2006-03-01020 7 Morita, Y., H. Ema, and H. Nakauchi.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1084/jem.2009131 8 Muller-Sieburg, C.E., C.A.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1016/0092-8674(86)90274- 6 Nombela-Arrieta, C., G. Pivarnik, B. Winkel, K.J.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
http://dx.doi.org/10.1038/ncb273 0,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .4049/jimmunol.080376 7 Till, J.E., and E.A.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"14:213– 222. http://dx.doi.org/10.2307/357089 2 Tumbar, T., G. Guasch, V. Greco, C. Blanpain, W.E.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1126/science.109243 6 Wakabayashi, Y., H. Watanabe, J. Inoue, N. Takeda, J. Sakata, Y. Mishima,  J. Hitomi, T. Yamamoto, M. Utsuyama, O. Niwa, et al.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1038/ni92 7 Weissman, I.L.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10   .1016/S0092-8674(00)81692- X Weksberg, D.C., S.M.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1182/blood-2007-09-11500 6 Wilborn, T.W., K.A.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/   10.1016/j.cell.2008.10.04 8 Wolf, N.S., A. Koné, G.V.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1182/blood-2008-07-16710 6 Zhou, B., Q. Ma, S. Rajagopal, S.M.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
"http://dx.doi.org/10.1038/   nature0706 0 Zou, P., H. Yoshihara, K. Hosokawa, I. Tai, K. Shinmyozu, F. Tsukahara,  Y. Maru, K. Nakayama, K.I.",OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
http://dx.doi.org/10.1016/j.stem.2011.07.00 3,OADS,/arxiv_data1/oa_pdf/a5/0e/JEM_20130428.PMC4076584.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
Online supplemental material is available  at http://www.jem.org/cgi/content/full/jem.20140410/DC1.,Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1182/blood-2009-07-23535 8 Dorsam, R.T., and J.S.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1038/nrc206 9 Doulatov, S., F. Notta, E. Laurenti, and J.E.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/   10.1016/j.stem.2012.01.00 6 Endo, T., K. Kano, R. Motoki, K. Hama, S. Okudaira, M. Ishida,  H. Ogiso, M. Tanaka, N. Matsuki, R. Taguchi, et al.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi   .org/10.1038/sj.emboj.760124 4 Gilleron, M., S. Stenger, Z. Mazorra, F. Wittke, S. Mariotti, G. Böhmer,  J. Prandi, L. Mori, G. Puzo, and G. De Libero.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1084/jem.2003109 7 Gumperz, J.E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y.  Koezuka, S.A. Porcelli, S. Cardell, M.B.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80174- 0 Han, X., and R.W.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1021/   ja952326 r Hsu, F.F., and J. Turk.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/j.cell.2008.08.02 1 Jäger, D., E. Jäger, and A. Knuth.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1136/jcp.54.9.66 9 Jedema, I., N.M. van der Werff, R.M.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi   .org/10.1182/blood-2003-06-207 0 Kinjo, Y., D. Wu, G. Kim, G.W.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"434:520– 525. http://dx.doi.org/10.1038/nature0340 7 Kolb, H.J.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1182/blood-   2008-03-07797 4 Manolova, V., Y. Hirabayashi, L. Mori, and G. De Libero.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10   .1002/immu.20039000 4 Matsushita, H., M.D.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10   .1038/nature1075 5 Mattner, J., K.L.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1038/nature0340 8REFERENCES Amprey, J.L., J.S.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1084 /  jem.2004070 4 Berzofsky, J.A., and M. Terabe.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.2174/   15665240978897070 6 Bondanza, A., V. Valtolina, Z. Magnani, M. Ponzoni, K. Fleischhauer, M.   Bonyhadi, C. Traversari, F. Sanvito, S. Toma, M. Radrizzani, et al.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi   .org/10.1182/blood-2005-09-371 6 Boon, T., P.G.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"24:175– 208. http://dx.doi.org/10.1146/annurev.immunol.24.021605.09073 3 Brigl, M., and M.B.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.22.012703.10460 8 Canderan, G., P .",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"6:10.1371/annotation/df559170-4836-4bc7-a16d- 44c7c6339cda) http://dx.doi.org/10.1371/journal.pone.001201 4 Cerundolo, V., J.D.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1038/nri245 1 Cha, M.K., K.H.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"28:93. http://dx.doi.org/10.1186/1756-9966-28-9 3 Chang, D.H., H. Deng, P. Matthews, J. Krasovsky, G. Ragupathi, R. Spisek,  A. Mazumder, D.H. Vesole, S. Jagannath, and M.V.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/   10.1182/blood-2008-04-14983 1 Ciceri, F., C. Bonini, M.T.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/S1470-2045(09)70074- 9 de Jong, A., V. Peña-Cruz, T.Y.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1038/ni.195 6 de Lalla, C., M. Lepore, F.M.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1002/eji.20104121 1 De Libero, G., A.P.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/j   .immuni.2005.04.01 3 Dellabona, P., G. Casorati, B. Friedli, L. Angman, F. Sallusto, A. Tunnacliffe,  E. Roosneek, and A. Lanzavecchia.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1084/jem.177.6.176 3 Dhodapkar, M.V., and J. Richter.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/j.clim.2010.12.01 0 Döhner, H., E.H. Estey, S. Amadori, F.R.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1002/(SICI)1521-4141(199905)   29:05<1667::AID-IMMU1667>3.0.CO;2- U Shamshiev, A., A. Donda, T.I.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)00025- X Shamshiev, A., H.J.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1084/jem.2001196 3 Socié, G., and B.R.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10   .1182/blood-2009-06-20466 9 Speiser, D.E., and P .",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/j.smim.2010.03.00 4 Sriram, V ., W .",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1002/   eji.20052615 7 Vago, L., S.K.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1056/NEJMoa081103 6 van Meeteren, L.A., and W .H.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1126/science.116080 9 Vidriales, M.B., J.J. Pérez, M.C.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi   .org/10.1182/blood-2002-08-261 3 Vincent, M.S., D.S.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1038/ni85 1 Vincent, M.S., X. Xiong, E.P .",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.4049/   jimmunol.175.10.634 4 Wanders, R.J., S. Ferdinandusse, P .",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/j.bbalip.2010.01.00 1 Wingard, J.R., N.S.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi   .org/10.1200/JCO.2010.33.721 2 Wu, D.Y ., N.H. Segal, S. Sidobre, M. Kronenberg, and P .B.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1084/jem.2003044 6 Wu, D., G.W .",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/   10.1073/pnas.040869610 2 Zhao, Z., and Y .",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1194/jlr.D00150 3Metelitsa, L.S.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/j.clim.2010.10.00 5 Mills, G.B., and W .H.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1038/   nrc114 3 Montagna, D., R. Maccario, F .",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1182/blood-2006-05-02153 5 Montamat-Sicotte, D.J., K.A.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/   10.1172/JCI4621 6 Moody, D.B., T. Ulrichs, W .",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi   .org/10.1038/3500911 9 Moody, D.B., D.C. Y oung, T.Y .",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/   10.1016/j.cell.2009.11.02 7 Nowbakht, P ., M.C.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1182/blood-2004-07-258 5 Porcelli, S.A., and R.L.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1146/annurev .immunol.17.1.29 7 Provasi, E., P .",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1038/nm.270 0 Pui, C.H., M.V .",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/   10.1056/NEJMra02300 1 Pui, C.H., W .L.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1200/JCO.2010.30.740 5 Pulfer, M., and R.C.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1002/   mas.1006 1 Rubnitz, J.E., B. Gibson, and F .O.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/j.pcl   .2007.11.00 3 Schrader, M., and H.D.",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"http://dx.doi.org/10.1016/   j.bbamcr.2006.09.00 6 Seremet, T., F .",OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
"17:325–   330. http://dx.doi.org/10.1097/PPO.0b013e318232600 4 Shamshiev, A., A. Donda, I. Carena, L. Mori, L. Kappos, and G. De   Libero.",Non-OADS,/arxiv_data1/oa_pdf/43/e2/JEM_20140410.PMC4076585.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"174:2787– 2795. http://dx.doi.org/10.4049/jimmunol.174.5.278 7 Dam, T.K., and C.F .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"20:270– 279. http://dx.doi.org/10.1093/glycob/cwp18 6 Darrasse-Jèze, G., S. Deroubaix, H. Mouquet, G.D. Victora, T. Eisenreich, K.-H.   Yao, R.F .",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10   .1084/jem.2009074 6 De Groot, C.J., E. Bergers, W .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1093/brain/124   .8.163 5 de Groot, C.J., S. Hulshof, J.J. Hoozemans, and R. Veerhuis.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1002/jemt.111 8 de Vos, A.F ., M. van Meurs, H.P .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi   .org/10.4049/jimmunol.169.10.541 5 Engering, A., T.B.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"168:2118– 2126. http://dx.doi.org/10.4049/jimmunol.168.5.211 8 Engering, A., S.J.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)63717- 0 Fabriek, B.O., E.S.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1002/glia.2020 8 Fabriek, B.O., J.N.P .",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1093/intimm/dxh17 8 García-Vallejo, J.J., and Y .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
http://dx.doi.org/10.1111/j.1600-065X.2009.00786.,Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1016/j.ab.2004.02.03 7 Geijtenbeek, T.B.H., and S.I.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1038/nri256 9 Geijtenbeek, T.B.H., S.J.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.4049/jimmunol.170.4.163 5 Becher, B., and B.M.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10   .1016/j.coi.2011.08.00 5 Birnberg, T., L. Bar-On, A. Sapoznikov, M.L.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1016/j.immuni   .2008.10.01 2 Boven, L.A., M. Van Meurs, M. Van Zwam, A. Wierenga-Wolf, R.Q.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10   .1093/brain/awh70 7 Brynedal, B., J. Wojcik, F .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1016/j.jneuroim.2010.01.00 3 Buntinx, M., J. Vanderlocht, N. Hellings, F .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1023/A:102732423092 3 Cambi, A., I. Beeren, B. Joosten, J.A.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1002/eji.20093935 1 Caparrós, E., P .",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"107:3950– 3958. http://dx.doi.org/10.1182/blood-2005-03-125 2 Clements, C.S., H.H.",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1073/   pnas.183315810 0 Cong, Y ., A. Konrad, N. Iqbal, R.D.",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
http://dx.doi.org/10.1111/ j.1471-4159.1973.tb07519.,Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1084/jem.2008239 4 Olson, J.K., and S.D.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.4049/jimmunol.173.6.391 6 Ortyn, W .E., B.E.",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1002/cyto.a.2030 6 Ortyn, W .E., D.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1002/cyto.a.2037 0 Park, C.G., K. Takahara, E. Umemoto, Y .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1093/intimm/13.10.128 3 Patnaik, S.K., B. Potvin, and P .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1074/jbc.M40875520 0 Powlesland, A.S., E.M. Ward, S.K.",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"281:20440– 20449. http://dx.doi.org/10.1074/jbc.M60192520 0 Rappocciolo, G., H.R.",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1128/JVI.01587-0 7 Serafini, B., B. Rosicarelli, R. Magliozzi, E. Stigliano, E. Capello, G.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1146/   annurev.biophys.32.110601.14180 3 Singh, S.K., J. Stephani, M. Schaefer, H. Kalay, J.J. García-Vallejo, J. den Haan,  E. Saeland, T. Sparwasser, and Y .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1002/eji.20042584 2 Sofroniew, M.V .",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1016/j   .tins.2009.08.00 2 Soilleux, E.J., L.S.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
27:660– 669. http://dx.doi.org/10.1016/j.immuni.2007.08.01 32003.,OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1084/jem.2002122 9 Green, R.S., E.L. Stone, M. T enno, E. Lehtonen, M.G.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.06.00 8 Gringhuis, S.I., J. den Dunnen, M. Litjens, B. van Het Hof, Y .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10   .1016/j.immuni.2007.03.01 2 Gringhuis, S.I., J. den Dunnen, M. Litjens, M. van der Vlist, and T.B.H.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10   .1038/ni.177 8 Hawiger, D., K. Inaba, Y .",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1084/jem.194.6.76 9 Hoppenbrouwers, I.A., Y .S.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1038/jhg.2009.9 6 Husain, S., C. Yildirim-T oruner, J.P .",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1371/journal.pone.000265 3 Jagessar, S.A., Y .S.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1097/NEN.0b013e3181d5d05 3 Kalay , H., M. Ambrosini, P .H.C.",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10   .1016/j.ab.2012.01.01 5 Kim, T., and S.E.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10   .1023/A:100700142759 7 Lambert, C., J. Desbarats, N. Arbour, J.A.",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10   .1074/jbc.M20787320 0 Liu, K., T. Iyoda, M. Saternus, Y .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1084/jem.2002121 5 Martinon, F ., K. Burns, and J. Tschopp.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10   .1016/S1097-2765(02)00599- 3 Nonaka, M., B.Y .",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
http://dx.doi.org/   10.4049/jimmunol.180.5.334 7,Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-04-414 0 van Kooyk, Y ., and T.B.H.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi .org/10   .1038/nri118 2van Zwam, M., R. Huizinga, M.-J.",Non-OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
"http://dx.doi.org/10.1007/s00109-008-0421- 4 Wang, S.-F ., J.C. Huang, Y .-M. Lee, S.-J.",OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
373:561– 566. http://dx.doi.org/10.1016/j.bbrc.2008.06.07 8,OADS,/arxiv_data1/oa_pdf/e8/f5/JEM_20122192.PMC4076586.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after   the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"After six months it  is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1002/ibd.2075 3Caco-2 and HT-29 cells were grown in adherent culture in DMEM supple - mented with 10% fetal bovine serum, penicillin/streptomycin, and 1X Glu - tamax (Life Technologies) and stimulated at 70% confluence.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.4049/jimmunol.180.7.492 4 Giblin, L.J., C.J.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1369/   jhc.5A6724.200 5 Grootjans, J., C.M.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1053/j.gastro.2010.10.04 0 Guy-Grand, D., J.P .",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1002/dvdy.2044 6 Kaser, A., A.-H. Lee, A. Franke, J.N.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1016/j.cell.2008.07.02 1 Kobayashi, K.S., M. Chamaillard, Y .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1126/science.110491 1 Kontoyiannis, D., G. Boulougouris, M. Manoloukos, M. Armaka, M.  Apostolaki, T. Pizarro, A. Kotlyarov, I. Forster, R. Flavell, M. Gaestel, et al.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1084/jem.2002028 1 Koo, B.-K., D.E.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1038/nmeth.180 2 Lee, H.T ., M. Kim, J.Y .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1152/ajpgi.00201.201 2 Levine, J.E., E. Huber, S.T .G.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1182/blood-2013-02-48581 3 Lotz, M., D. Gütle, S. Walther, S. Ménard, C. Bogdan, and M.W .",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1084/   jem.2005062 5 Merger, M., J.L.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1136/gut.2007.14148 1 Miura, N., M. Yamamoto, M. Fukutake, N. Ohtake, S. Iizuka, A. Ishige, H.  Sasaki, K. Fukuda, T. Yamamoto, and S. Hayakawa.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1093/intimm/dxh23 1Ayabe, T., D.P .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1038/ng.17 5 Bendelac, A., O. Lantz, M.E.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1126/science.753869 7 Bialecki, E., C. Paget, J. Fontaine, M. Capron, F .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.4049/jimmunol   .080227 3 Brandl, K., G. Plitas, B. Schnabl, R.P .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1084/jem.2007056 3 Brinkmann, V ., U. Reichard, C. Goosmann, B. Fauler, Y .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1126   /science.109238 5 Cadwell, K., J.Y .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1038/nature0741 6 Cadwell, K., K.K.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/   10.1016/j.cell.2010.05.00 9 Cheroutre, H., F .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1038/nri300 7 Chu, H., M. Pazgier, G. Jung, S.-P .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1126/   science.121883 1 Clevers, H.C., and C.L.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1146/   annurev-physiol-030212-18374 4 Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1126/science.845630 0 Di Sabatino, A., E. Miceli, W .",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1309/5ADNAR4VN11TTKQ 6 Duerkop, B.A., S. Vaishnava, and L.V .",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.08.00 9 Eriguchi, Y ., S. Takashima, H. Oka, S. Shimoji, K. Nakamura, H. Uryu, S.  Shimoda, H. Iwasaki, N. Shimono, T. Ayabe, et al.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1182/blood-2011-12-40116 6 Farin, H.F ., J.H.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1053/j.gastro   .2012.08.03 1 Fernandez, M.-I., B. Regnault, C. Mulet, M. Tanguy, P .",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1007/s00018-008-8182- 3 Nieuwenhuis, E.E., T. Matsumoto, M. Exley, R.A. Schleipman, J. Glickman,  D.T.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1172/JCI3650 9 Nilsen, E.M., F .L.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1016/S0016-5085(98)70134- 9 Raetz, M., S.H.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/   10.1038/ni.250 8 Rumio, C., M. Sommariva, L. Sfondrini, M. Palazzo, D. Morelli, L. Viganò, L.  De Cecco, E. Tagliabue, and A. Balsari.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1002/jcp.2283 0 Saha, S., X. Jing, S.Y .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1016/   j.chom.2010.07.00 5 Salzman, N.H., K. Hung, D. Haribhai, H. Chu, J. Karlsson-Sjöberg, E. Amir,  P .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1038/ni.182 5 Sato, T., R.G.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1038/nature0793 5 Sato, T., J.H.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1038/nature0963 7 Sato, T., D.E.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1053/j.gastro.2011.07.05 0 Satoh, Y .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1007/BF0022229 6 Satoh, Y ., K. Ishikawa, Y .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi   .org/10.1007/BF0031961 1 Sawada, M., K. Takahashi, S. Sawada, and O. Midorikawa.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1371/journal.pone.007687 1 Tanabe, H., T. Ayabe, B. Bainbridge, T. Guina, R.K. Ernst, R.P .",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1128/IAI.73.4.2312-2320.200 5 T ewary, P ., G. de la Rosa, N. Sharma, L.G.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1038/ncb124 0 van Es, J.H., T. Sato, M. van de Wetering, A. Lyubimova, A.N.Y .",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10.1038/ncb258 1 Wehkamp, J., and E.F .",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"4:523– 531. http://dx.doi.org/10.1016/j.crohns.2010.05.01 0 W ehkamp, J., J.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10   .1136/gut.2003.03280 5 Wehkamp, J., G. Wang, I. Kübler, S. Nuding, A. Gregorieff, A. Schnabel, R.J.  Kays, K. Fellermann, O. Burk, M. Schwab, et al.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/10 .4049/jimmunol   .179.5.310 9 Wilson, C.L., A.J.",OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
"http://dx.doi.org/   10.1126/science.286.5437.11 3 Zhao, F ., R. Edwards, D. Dizon, K. Afrasiabi, J.R. Mastroianni, M. Geyfman,  A.J.",Non-OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
http://dx.doi.org/10.1016/   j.ydbio.2009.12.00 8,OADS,/arxiv_data1/oa_pdf/07/cf/JEM_20130753.PMC4076587.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/   10.1038/ni.239 5 Bouillet, P ., and L.A. O’Reilly.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1038/nri257 0 Bouillet, P ., D. Metcalf, D.C. Huang, D.M.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10   .1126/science.286.5445.173 5 Brown, M.G., A.O.",OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1182/blood-2008-10-18717 9 Cooper, M.A., J.E.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1182/blood-2001-12-029 3 Cooper, M.A., J.M.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1073/   pnas.081319210 6 Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M.  López-Botet.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10   .1182/blood-2004-05-205 8 Hildeman, D.A., Y .",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/   10.1016/S1074-7613(02)00322- 9 Huntington, N.D., H. Puthalakath, P .",OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1038/ni148 7 Jay, D.C., D.M.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1371/journal.pone.006736 3 Koenen, P ., S. Heinzel, E.M. Carrington, L. Happo, W .S.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"4:1735. http://dx.doi.org/10   .1038/ncomms271 9 Kurtulus, S., P .",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1111/j.1600-065X   .2010.00920. x Lee, S.H., S. Girard, D. Macina, M. Busà, A. Zafer, A. Belouchi, P .",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/   10.1038/ng0501-4 2 Li, Q., C. Eppolito, K. Odunsi, and P .A.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"177:7618– 7625. http://dx.doi.org/10.4049/jimmunol.177.11.761 8Lopez-Vergès, S., J.M.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1016/j.it.2013.02.00 5 O’Connor, L., A. Strasser, L.A. O’Reilly, G. Hausmann, J.M.",OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10   .1093/emboj/17.2.38 4 Paust, S., and U.H.",OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1038/ni.203 2 Paust, S., H.S.",OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1038/ni.195 3 Prlic, M., and M.J. Bevan.",OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"197:967– 976. http://dx.doi.org/10.1084/jem.2002184 7 Strasser, A.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1038/nri156 8 Strasser, A., A.W .",OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1038/   nature0766 5 Sun, J.C., J.N.",OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
"http://dx.doi.org/10.1084/   jem.2010047 9 Sun, J.C., S. Madera, N.A.",OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
http://dx.doi.org/   10.1084/jem.2011176 0,Non-OADS,/arxiv_data1/oa_pdf/ee/3a/JEM_20132459.PMC4076589.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"Known immunoprevalent epitopes are strongly   represented in the preexposure repertoire We next compared the mapped epitopes identified in the  preexisting repertoire against HIV-1 epitope data stored in  the Los Alamos National Laboratory (LANL) database (LANL-   Immunology-Database, http://www.hiv.lanl.gov/content/ immunology).",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"Ad - ditional human proteome sequence data were downloaded from UniProt  (UniProt Consortium, 2012), whereas further human microbiome sequences  (shotgun sequences derived from body location samples) were obtained from  the Human Microbiome Project (HMP) clustered gene indices catalog  (http://www.hmpdacc.org/HMGC/).",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"HIV-1 peptides spanned  the entire HIV-1 proteome and were designed according to the 2004 consen - sus clade C HIV-1 sequence (LANL-Sequence-Database, http://www.hiv   .lanl.gov /).",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20130555/DC1.,Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi   .org/10.1016/S0022-2836(05)80360- 2 Birnbaum, M.E., J.L.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.1016/j.cell.2014.03.04 7 Bunce, M. 2003.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"12:396– 407. http://dx.doi.org/10.1016/j.chom.2012.09.00 8 Douek, D.C., J.M.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.1038/417095 a Edgar, R.C.",Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.1093/bioinformatics/   btq46 1 Geiger, R., T. Duhen, A. Lanzavecchia, and F. Sallusto.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.1084/jem.2009050 4 Haynes, B.F ., P .B.",Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.1056/NEJMoa111342 5 Ho, O., and W .R.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.4049/jimmunol.177.12.828 3 Jenkins, M.K., A. Khoruts, E. Ingulli, D.L.",Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/   10.1146/annurev.immunol.19.1.2 3 Jones, L., A.P .",Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/   10.1002/eji.20073764 8 Kaufmann, D.E., P .M.",Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.1128/JVI.78.9.4463-4477.200 4 Keele, B.F ., E.E.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10   .4049/jimmunol.110219 0 Lefkovits, I., and H. Waldmann.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
http://dx.doi.org/10.1111/j.1365-2249.2008.03633.,Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.07.00 7 Ranasinghe, S., M. Flanders, S. Cutler, D.Z.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.1128/JVI.05577-1 1 Rerks-Ngarm, S., P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal,  J. Chiu, R. Paris, N. Premsri, C. Namwat, M. de Souza, E. Adams,   et al.",Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.1056/NEJMoa090849 2 Ritchie, A.J., S.L.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/10.1128/JVI.02444-1 0 Roederer, M., and R.A. Koup.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/   10.1016/S0022-1759(02)00423- 4 Rosenberg, E.S., J.M.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"278:1447– 1450. http://dx.doi.org/10.1126/science.278.5342.144 7 Sallusto, F ., A. Lanzavecchia, K. Araki, and R. Ahmed.",Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
"http://dx.doi.org/   10.1016/j.immuni.2010.10.00 8 Su, L.F., B.A.",OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
http://dx.doi.org/10.1016/j.immuni.2012   .10.02 1 UniProt Consortium.,OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
http://dx.doi.org/10.1084/jem.2003159 8,Non-OADS,/arxiv_data1/oa_pdf/fb/c9/JEM_20130555.PMC4076590.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).cessive bleeding after surgical intervention or  trauma.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1182/blood-2002-11-342 7 Aslan, J.E., and O.J.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1111/jth.1205 1 Bergmeier, W., T. Goerge, H.W.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"117:1699– 1707. http://dx.doi.org/10.1172/JCI3057 5 Bernardi, B., G.F. Guidetti, F. Campus, J.R. Crittenden, A.M. Graybiel, C.  Balduini, and M. Torti.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1182/blood-2005-   07-302 3 Bertoni, A., S. Tadokoro, K. Eto, N. Pampori, L.V.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1074/jbc.M20279120 0 Boriack-Sjodin, P.A., S.M.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"394:337– 343. http://dx.doi.org/10.1038/2854 8 Boudreaux, M.K., J.L.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi   .org/10.1016/j.trsl.2007.03.00 6 Boudreaux, M.K., S.M.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1354/vp.44-6-93 2 Carbo, C., D. Duerschmied, T. Goerge, H. Hattori, J. Sakai, S.M.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
http://dx.doi.org/10.1038/nm109 8incubated 48 h. Cells were then washed and cultured in serum-free medium  supplemented with the human cytokines: TPO (100 ng/ml) and SCF (250  ng/ml) for 14 d. Flow-cytometric analysis of fibrinogen binding to transfected  megakaryocytes.,OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/   10.1074/jbc.M21203620 0 Eto, K., R. Murphy, S.W.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1182/   blood-2007-03-07762 8 Gopalan, P.K., A.R.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1160/   TH09-10-068 9 Kawasaki, H., G.M.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi   .org/10.1073/pnas.95.22.1327 8 Kuijpers, T.W., R. van Bruggen, N. Kamerbeek, A.T. Tool, G. Hicsonmez,  A. Gurgey, A. Karow, A.J.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1182/blood-2006-05-02140 2 Kuijpers, T.W., E. van de Vijver, M.A.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1182/blood-2008-10-18215 4 Li, H., B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth,  G. Abecasis, and R. Durbin; 1000 Genome Project Data Processing  Subgroup.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1093/bioinformatics/   btp35 2 Malinin, N.L., L. Zhang, J. Choi, A. Ciocea, O. Razorenova, Y.Q.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1038/nm.191 7 McDowall, A., L. Svensson, P. Stanley, I. Patzak, P. Chakravarty, K.  Howarth, H. Sabnis, M. Briones, and N. Hogg.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"115:4834– 4842. http://dx.doi.org/10.1182/blood-2009-08-23870 9 Miller, S.A., D.D.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"16:1215. http://dx.doi.org/10.1093/nar/16.3.121 5 Minato, N., K. Kometani, and M. Hattori.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"93:229– 264. http://dx.doi.org/10.1016/S0065-2776(06)93006- 5 Naldini, L., U. Blömer, P. Gallay, D. Ory, R. Mulligan, F.H.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1126/science.272.5259.26 3 Nurden, A., and P. Nurden.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
http://dx.doi.org/10.1111/j.1538-7836.2011.04274.,Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1074/jbc   .R80006120 0 Raslova, H., E. Komura, J.P.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/   10.1172/JCI11885 9 Robert, P., M. Canault, C. Farnarier, A. Nurden, C. Grosdidier, V. Barlogis,  P. Bongrand, A. Pierres, H. Chambost, and M.C.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.4049/   jimmunol.100314 1 Stadtmann, A., L. Brinkhaus, H. Mueller, J. Rossaint, M. Bolomini-Vittori,  W .",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1002/eji.20104119 6 Stefanini, L., R.C.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"114:2506– 2514. http://dx.doi.org/10.1182/blood-2009-04-21876 8 Stefanini, L., Y. Boulaftali, T.D.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1161/ATVBAHA.111.23919 4 Stolla, M., L. Stefanini, P .",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1182/blood-2011-   03-34235 2 Stolla, M., L. Stefanini, R.C.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1182/blood-2010-07-29771 3 Stone, J.C. 2011.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10   .1177/194760191140808 2 Svensson, L., K. Howarth, A. McDowall, I. Patzak, R. Evans, S. Ussar, M. Moser,  A. Metin, M. Fried, I. Tomlinson, and N. Hogg.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1038/nm.193 1 van de Vijver, E., A. Maddalena, O. Sanal, S.M.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/   10.1016/j.bcmd.2011.10.00 4 van der Meijden, P.E., M.A.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1007/   s00018-012-1033- 2 Wang, K., M. Li, and H. Hakonarson.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
"http://dx.doi.org/10.1093/nar/gkq60 3 Zhang, G., B. Xiang, S. Ye, M. Chrzanowska-Wodnicka, A.J.",OADS,/arxiv_data1/oa_pdf/b4/0e/JEM_20130477.PMC4076591.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10   .1084/jem.2005237 1 Chen, X.S., J.R. Sheller, E.N.",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10.1038/372179a 0 Dumont, F ., and R. Barrois.",Non-OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10.1083/jcb.20110512 7 Haeggström, J.Z., and A. Wetterholm.",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10   .1007/s00018-002-8463- 1 Hallem, E.A., M. Rengarajan, T .A.",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10.1016/j.cub.2007.04.02 7 Henderson, W .R., J.B. Harley, and A.S. Fauci.",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10.4049/jimmunol   .173.3.150 3 Kang, Y .S., S. Y amazaki, T .",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi   .org/10.1093/intimm/dxg01 9 Klion, A.D., and T.B.",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10   .1016/j.molimm.2009.05.01 6 Lämmermann, T ., P .V .",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10.2174/09298671279982833 7 Matthews, A.N., D.S.",Non-OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20132336/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.02.00 3 Allen, C.D., K.M.",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi   .org/10.1038/ni110 0 Balla, K.M., G. Lugo-Villarino, J.M.",Non-OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi   .org/10.1074/jbc.M113.48540 9 Rao, A.U., L.K.",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10.1038/nature0574 6 Rouzer, C.A., A.W .",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi.org/10.1016/   j.it.2011.06.00 8 Sadik, C.D., N.D. Kim, Y .",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
"http://dx.doi   .org/10.1073/pnas.121379710 9 Spada, C.S., A.L.",OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
http://dx.doi.org/   10.1084/jem.192.3.43 9,Non-OADS,/arxiv_data1/oa_pdf/18/12/JEM_20132336.PMC4076593.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1016/   j.immuni.2011.09.00 7 Hashimoto, D., A. Chow, C. Noizat, P. Teo, M.B.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi   .org/10.1016/j.immuni.2013.04.00 4 Herskowitz, A., S. Campbell, J. Deckers, E.K.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1016/   0002­9149(93)90918­ 3 Hilgendorf, I., L.M.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"114:1611– 1622. http://dx.doi.org/10.1161/CIRCRESAHA.114.30320 4 Hiroi, T., T. Wajima, T. Negoro, M. Ishii, Y. Nakano, Y. Kiuchi, Y. Mori,  and S. Shimizu.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1093/cvr/cvs33 2 Kono, H., H. Fujii, M. Ogiku, N. Hosomura, H. Amemiya, M. Tsuchiya,  and M. Hara.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.4049/jimmunol.110049 0 Korn, T., E. Bettelli, M. Oukka, and V .K.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1016/j.jaut.2008.11.00 1 Liao, Y.­H., N. Xia, S.­F.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1016/j.jacc.2011.10.86 3 Liu, Y ., H. Zhu, Z. Su, C. Sun, J. Yin, H. Y uan, S. Sandoghchian, Z. Jiao, S.  Wang, and H. Xu.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/   10.1093/intimm/dxs05 6 Livak, K.J., and T.D.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1006/meth.2001.126 2 Maekawa, Y., T. Anzai, T. Yoshikawa, Y. Sugano, K. Mahara, T. Kohno,  T. Takahashi, and S. Ogawa.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1084/jem.2007088 5 Papatriantafyllou, M. 2011.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1038/nri299 6 Pietra, B.A., P .F .",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1161/   CIRCULATIONAHA.110.01199 9 Ramachandran, P., A. Pellicoro, M.A.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10   .1073/pnas.111996410 9REFERENCES Aretz, H.T., M.E.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1016/   j.bbamcr.2012.10.00 8 Čiháková, D., and N.R.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1016/   S0065­2776(08)00604­ 4 Čiháková, D., R.B.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.2353/ajpath.2008.07020 7 Cooper, L.T.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1056/NEJMra080002 8 Cooper, L.T., K.L.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1093/eurheartj/ehm45 6 Dimas, V .V ., S.W .",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10   .1016/j.amjcard.2009.07.03 4 Ding, L., H. Hanawa, Y. Ota, G. Hasegawa, K. Hao, F. Asami, R. Watanabe,  T. Yoshida, K. Toba, K. Yoshida, et al.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"74:523– 530. http://dx.doi.org/10.1253/circj.CJ­09­048 5 Epelman, S., K.J.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1016/j.immuni.2013.11.01 9 Frangogiannis, N.G.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1152/physrev   .00008.201 1 Gaffen, S.L.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1038/nri258 6 Geissmann, F., S. Jung, and D.R.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1016/S1074­7613(03)00174­ 2 Gordon, S., and P .R.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
http://dx.doi.org/10.1038/nri173 3,Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"279:2559– 2567. http://dx.doi.org/10.1074/jbc.M30880920 0 Sagar, S., P.P.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"379:738– 747. http://dx.doi.org/10.1016/S0140­6736(11)60648­ X Shi, C., and E.G.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1038/   nri307 0 Sica, A., and A. Mantovani.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1172/   JCI5964 3 Smith, S.C., and P.M. Allen.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1006/clin.1993.110 3 Swirski, F.K.F.K., M. Nahrendorf, M. Etzrodt, M. Wildgruber, V. Cortez­ Retamozo, P. Panizzi, J.L.J.­L.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1126/science.117520 2 van Rooijen, N., A. Sanders, and T.K.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1016/j.cardiores.2003.10.01 1Wantha, S., J.­E.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1161/   CIRCRESAHA .112.30066 6 Wilson, M.S., S.K.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1084/jem.2009212 1 Wynn, T.A., A. Chawla, and J.W.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1016/j   .immuni.2012.12.00 1 Yu, J.J., M.J. Ruddy, H.R.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1128/IAI.01209­0 7 Yuan, J., A.­L.",OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"http://dx.doi.org/10.1007/s10875­009­9355­ z Zbinden, S., R. Zbinden, P. Meier, S. Windecker, and C. Seiler.",Non-OADS,/arxiv_data1/oa_pdf/9a/e9/JEM_20132126.PMC4076595.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/62/TOORTHJ-8-130.PMC4076617.pdf
Available from: http://www.magnetodyn.de/en/ [9] ARCO (Association Research Circulation Osseous): committee on terminology and classification.,OADS,/arxiv_data1/oa_pdf/83/6f/TOORTHJ-8-125.PMC4076618.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/6f/TOORTHJ-8-125.PMC4076618.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/2e/TODENTJ-8-125.PMC4076627.pdf
Available from: http://www.unsystem.org/SCN/Publications/html/task_force/Factsheet%20MUAC%20Hanoi.doc  4.,Non-OADS,/arxiv_data1/oa_pdf/cd/49/pr-2014-2-5368.PMC4076652.pdf
Available from: http://www.who.int/nutri- tion/topics/statement_commbased_mal- nutrition/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/cd/49/pr-2014-2-5368.PMC4076652.pdf
Clinical trial registration URL: http://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/f6/7c/ehu112.PMC4076663.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/7c/ehu112.PMC4076663.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/1c/ehu176.PMC4076664.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5516 | DOI: 10.1038/srep05516 5",Non-OADS,/arxiv_data1/oa_pdf/cd/45/srep05516.PMC4076675.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/16/66/srep05504.PMC4076676.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5504 | DOI: 10.1038/srep05504 6",Non-OADS,/arxiv_data1/oa_pdf/16/66/srep05504.PMC4076676.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c8/ed/srep05505.PMC4076678.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5505 | DOI: 10.1038/srep05505 7",Non-OADS,/arxiv_data1/oa_pdf/c8/ed/srep05505.PMC4076678.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5518 | DOI: 10.1038/srep05518 8,Non-OADS,/arxiv_data1/oa_pdf/3b/5e/srep05518.PMC4076680.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5518 | DOI: 10.1038/srep05518 9",Non-OADS,/arxiv_data1/oa_pdf/3b/5e/srep05518.PMC4076680.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e1/97/srep05519.PMC4076681.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5519 | DOI: 10.1038/srep05519 9",Non-OADS,/arxiv_data1/oa_pdf/e1/97/srep05519.PMC4076681.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5520 | DOI: 10.1038/srep05520 6",Non-OADS,/arxiv_data1/oa_pdf/53/e2/srep05520.PMC4076687.pdf
"Hoover, J. in ‘‘Forest fire in Karnataka’s tiger reserves’’ published in Cable News Network (IBN) news website on 03/01/2012 (Available online at: http://ibnlive.in.",Non-OADS,/arxiv_data1/oa_pdf/74/07/srep05508.PMC4076688.pdf
"Mackowski, D., Fuller, K. & Mishchenko, M. Codes for Calculation of Scattering by Clusters of Spheres (Available at: ftp://ftp.eng.auburn.edu/pub/dmckwski/ scatcodes/index.html), Retrieved 03/18/2014).",OADS,/arxiv_data1/oa_pdf/74/07/srep05508.PMC4076688.pdf
"Haagenson, G. in ‘‘Fire on shore of Millerton Lake contained’’ published in American Broadcasting Company (ABC30) news website on 06/22/2010 (Available online at: http://abclocal.go.com/kfsn/story?section 5news/local&id 57515202 Retrieved 03/18/2014).",Non-OADS,/arxiv_data1/oa_pdf/74/07/srep05508.PMC4076688.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/74/07/srep05508.PMC4076688.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5508 | DOI: 10.1038/srep05508 8",Non-OADS,/arxiv_data1/oa_pdf/74/07/srep05508.PMC4076688.pdf
United States National Cancer Institute http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/ce/8b/srep05512.PMC4076689.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5512 | DOI: 10.1038/srep05512 8",Non-OADS,/arxiv_data1/oa_pdf/ce/8b/srep05512.PMC4076689.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/63/dd/srep05473.PMC4076690.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5473 | DOI: 10.1038/srep05473 13",Non-OADS,/arxiv_data1/oa_pdf/63/dd/srep05473.PMC4076690.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8f/82/srep05517.PMC4076691.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5517 | DOI: 10.1038/srep05517 8",Non-OADS,/arxiv_data1/oa_pdf/8f/82/srep05517.PMC4076691.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ec/0d/srep05514.PMC4076692.pdf
All authors read and commented on the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/10/26/srep05521.PMC4076700.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5521 | DOI: 10.1038/srep05521 6",Non-OADS,/arxiv_data1/oa_pdf/10/26/srep05521.PMC4076700.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bb/88/srep05513.PMC4076733.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5513 | DOI: 10.1038/srep05513 6",Non-OADS,/arxiv_data1/oa_pdf/bb/88/srep05513.PMC4076733.pdf
"To facilitate broad access to these RPPA data sets, we devel- oped a user-friendly data portal, The Cancer Proteome Atlas (TCPA; http://bioinformatics.mdanderson.org/main/TCPA:Overview).",OADS,/arxiv_data1/oa_pdf/b7/8b/41592_2013_Article_BFnmeth2650.PMC4076789.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ .",Non-OADS,/arxiv_data1/oa_pdf/b7/8b/41592_2013_Article_BFnmeth2650.PMC4076789.pdf
<http://www.page-meeting.org/default.asp?abstract=738>.,Non-OADS,/arxiv_data1/oa_pdf/00/39/psp201415a.PMC4076802.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/00/39/psp201415a.PMC4076802.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/c9/76/psp201417a.PMC4076804.pdf
All simulations were conducted using R version 3.0 (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/4b/e8/psp201418a.PMC4076805.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/4b/e8/psp201418a.PMC4076805.pdf
(http://www.public-health.uiowa.edu/boa/).,Non-OADS,/arxiv_data1/oa_pdf/cf/05/psp201419a.PMC4076806.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/cf/05/psp201419a.PMC4076806.pdf
"A  Persian version of this article is previously published   in a local journal [in authors' native language] and is  available here: http://jims.mui.ac.ir/index.php/jims/ article/download/1084/1534 AUTHORS’ CONTRIBUTION Both authors contributed the idea of research, design  of study, data analysis and manuscript preparation.",Non-OADS,/arxiv_data1/oa_pdf/df/24/JRPP-1-25.PMC4076850.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/df/24/JRPP-1-25.PMC4076850.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/7f/f2/JRPP-1-37.PMC4076851.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/3f/6f/JRPP-1-30.PMC4076853.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/3f/6f/JRPP-1-30.PMC4076853.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/73/26/JRPP-1-34.PMC4076858.pdf
"American Dentistry  Association [Continuing Education], 2009; Available from:  http://www.oraverse.com/assets/pdf/dtce_malamed_mar10.",Non-OADS,/arxiv_data1/oa_pdf/77/e7/JRPP-1-55.PMC4076863.pdf
"ADA [Continuing Education],  2009; Available from: http://www.ineedce.com/courses/2088/ PDF/1103cei_phentolamine_web.pdf.",Non-OADS,/arxiv_data1/oa_pdf/77/e7/JRPP-1-55.PMC4076863.pdf
Available from: http://www.fda.gov/cder/foi/ anda/98/40235ap.pdf.,Non-OADS,/arxiv_data1/oa_pdf/77/e7/JRPP-1-55.PMC4076863.pdf
Start a QR-code reading software (see list of free  applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/77/e7/JRPP-1-55.PMC4076863.pdf
See http:// tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/77/e7/JRPP-1-55.PMC4076863.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d2/fd/JRPP-1-41.PMC4076864.pdf
"Pharm Pract (Internet) 2012;10:40‑4, Available  from: http://www.pharmacypractice.org/vol10/pdf/040‑044.",Non-OADS,/arxiv_data1/oa_pdf/2a/30/JRPP-1-81.PMC4076866.pdf
Available  from: http://www.globalburden.org/GBD_Study_Operations_ Manual_Jan_20_2009.pdf [Last accessed on 2012 Jun 1].,Non-OADS,/arxiv_data1/oa_pdf/2a/30/JRPP-1-81.PMC4076866.pdf
Available from: http://ssmon.chb.kth.se/vol15/ issue3/4_Thomas.pdf [Last accessed on 2012 Jun 22].,Non-OADS,/arxiv_data1/oa_pdf/2a/30/JRPP-1-81.PMC4076866.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/2a/30/JRPP-1-81.PMC4076866.pdf
Available from: http://www.ec.europa.eu/health/human‑use/ pharmacovigilance/index_en.htm.,Non-OADS,/arxiv_data1/oa_pdf/3a/30/JRPP-2-44.PMC4076892.pdf
Available from: http://www.ema.europa.eu/./ en_GB/document_library/Regulatory_and_procedural_ guideline/2009/11/WC500015697.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/30/JRPP-2-44.PMC4076892.pdf
Available from: http://www.europarl.europa.eu/register/./r1049_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/30/JRPP-2-44.PMC4076892.pdf
Available from: http://www.meddramsso.,OADS,/arxiv_data1/oa_pdf/3a/30/JRPP-2-44.PMC4076892.pdf
Available from: http://www.whocc.no/atc_ddd_ index/.,OADS,/arxiv_data1/oa_pdf/3a/30/JRPP-2-44.PMC4076892.pdf
Available from:  URL: http://www.ispor.org/terminology/default.asp.,OADS,/arxiv_data1/oa_pdf/da/64/JRPP-2-3.PMC4076893.pdf
Available from: http://www.hwbooks.,Non-OADS,/arxiv_data1/oa_pdf/da/64/JRPP-2-3.PMC4076893.pdf
Available from: http://pharmaceuticals.gov.in/ mshT2810/FTY2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/64/JRPP-2-3.PMC4076893.pdf
Available  from: http://www.makanaka.wordpress.com/2011/04/01/ indias‑2011‑census‑a‑population‑turning‑point/.,Non-OADS,/arxiv_data1/oa_pdf/da/64/JRPP-2-3.PMC4076893.pdf
Available from: http://www.downtoearth.,Non-OADS,/arxiv_data1/oa_pdf/da/64/JRPP-2-3.PMC4076893.pdf
Available from: http://www.ibef.,Non-OADS,/arxiv_data1/oa_pdf/da/64/JRPP-2-3.PMC4076893.pdf
"15‑21,  Available from: http://www.apps.who.int/medicinedocs/en/d/ Js4882e/5.html.",Non-OADS,/arxiv_data1/oa_pdf/da/64/JRPP-2-3.PMC4076893.pdf
Available from: http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/58/39/JRPP-2-18.PMC4076895.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/41/eb/JRPP-2-59.PMC4076903.pdf
Available from : http://www.who .int/healthinfo /global_ burden_disease/GDB_report_2004updat_fullpdf.,OADS,/arxiv_data1/oa_pdf/1b/0d/JRPP-2-83.PMC4076905.pdf
Start a QR-code reading software (see list of free applica - tions from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/1b/0d/JRPP-2-83.PMC4076905.pdf
com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/1b/0d/JRPP-2-83.PMC4076905.pdf
Available from:  http://www.eudravigilance.ema.europa.eu/human/index.,Non-OADS,/arxiv_data1/oa_pdf/7d/4f/JRPP-2-93.PMC4076906.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/7d/4f/JRPP-2-93.PMC4076906.pdf
Available from:  http://www.medscape.com/viewarticle/722032.,Non-OADS,/arxiv_data1/oa_pdf/04/2e/JRPP-2-70.PMC4076908.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/db/78/JRPP-2-88.PMC4076909.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/71/83/srep05507.PMC4076911.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5507 | DOI: 10.1038/srep05507 6",Non-OADS,/arxiv_data1/oa_pdf/71/83/srep05507.PMC4076911.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/0a/72/JRPP-2-123.PMC4076915.pdf
Available from: http://www.bvs.org.ar/pdf/seguridadpaciente.,Non-OADS,/arxiv_data1/oa_pdf/72/b0/JRPP-2-118.PMC4076918.pdf
Available from: http://www.idf.org//2011/ diabetes‑atlas/5e.,Non-OADS,/arxiv_data1/oa_pdf/5a/73/JRPP-2-114.PMC4076919.pdf
Available from: http://www.idf.org/diabetesatlas/5e/ south‑east‑asia.,Non-OADS,/arxiv_data1/oa_pdf/5a/73/JRPP-2-114.PMC4076919.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/5a/73/JRPP-2-114.PMC4076919.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/dd/07/JRPP-2-99.PMC4076920.pdf
Start a QR-code reading software (see list of free  applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/dd/07/JRPP-2-99.PMC4076920.pdf
See http:// tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/dd/07/JRPP-2-99.PMC4076920.pdf
Available from: http://www.who.Int/evidence/bod.,OADS,/arxiv_data1/oa_pdf/97/77/JRPP-2-162.PMC4076924.pdf
Available from: http://www.who.Int/ evidence/bod.,OADS,/arxiv_data1/oa_pdf/97/77/JRPP-2-162.PMC4076924.pdf
Available from:  http://www.ginasthma.org/.,Non-OADS,/arxiv_data1/oa_pdf/97/77/JRPP-2-162.PMC4076924.pdf
Available from:  http://www.ginasthma.org/.,Non-OADS,/arxiv_data1/oa_pdf/97/77/JRPP-2-162.PMC4076924.pdf
Available  from: http://www.cbi.ir .,Non-OADS,/arxiv_data1/oa_pdf/97/77/JRPP-2-162.PMC4076924.pdf
Available from: http://www.euro.who.int/ document/E86575.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/77/JRPP-2-162.PMC4076924.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/c4/a8/JRPP-2-138.PMC4076925.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Diarrhea-Predominant Irritable Bowel Syndrome Marquis et al.",Non-OADS,/arxiv_data1/oa_pdf/a5/31/ctg20147a.PMC4077041.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Effects of Omeprazole on Sleep Disturbance Aimi et al.",Non-OADS,/arxiv_data1/oa_pdf/0e/ca/ctg20148a.PMC4077042.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Clinical and Tr anslational Gastroenterology website (http://www.nature.com/ctg)Oats Affect Local Immunity in Some Celiac Disease Patients Sjo¨berg et al.",Non-OADS,/arxiv_data1/oa_pdf/e6/a0/ctg20149a.PMC4077043.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/4a/64/JOS-3-34.PMC4077106.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/79/47/JOS-3-46.PMC4077108.pdf
URL:http://cran.r-project.org/web/packages/e1071/index.html.,OADS,/arxiv_data1/oa_pdf/a6/87/art0066-1363.PMC4077198.pdf
"For further details on atlas data methods, please see: http://www.proteinatlas.",OADS,/arxiv_data1/oa_pdf/45/a4/ni-2014-2-5348.PMC4077206.pdf
"3 Details on the technical aspects of the BGEM project for tissue processing, generation of tem- plate DNA, RNA isolation, generation of theriboprobe for in-situhybridization (ISH), actual hybridization method as well a s autoradi- ographic details are found at: http://www.stjude-bgem.org/.",Non-OADS,/arxiv_data1/oa_pdf/f3/63/ni-2014-2-5367.PMC4077210.pdf
"Originally researched as part of the GENSAT data base, many but not all of the results are currently archived at different location, and found within the Mouse Genome Informatics website under: http://www.informatics.jax.org/ gxdlit/reference/J:162220.",OADS,/arxiv_data1/oa_pdf/f3/63/ni-2014-2-5367.PMC4077210.pdf
"For an illustration of the current limita- tions in accessing the original GENSAT data, the reader is referred to the curre nt web a rchive for Fibroblast Growth Factor as an example: http://www.informatics.jax.org/assay/ MGI:4945600#g01133_P7_id.",Non-OADS,/arxiv_data1/oa_pdf/f3/63/ni-2014-2-5367.PMC4077210.pdf
"6Details on the tech- nical aspects of the GENSAT project for tissue processing of EGFP transgenic mice, as well ashistochemical details are found at: http://www.gensat.org/HistologyProtocol.pdf.",Non-OADS,/arxiv_data1/oa_pdf/4d/1c/ni-2014-2-5388.PMC4077213.pdf
"The orig inal p arasagittal images of the 16 selected genes were enlarged to show just theCA1 region as shown in Figure 1, with Kyte &Doolittle hydropathy plots made for the gene’samino acid sequence (http://web.expasy.org/ protscale/) and shown along the left and right hand outer panels of Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/4d/1c/ni-2014-2-5388.PMC4077213.pdf
A study into the information needs and perceptions of older Australians concerning falls and their prevention; 2000.http://www.health.gov.au/interne t/main/publishing.nsf/Content/ D6CD9BAFB0E54DB1CA257BF0001D238E/$File/fallsinfo.pdf .,Non-OADS,/arxiv_data1/oa_pdf/93/7f/40264_2014_Article_179.PMC4077245.pdf
Commonwealth Departmentof Health and Ageing; 2003. http://www.health.gov.au/internet/ main/publishing.nsf/Content/1063D7B1A50DA9B5CA256F19000 40484/$File/falls_costs.pdf .,Non-OADS,/arxiv_data1/oa_pdf/93/7f/40264_2014_Article_179.PMC4077245.pdf
Preventing falls and harm from falls in older people: best practiceguidelines for Australian hospitals; 2009. http://www.safetyand quality.gov.au/internet/safety/publis hing.nsf/Content/FallsGuidelines- AustHospitals .,Non-OADS,/arxiv_data1/oa_pdf/93/7f/40264_2014_Article_179.PMC4077245.pdf
Preventing falls and harm from falls in older people: best practice guidelines for Australian residential aged care facilities 2009; 2009. http://www.safetyandquality.gov.au/internet/safety/publishing.nsf/Content/FallsGuidelines-AustRACF .,Non-OADS,/arxiv_data1/oa_pdf/93/7f/40264_2014_Article_179.PMC4077245.pdf
Treatment population statistics; 2011. http://www.dva.gov.au/aboutDVA/ Statistics/Documents/TpopSep2011.pdf .,OADS,/arxiv_data1/oa_pdf/93/7f/40264_2014_Article_179.PMC4077245.pdf
Deﬁned daily dose—deﬁ-nition and general considerations; 2009. http://www.whocc.no/ ddd/deﬁnition_and_general_considera/ .,Non-OADS,/arxiv_data1/oa_pdf/93/7f/40264_2014_Article_179.PMC4077245.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/45/amep-5-197.PMC4077330.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 197–204Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  197OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S6118 9T eaching teamwork: an evaluation of an  interprofessional training ward placement   for health care students Julia Morphet1 Kerry hood2 robyn cant2 Julie Baulch3 Alana gilbee3 Kate sandry4 1school of n ursing and Midwifery,   Monash University, Frankston, Victoria,   Australia; 2school of nursing and  Midwifery, Monash University, clayton,   Victoria, Australia; 3southern clinical  school, Monash University, Monash  health, clayton, Victoria, Australia;   4Dandenong Emergency Department,   Monash health, David st, Dandenong,   Victoria, Australia correspondence: robyn cant   school of nursing and Midwifery,   Monash University, Berwick,   Victoria, Australia, 3806   Tel +61 4 3836 3634   Email robyn.cant@monash.ed uAbstract:  The es tablishment of interprofessional teamwork training in the preprofessional  health care curriculum is a major challenge for teaching faculties.",Non-OADS,/arxiv_data1/oa_pdf/a6/45/amep-5-197.PMC4077330.pdf
Available from: http://teamstepps.ahrq.gov /.,Non-OADS,/arxiv_data1/oa_pdf/a6/45/amep-5-197.PMC4077330.pdf
Available  from: http://www.who.int/hrh/resources/framework_action/en /.,OADS,/arxiv_data1/oa_pdf/a6/45/amep-5-197.PMC4077330.pdf
"Available from: http://www.amc.org.au/images/ Medschool/standards.pd f. Accessed: January 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a6/45/amep-5-197.PMC4077330.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/a6/45/amep-5-197.PMC4077330.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/45/amep-5-197.PMC4077330.pdf
"Available from: http://healthsciences.curtin.edu.au/local/docs/ IPE_Annual_Report_2012.pd f. Accessed: January 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a6/45/amep-5-197.PMC4077330.pdf
Available from: http://curriculum.cpmec.org.au /.,Non-OADS,/arxiv_data1/oa_pdf/a6/45/amep-5-197.PMC4077330.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/cia-9-997.PMC4077386.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 997–1001Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  997OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6485 3Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Uchmanowicz et al Running head recto: Reliability of the Tilburg Frailty Indicator DOI: http://dx.doi.org/10.2147/CIA.S64853 Izabella Uchmanowicz1 Beata Jankowska-Polańska1 Maria Łoboz-Rudnicka2 Stanisław Manulik3 Krystyna Łoboz-Grudzień1,2 robbert JJ gobbens4 1Department of Clinical nursing,   Wrocław Medical University,   2Department of Cardiology,    T Marciniak Memorial hospital,   3Primary Care Practice, Wrocław,   Poland; 4research and Development  Center Innovations in Care,   rotterdam University of Applied  sciences, rotterdam, the netherlands Correspondence: Izabella Uchmanowicz   Department of Clinical nursing   Wrocław Medical University, ul   Bartla 5, 51-618 Wrocław, Poland   T el +48 71 784 1824   Fax +48 71 345 9324   email izabella.uchmanowicz@umed.wroc.p lCross-cultural adaptation and reliability testing   of the Tilburg Frailty Indicator for optimizing   care of Polish patients with frailty syndrome Background:  Frail older people are at high risk of developing adverse outcomes, such as dis - ability, mortality, hospitalization, and institutionalization.",Non-OADS,/arxiv_data1/oa_pdf/6f/a0/cia-9-997.PMC4077386.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6f/a0/cia-9-997.PMC4077386.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/cia-9-997.PMC4077386.pdf
Available from: http://ec.europa.eu/economy_finance/publications/ publication14992_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/cia-9-997.PMC4077386.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/59/dddt-8-859.PMC4077387.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 859–867Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  859Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S6639 8assessing the potential impact of non-proprietary   drug copies on quality of medicine and treatment   in patients with relapsing multiple sclerosis:   the experience with fingolimod Jorge correale1 erwin chiquete2 snezana Milojevic3 nadina Frider3 imre Bajusz3 1raúl carrea institute for   neurological research, Foundation  for the Fight against infant  neurological illnesses, Buenos  aires, argentina; 2Department of  neurology and Psychiatry, salvador  Zubirán national institute of Medical  science and nutrition, Mexico city,   Mexico; 3novartis Pharma ag, Basel,   switzerland correspondence: Jorge correale   raúl carrea institute for neurological   research, Foundation for the Fight   against infant neurological illnesses,   Montañeses 2325, (1428) Buenos   aires, argentina   Tel +54 11 5777 3200, ext  2704/2706/2708   Fax +54 11 5777 3209   email jcorreale@fleni.org.a rBackground:  Fingolimod is a once-daily oral treatment for relapsing multiple sclerosis, the  proprietary production processes of which are tightly controlled, owing to its susceptibility to  contamination by impurities, including genotoxic impurities.",Non-OADS,/arxiv_data1/oa_pdf/d8/59/dddt-8-859.PMC4077387.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2013/02/WC500139217.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d8/59/dddt-8-859.PMC4077387.pdf
Available  from: https://www.tga.gov.au/pdf/euguide/qwp205403en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d8/59/dddt-8-859.PMC4077387.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d8/59/dddt-8-859.PMC4077387.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/59/dddt-8-859.PMC4077387.pdf
Available from: http://apps.who.int/ medicinedocs/documents/s19639en/s19639en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d8/59/dddt-8-859.PMC4077387.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/d8/59/dddt-8-859.PMC4077387.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 981–996Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  981OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6209 5Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Williams et al Running head recto: Reasoning exercises in assisted living DOI: http://dx.doi.org/10.2147/CIA.S62095 Kristine Williams1 ruth herman2 Daniel Bontempo3 1College of nursing, University   of Iowa, Iowa City, IA, UsA; 2school  of nursing, University of Kansas  Medical Center, Kansas City, K s, UsA;   3The schiefelbusch Institute for life  span studies, University of Kansas,   Dole human Development Center,   lawrence, K s, UsA Correspondence: Kristine Williams   446 College of nursing, University   of Iowa, 50 newton road, Iowa City,   IA 52240, UsA   email kristine-n-williams@uiowa.ed ureasoning exercises in Assisted living: a cluster  randomized trial to improve reasoning and  everyday problem solving Purpose of the study:  Assisted living (AL) residents are at risk for cognitive and functional  declines that eventually reduce their ability to care for themselves, thereby triggering nurs - ing home placement.",Non-OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from: http://aspe.hhs.gov/daltcp/ reports/2005/04alcom.htm.,OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from:  http://www.ahcancal.org/ncal/resources/Pages/ResidentProfile.aspx.,OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from: http://www.ahcancal.org/ncal/about/ Documents/GPAssistedLiving.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from: http://www.alz.org/news_and_ events_13106.asp.,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from: http://www.aarp.org/content/dam/aarp/research/ public_policy_institute/ltc/2013/baby-boom-and-the-growing-care- gap-insight-AARP-ppi-ltc.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from: http://aspe.hhs.gov/daltcp/reports/2000/alresid.htm.,OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
"Available  from: http://aspe.hhs.gov/daltcp/reports/hshp.ht m. Accessed May 15,  2007.",OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from: http://www.cdc.gov/nchs/data/nhsr/nhsr052.pdf.,OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from: http://www.stata.com/products/stb/journals/ stb15.pdf.,OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from: http://www.stata.com/products/stb/journals/ stb18.pdf.,OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
Available from: http://www.nap.edu/catalog.php?record_id=18538.,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/cia-9-981.PMC4077388.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/78/dddt-8-851.PMC4077389.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 851–858Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  851Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S6217 6novel nanocrystal formulation of megestrol   acetate has improved bioavailability compared   with the conventional micronized formulation   in the fasting state Kyungho Jang seonghae Y oon sung-eun Kim Joo-Y oun cho seo hyun Y oon Kyoung soo lim Kyung-sang Yu in-Jin Jang howard lee Department of clinical   Pharmacology and Therapeutics,    seoul national University college   of Medicine and hospital, seoul,    republic of Korea correspondence: howard lee   Department of clinical Pharmacology   and Therapeutics, seoul national   University college of Medicine and   hospital,  103 Daehak-ro, Jongno-gu,   seoul  110-799, republic of Korea   Tel +82 2740 7602  Fax +82 2742 9252   email howardlee@snu.ac.k rBackground:  Megestrol acetate is an effective treatment for improving appetite and increasing  body weight in patients with cancer-associated anorexia.",Non-OADS,/arxiv_data1/oa_pdf/91/78/dddt-8-851.PMC4077389.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/nda/2005/021778s000_ClinPharmR.pd f. Accessed  December  12, 2013.",OADS,/arxiv_data1/oa_pdf/91/78/dddt-8-851.PMC4077389.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/91/78/dddt-8-851.PMC4077389.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/78/dddt-8-851.PMC4077389.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/72/dddt-8-827.PMC4077390.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 827–838Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  827Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6377 9Quetiapine for acute bipolar depression:   a systematic review and meta-analysis sirijit suttajit Manit srisurapanont narong Maneeton Benchalak Maneeton Department of Psychiatry, Faculty  of Medicine, chiang Mai University,   chiang Mai, Thailand correspondence: sirijit suttajit   Department of Psychiatry, Faculty   of Medicine, chiang Mai University,   chiang Mai,  50200, Thailand   Tel +66 53 94 5422  Fax +66 53 94 5426  email sirijits@gmail.co mBackground:  Precise estimated risks and benefits of quetiapine for acute bipolar depression  are needed for clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/65/72/dddt-8-827.PMC4077390.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/65/72/dddt-8-827.PMC4077390.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/72/dddt-8-827.PMC4077390.pdf
Available from: http://www.astrazenecaclinicaltrials.com/Submis- sion/View?id=1464.,Non-OADS,/arxiv_data1/oa_pdf/65/72/dddt-8-827.PMC4077390.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS – Research and Palliative Care 2014:6 109–116HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  109ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S5581 6Factors associated with adherence   to antiretroviral therapy in HIV-infected   patients in Kathmandu District, nepal Rajesh Shigdel1 elise Klouman2 Anita Bhandari2 luai A Ahmed1 1Department of Health and Care  Sciences,  2Department of Community  Medicine, Faculty of Health Sciences,   UiT The Arctic University of n orway,   Tromsø, norway Correspondence: Rajesh Shigdel   Department of Health and Care Sciences,  Faculty of Health Sciences, UiT The  Arctic University of norway,   n-9037 Tromsø, norway   email rajesh.shigdel@uit.n oPurpose:  There are a high number of HIV -infected patients receiving antiretroviral therapy  (ART) in the Kathmandu District of Nepal, but information on adherence and factors influ - encing it are scarce in this population.",Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
"Available from: http://www.unaids.org/en/media/ unaids/contentassets/documents/unaidspublication/2011/JC2216_  WorldAIDSday_report_2011_en.pd f. Accessed September 13, 2012.",Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
Available from: http://www.popcouncil.,Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
Available from: http://hivinsite.ucsf.edu/InSite?page =kb- 00&doc=kb-03-02-0 9.,Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
Available from: http://pdf.usaid.,Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
Available from:  http://www.who.int/hiv/facts/WHD2011-HIVdr-fs- final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
Available from: http://www.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
"Available from: http://www.unaids.org/en/ dataanalysis/knowyourresponse/countryprogressreports/2012count ries/  ce_NP_Narrative_Report.pd f. Accessed July 13, 2013.",OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
Available from: http://www.who.int/ hiv/pub/guidelines/nepal_art.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
Available from:  http://www.ncasc.gov.np/uploaded/ facts_n_figure/FactSheet_2012/Factsheet%204_ART_2012_Nov_25.,Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
"Available from:  http://www.cdc.gov/hiv/   pdf/library_factsheet_HIV_among_PersonsAged50andOlder.pd f.  Accessed September 13, 2012.",OADS,/arxiv_data1/oa_pdf/4b/aa/hiv-6-109.PMC4077521.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/55/ijgm-7-311.PMC4077522.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 311–317International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  311OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S6364 5Incidence rate of non-hodgkin’s lymphomas  among males in saudi arabia: an observational  descriptive epidemiological analysis of data   from the saudi cancer registry, 2001–2008 Ibrahim G alghamdi1,2 Issam I hussain1 Mohamed s alghamdi3 ahlam a Dohal4 Mansour M alghamdi4 Mohammed a el-sheemy5 1school of life sciences, University  of lincoln, lincoln, UK; 2albaha  University, al Baha, saudi arabia;   3General Directorate of health  affairs, Ministry of health, al Baha,   4King Fahad specialist hospital,   Dammam, saudi arabia; 5research  and Development, lincoln hospital,   United lincolnshire hospitals  nhsTrust, lincoln, UK correspondence: Ibrahim G alghamdi   school of life sciences, University  of lincoln, Brayford Pool, lincoln,  lincolnshire ln6 7Ts, UK   T el +44 116 276 1913   email bio-stat@hotmail.co mBackground:  This study describes epidemiological data of non-Hodgkin’ s lymphoma (NHL)  diagnosed from 2001 to 2008 among Saudi men.",Non-OADS,/arxiv_data1/oa_pdf/64/55/ijgm-7-311.PMC4077522.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/64/55/ijgm-7-311.PMC4077522.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/55/ijgm-7-311.PMC4077522.pdf
"Available from: http://www.cancerresearchuk.org/cancer-info/ cancerstats/types/nhl/mortality/uk-nonhodgkin-lymphoma-mortality- statistic s. Accessed May 8, 2013.",Non-OADS,/arxiv_data1/oa_pdf/64/55/ijgm-7-311.PMC4077522.pdf
"In this study, we attempted to replicate the results and enlarge Molecular Vision  2014; 20:939-946 <http://www.molvis.org/molvis/v 20/939> Received 18 February 2014 | Accepted 28 June 2014 | Published 30 June 2014© 2014 Molecular Vision 939New ZNF644  mutations identified in patients with high myopia Xinying Xiang,1,4 Tianyun Wang,1 Ping Tong,2 Yunping Li,2 Hui Guo,1,4 Anran Wan,1 Lu Xia,1 Yanling Liu,1  Ying Li,1 Qi Tian,1 Lu Shen,1 Xinzhang Cai,1 Lei Tian,3 Xuemin Jin,3 Kun Xia,1,4,5 Zhengmao Hu1,4 (The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/61/64/mv-v20-939.PMC4077594.pdf
Molecular Vision  2014; 20:939-946 <http://www.molvis.org/molvis/v 20/939> © 2014 Molecular Vision  940Table  1.,Non-OADS,/arxiv_data1/oa_pdf/61/64/mv-v20-939.PMC4077594.pdf
Molecular Vision  2014; 20:939-946 <http://www.molvis.org/molvis/v 20/939> © 2014 Molecular Vision  941the mutation spectrum of ZNF644  in a separate Chinese high  myopia cohort.,Non-OADS,/arxiv_data1/oa_pdf/61/64/mv-v20-939.PMC4077594.pdf
Molecular Vision  2014; 20:939-946 <http://www.molvis.org/molvis/v 20/939> © 2014 Molecular Vision  942silver staining.,Non-OADS,/arxiv_data1/oa_pdf/61/64/mv-v20-939.PMC4077594.pdf
Molecular Vision  2014; 20:939-946 <http://www.molvis.org/molvis/v 20/939> © 2014 Molecular Vision  943Table  4. m uTaTions of ZNF644  iden Tified  in high  myo Pia PaTienTs uP To now and The fun CTional  and Conserva Tion Predi CTion for These  muTaTions.,Non-OADS,/arxiv_data1/oa_pdf/61/64/mv-v20-939.PMC4077594.pdf
"Molecular Vision  2014; 20:939-946 <http://www.molvis.org/molvis/v 20/939> © 2014 Molecular Vision  944association analysis using 197 Chinese subjects (CHB, CHS)  who had no phenotype record from the 1000 Genome project  as the controls.",Non-OADS,/arxiv_data1/oa_pdf/61/64/mv-v20-939.PMC4077594.pdf
Molecular Vision  2014; 20:939-946 <http://www.molvis.org/molvis/v 20/939> © 2014 Molecular Vision  945addressed to Zhengmao Hu (huzhengmao@sklmg.edu.cn) or  Kun Xia (xiakun@sklmg.edu.cn).,Non-OADS,/arxiv_data1/oa_pdf/61/64/mv-v20-939.PMC4077594.pdf
"Molecular Vision  2014; 20:939-946 <http://www.molvis.org/molvis/v 20/939> © 2014 Molecular Vision  946JS, Vitart V, Williams C, Baird PN, Wong TY, Oexle K,  Pfeiffer N, Mackey DA, Young TL, van Duijn CM, Saw SM,  Bailey-Wilson JE, Stambolian D, Klaver CC, Hammond  CJ.",Non-OADS,/arxiv_data1/oa_pdf/61/64/mv-v20-939.PMC4077594.pdf
"Currently available treatment modalities for dry eye disease Molecular Vision  2014; 20:929-938 <http://www.molvis.org/molvis/v 20/929> Received 13 August 2012 | Accepted 26 June 2014 | Published 28 June 2014© 2014 Molecular Vision 929The effects of 3% diquafosol sodium application on the tear  functions and ocular surface of the Cu,Zn-superoxide dismutase-1  (Sod1 )–knockout mice Takashi Kojima,1 Murat Dogru,1,2 Osama M. Ibrahim,1 Taeko Nagata,1 Kazunari Higa,2 Takahiko Shimizu,3  Takuji Shirasawa,4 Yoshiyuki Satake,2 Seika Shimazaki,2 Jun Shimazaki,2 Kazuo Tsubota1 1Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan; 2Department of Ophthalmology,  Tokyo Dental College, Ichikawa, Chiba, Japan; 3Department of Advanced Aging Medicine, Chiba University Graduate School of  Medicine, Chuo-ku, Chiba, Japan; 4Department of Aging Control Medicine, Juntendo University Graduate School of Medicine,  Bunkyo-ku, Tokyo, Japan Purpose:  To investigate the role of a water and mucin secretagogue (3% diquafosol sodium eye drops) on the tear func - tion and conjunctival ocular surface changes in Sod1−/− in comparison to the wild-type (WT) mice.",Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
"Molecular Vision  2014; 20:929-938 <http://www.molvis.org/molvis/v 20/929> © 2014 Molecular Vision  930include artificial tears substitutes, gels/ointments, moisture  chamber spectacles, anti-inflammatory agents (topical CsA  and corticosteroids, omega-3 fatty acids), tetracyclines, punc - tual plugs, secretagogues, autologous serum drops, contact  lenses, systemic immunosuppressives, and surgery [ 19].",Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
"Molecular Vision  2014; 20:929-938 <http://www.molvis.org/molvis/v 20/929> © 2014 Molecular Vision  931ascending grades of alcohol (70%, 80%, 90%, 100%; 2 min  in each solution), treated with xylene for 6 min, and finally  coverslipped after mounting.",Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
Molecular Vision  2014; 20:929-938 <http://www.molvis.org/molvis/v 20/929> © 2014 Molecular Vision  932 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
Molecular Vision  2014; 20:929-938 <http://www.molvis.org/molvis/v 20/929> © 2014 Molecular Vision  933 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
Molecular Vision  2014; 20:929-938 <http://www.molvis.org/molvis/v 20/929> © 2014 Molecular Vision  934 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
Molecular Vision  2014; 20:929-938 <http://www.molvis.org/molvis/v 20/929> © 2014 Molecular Vision  935 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
"Molecular Vision  2014; 20:929-938 <http://www.molvis.org/molvis/v 20/929> © 2014 Molecular Vision  936Conjunctival muc5AC messenger RNA expression altera - tions:  The expression of conjunctival muc5AC mRNA was  significantly lower in the Sod1−/− mice than the WT mice  before eye drop instillations (p<0.01), as shown in Figure 8.",Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
Molecular Vision  2014; 20:929-938 <http://www.molvis.org/molvis/v 20/929> © 2014 Molecular Vision  937invaluable knowledge for the literature.,Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
< http://www.molvis.org/molvis/v5/a32/ > 7.,Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
Molecular Vision  2014; 20:929-938 <http://www.molvis.org/molvis/v 20/929> © 2014 Molecular Vision  938secretion.,Non-OADS,/arxiv_data1/oa_pdf/79/09/mv-v20-929.PMC4077595.pdf
"METHODS Cell culture:  All experiments were conducted according to  the tenets of the Declaration of Helsinki for research involving  human subjects and approved by the Ethics Committee of  Zhongshan Ophthalmic Center, Sun Yat-sen University, Molecular Vision  2014; 20:921-928 <http://www.molvis.org/molvis/v 20/921> Received 22 December 2013 | Accepted 26 July 2014 | Published 28 June 2014© 2014 Molecular Vision 921Interleukin-4 and melatonin ameliorate high glucose and  interleukin-1β stimulated inflammatory reaction in human retinal  endothelial cells and retinal pigment epithelial cells Manyun Xie,1 Andina Hu,1 Yan Luo,1 Wei Sun,1 Xinqian Hu,1 Shibo Tang2,3,4 1The State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China; 2Aier  School of Ophthalmology, Central South University, Changsha, China; 3Aier Eye Hospital Group, Changsha, China; 4Aier  Research Institute of Ophthalmology, Changsha, China Purpose:  We aimed to evaluate the effects of two immune regulatory factors, interleukin-4 (IL-4) and melatonin, on  several in ﬂammatory mediators that are involved in in ﬂammation and angiogenesis in diabetic retinopathy (DR), in high  glucose or interleukin-1β (IL-1β) induced primary human retinal endothelial cells (RECs) and human retinal pigment  epithelial (RPE) cells.",Non-OADS,/arxiv_data1/oa_pdf/54/ef/mv-v20-921.PMC4077596.pdf
"Molecular Vision  2014; 20:921-928 <http://www.molvis.org/molvis/v 20/921> © 2014 Molecular Vision  922Guangzhou, China.",Non-OADS,/arxiv_data1/oa_pdf/54/ef/mv-v20-921.PMC4077596.pdf
Molecular Vision  2014; 20:921-928 <http://www.molvis.org/molvis/v 20/921> © 2014 Molecular Vision  923expression.,Non-OADS,/arxiv_data1/oa_pdf/54/ef/mv-v20-921.PMC4077596.pdf
"Molecular Vision  2014; 20:921-928 <http://www.molvis.org/molvis/v 20/921> © 2014 Molecular Vision  924DISCUSSION In the present study, we observed that IL-4 and melatonin  inhibited the expression of several cytokines, including  VEGF, ICAM-1, MMP2, and MMP9, induced by high  glucose and IL-1β in human RECs and RPE cells.",Non-OADS,/arxiv_data1/oa_pdf/54/ef/mv-v20-921.PMC4077596.pdf
Molecular Vision  2014; 20:921-928 <http://www.molvis.org/molvis/v 20/921> © 2014 Molecular Vision  925 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/54/ef/mv-v20-921.PMC4077596.pdf
Molecular Vision  2014; 20:921-928 <http://www.molvis.org/molvis/v 20/921> © 2014 Molecular Vision  926cascade.,Non-OADS,/arxiv_data1/oa_pdf/54/ef/mv-v20-921.PMC4077596.pdf
Molecular Vision  2014; 20:921-928 <http://www.molvis.org/molvis/v 20/921> © 2014 Molecular Vision  9272.,Non-OADS,/arxiv_data1/oa_pdf/54/ef/mv-v20-921.PMC4077596.pdf
Molecular Vision  2014; 20:921-928 <http://www.molvis.org/molvis/v 20/921> © 2014 Molecular Vision  92827.,Non-OADS,/arxiv_data1/oa_pdf/54/ef/mv-v20-921.PMC4077596.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/75/ijn-9-3131.PMC4077603.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3131–3135International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3131Short reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/IJN.S5643 9Lubricin as a novel nanostructured protein  coating to reduce fibroblast density George ejiofor Aninwene II1 Zifan Yang2 Vishnu ravi3 Gregory D Jay2,4 thomas J Webster1,5 1Department of Chemical Engineering  and program in Bioengineering,   Northeastern University, Boston,   MA, USA; 2School of engineering,   Brown University, Providence, RI,   USA; 3Albany Medical College, Albany,   NY, USA; 4Department of Emergency  Medicine, Brown University, School  of Medicine, providence, rI, USA;   5Center of Excellence for Advanced  Materials research, King Abdulaziz  University, Jeddah, Saudi Arabia Correspondence: Thomas J Webster   Department of Chemical Engineering and  program in Bioengineering, Northeastern  University, 360 Huntington Ave, Boston,  MA, USA, 02115   email th.webster@neu.ed uAbstract:  Excessive fibroblast adhesion and proliferation on the surface of medical implants  (such as catheters, endotracheal tubes, intraocular lenses, etc) can lead to major postsurgical  complications.",Non-OADS,/arxiv_data1/oa_pdf/95/75/ijn-9-3131.PMC4077603.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/95/75/ijn-9-3131.PMC4077603.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/75/ijn-9-3131.PMC4077603.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/ad/ijn-9-3027.PMC4077604.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3027–3036International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3027OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6399 1li Zhang* Junwei Yan* Zhaowei Yin cheng Tang Yang guo Dong li Bo Wei Yan Xu Qiangrong gu liming Wang Orthopedic laboratory of Nanjing  First hospital, Nanjing Medical  University, Nanjing, People’s republic  of china *Both of these authors contributed  equally to this work correspondence: liming Wang   Orthopedic Department, Nanjing First  hospital, Nanjing Medical University,  68 changle road, Nanjing 210006,  People’s republic of china   email limingwang99@163.co melectrospun vancomycin-loaded coating   on titanium implants for the prevention   of implant-associated infections Abstract:  The objectives of this work were to develop an antibiotic coating on the surface of a  titanium plate to determine its antibacterial properties in vitro and in vivo.",Non-OADS,/arxiv_data1/oa_pdf/8a/ad/ijn-9-3027.PMC4077604.pdf
It was Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Zhang et al Running head recto: Electrospun vancomycin-loaded coating on titanium implants DOI: http://dx.doi.org/10.2147/IJN.S63991,Non-OADS,/arxiv_data1/oa_pdf/8a/ad/ijn-9-3027.PMC4077604.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8a/ad/ijn-9-3027.PMC4077604.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 3036Zhang et al  17.,Non-OADS,/arxiv_data1/oa_pdf/8a/ad/ijn-9-3027.PMC4077604.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/3f/ijn-9-3057.PMC4077605.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3057–3068International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3057OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6410 0Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Rong et al Running head recto: Safety evaluation of PLGA/PLA microspheres through intravitreal injection DOI: http://dx.doi.org/10.2147/IJN.S64100 safety evaluation of poly(lactic-co-glycolic acid)/ poly(lactic-acid) microspheres through   intravitreal injection in rabbits correspondence: Yi lu Department of Ophthalmology and Vision  science, eye and eNT hospital, shanghai  Medical college, Fudan University,  shanghai 200031, People’s republic   of china  Tel +86 21 6437 7134 Fax +86 21 6437 7151 email luyiox@163.co m Xiaofen Mo Department of Ophthalmology and Vision  science, eye and eNT hospital, shanghai  Medical college, Fudan University,  shanghai 200031, People’s republic   of china Tel +86 21 6437 3954 Fax +86 21 6437 7151 email xfmo@fudan.edu.c nXianfang rong1 Weien Yuan2 Yi lu1 Xiaofen Mo1 1Department of Ophthalmology and  Vision science, eye and eNT hospital,   shanghai Medical college, Fudan  University, shanghai, People’s republic  of china; 2school of Pharmacy,   shanghai Jiao T ong University,   shanghai, People’s republic of chinaAbstract:  Poly(lactic-co-glycolic acid) (PLGA) and/or poly(lactic-acid) (PLA) microspheres  are important drug delivery systems.",Non-OADS,/arxiv_data1/oa_pdf/70/3f/ijn-9-3057.PMC4077605.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/70/3f/ijn-9-3057.PMC4077605.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3068rong et al  27.,Non-OADS,/arxiv_data1/oa_pdf/70/3f/ijn-9-3057.PMC4077605.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/52/ijn-9-3107.PMC4077606.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3107–3118International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3107OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6353 5Preparation and characterization of Tamoxifen  citrate loaded nanoparticles for breast   cancer therapy correspondence: Biswajit Mukherjee Department of Pharmaceutical  Technology, Jadavpur University,   Kolkata (calcutta) 700 032, India Tel +91 33 2457 2588 Fax +91 33 2414 6677 email biswajit55@yahoo.co mruma Maji Niladri shekhar Dey Bhabani sankar satapathy Biswajit Mukherjee subhasish Mondal Department of Pharmaceutical  T echnology, Jadavpur University,   Kolkata (calcutta), IndiaBackground:  Four formulations of Tamoxifen citrate loaded polylactide-co-glycolide  (PLGA) based nanoparticles (TNPs) were developed and characterized.",Non-OADS,/arxiv_data1/oa_pdf/64/52/ijn-9-3107.PMC4077606.pdf
"Delivering the drugs  through the nanoparticles makes it possible to achieve the desired concentration of  drug in the specific site, thus minimizing the side effects and reducing the toxicity, Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Maji et al Running head recto: Preparation and characterization of TNPs for breast cancer therapy DOI: http://dx.doi.org/10.2147/IJN.S63535",Non-OADS,/arxiv_data1/oa_pdf/64/52/ijn-9-3107.PMC4077606.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/64/52/ijn-9-3107.PMC4077606.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3118Maji et al  26.,Non-OADS,/arxiv_data1/oa_pdf/64/52/ijn-9-3107.PMC4077606.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8b/91/ijn-9-3091.PMC4077607.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3091–3105International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3091OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6566 4Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Du et al Running head recto: Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid DOI: http://dx.doi.org/10.2147/IJN.S65664 Antitumor effect of iRGD-modified liposomes  containing conjugated linoleic acid–paclitaxel  (cla-PTX) on B16-F10 melanoma correspondence: Xuan Zhang Department of Pharmaceutics, school  of Pharmaceutical sciences, Peking  University, 38 Xueyuan road, Beijing  100191, People’s republic of china Tel/fax +86 10 8280 5928 email xuanzhang@bjmu.edu.c nruo Du1 Ting Zhong1 Wei-Qiang Zhang1 Ping song1 Wen-Ding song1 Yang Zhao1 chao-Wang1 Yi-Qun Tang3 Xuan Zhang1,2 Qiang Zhang1,2 1Department of Pharmaceutics,    2state Key laboratory of Natural   and Biomimetic Drugs, school   of Pharmaceutical sciences, Peking  University, Beijing, 3Department  of clinical Pharmacy, china  Pharmaceutical University, Nanjing,   People’s republic of chinaAbstract:  In the present study, we prepared a novel delivery system of iRGD (CRGDK/ RGPD/EC)-modified sterically stabilized liposomes (SSLs) containing conjugated linoleic  acid–paclitaxel (CLA-PTX).",Non-OADS,/arxiv_data1/oa_pdf/8b/91/ijn-9-3091.PMC4077607.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8b/91/ijn-9-3091.PMC4077607.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3105Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid Supplementary materials Figure S1 Typical particle size and distribution of the ssl-cla-PTX ( A) and irgD-ssl-cla-PTX ( B).,Non-OADS,/arxiv_data1/oa_pdf/8b/91/ijn-9-3091.PMC4077607.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/74/ijn-9-3077.PMC4077608.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3077–3090International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3077OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S5930 2sinoporphyrin sodium, a novel sensitizer, triggers  mitochondrial-dependent apoptosis in eca-109  cells via production of reactive oxygen species haiping Wang1 Xiaobing Wang1 shaoliang Zhang2 Pan Wang1 Kun Zhang1 Quanhong liu1 1Key laboratory of Medicinal  resources and Natural  Pharmaceutical chemistry, Ministry  of education, National engineering  laboratory for resource Developing  of endangered chinese crude Drugs  in Northwest of china, college  of life sciences, shaanxi Normal  University, Xi’an, shaanxi, 2Qinglong  high-Tech co, ltd, Yichun, Jiangxi,  People’s republic of china correspondence: Xiaobing Wang;   Quanhong liu   Key laboratory of Medicinal resources   and Natural Pharmaceutical chemistry,   Ministry of education, National   engineering laboratory for resource   Developing of endangered chinese   crude Drugs in Northwest of china,   college of life sciences, shaanxi   Normal University, Xi’an 710062,   shaanxi, People’s republic of china   Tel +86 29 8531 0275   email wangxiaobing@snnu.edu.c n;  lshaof@snnu.edu.c nBackground:  Sonodynamic therapy (SDT) is a promising method that uses ultrasound to  activate certain chemical sensitizers for the treatment of cancer.",Non-OADS,/arxiv_data1/oa_pdf/95/74/ijn-9-3077.PMC4077608.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/95/74/ijn-9-3077.PMC4077608.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/74/ijn-9-3077.PMC4077608.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/7c/ijn-9-3037.PMC4077609.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3037–3056International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3037OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6127 3In vivo anticancer evaluation of the hyperthermic  efficacy of anti-human epidermal growth factor  receptor-targeted PEG-based nanocarrier  containing magnetic nanoparticles correspondence: Mauro comes Franchini Department of Industrial chemistry   T oso Montanari, Viale Risorgimento 4,  40136, Bologna, Italy T el +51 209 3626 Fax +51 209 3654 email mauro.comesfranchini@unibo.i tgiovanni Baldi1 Costanza Ravagli1 Filippo Mazzantini1 George Loudos2 Jaume adan3 Marc Masa3 Dimitrios Psimadas2 Eirini A Fragogeorgi2 erica locatelli4 claudia Innocenti5,6 Claudio Sangregorio5,7 Mauro comes Franchini4 1CERICOL, Sovigliana-Vinci, Italy;   2Technological Educational Institute  of Athens, Athens, Greece; 3leitat  T echnological Center, Barcelona,   Spain; 4Department of Industrial  chemistry Toso Montanari, University  of Bologna, Bologna, 5consorzio  Interuniversitario Nazionale  per la Scienza e Tecnologia dei  Materiali (IN sTM), 6Dipartimento  di chimica  U schiff, Università di  Firenze, Firenze, 7centro Nazionale  delle ricerche (IccOM – cNr),   Firenze, ItalyAbstract:  Polymeric nanoparticles with targeting moieties containing magnetic nanoparticles  as theranostic agents have considerable potential for the treatment of cancer.",Non-OADS,/arxiv_data1/oa_pdf/69/7c/ijn-9-3037.PMC4077609.pdf
"There have been very few published reports thus far of  their use in patients,17,18 even if recently more focused hyperthermic studies for bio - medical applications have begun to arise and have been reported due to the extremely  interesting perspectives.Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Baldi et al Running head recto: Hyperthermic treatment of skin cancer DOI: http://dx.doi.org/10.2147/IJN.S61273",Non-OADS,/arxiv_data1/oa_pdf/69/7c/ijn-9-3037.PMC4077609.pdf
"Regions of interest were analyzed using ImageJ software (available online from http://imagej.nih.gov/ij /).38  The heat generated by the intratumorally injected nanoparticle  dispersions was measured when the A431-bearing mice were  placed at the center of the coil, which induces the magnetic field.",OADS,/arxiv_data1/oa_pdf/69/7c/ijn-9-3037.PMC4077609.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/69/7c/ijn-9-3037.PMC4077609.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3056Baldi et al 0.05.010.015.020.025.030.035.040.045.0 0.01.02.03.04.05.06.07.08.09.010.0% of radioactivity Minutes post injectionConcentr ation of Fe3O4-1-PNPs -hEGFR on  various or gans % lungs % kidney s % bladder % tumor % brain % muscle % liverA 10 20 30 40 50 60 70 0102030405060708090100 00.511.522.533.5% of radioactivity  Minutes post injection% bladde r % spleen % lungs % liverConcentration of Fe3O4-1-PNPs on various organs 10 20 30 40 50 60 70B Figure S16 Percentage of radioactivity concentration using regions of interest in liver, muscle, brain, tumor, bladder, kidneys, and lungs in a dynamic study of Fe3O4-1-PNPs- hEGFR-99mTc in an A431 tumor-bearing mouse ( A).",Non-OADS,/arxiv_data1/oa_pdf/69/7c/ijn-9-3037.PMC4077609.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/93/ijwh-6-639.PMC4077694.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 639–645International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  639OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S6363 6Incidence rate of ovarian cancer cases   in saudi arabia: an observational descriptive  epidemiological analysis of data from saudi  cancer registry  2001–2008 Ibrahim g alghamdi1,2 Issam I Hussain1 Mohamed s alghamdi3 Mansour M alghamdi4 ahlam a Dohal4 Mohammed a el-sheemy5 1school of life sciences, University  of lincoln, Brayford Pool, lincoln,   UK;  2al-Baha University, Kingdom  of saudia arabia; 3Ministry of Health,   general Directorate of Health  affairs, al-Baha, Kingdom of saudi  arabia;  4King Fahad specialist  Hospital–Dammam, Kingdom of saudi  arabia;  5Department of research  and Development, lincoln Hospital,   United lincolnshire Hospitals,   national Health service Trust, lincoln,   UK correspondence: Ibrahim g alghamdi   15 copgrove close, Hamilton,   leicester, le5 1a W, UK   Tel +44 116 276 1913  email bio-stat@hotmail.co mPurpose:  This study provides descriptive epidemiological data, such as the percentage of cases  diagnosed, crude incidence rate (CIR), and age-standardized incidence rate (ASIR) of ovarian  cancer in Saudi Arabia from  2001–2008.",Non-OADS,/arxiv_data1/oa_pdf/f3/93/ijwh-6-639.PMC4077694.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/f3/93/ijwh-6-639.PMC4077694.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/93/ijwh-6-639.PMC4077694.pdf
"Available  from: http://globocan.iarc.fr/ia/World/atlas.htm l. Accessed September   21, 2013.",Non-OADS,/arxiv_data1/oa_pdf/f3/93/ijwh-6-639.PMC4077694.pdf
"Available from: http://www.kfshrc.edu.sa/oncology/   Tumor%202011%20New%206%20Final.pd f. Accessed June 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/f3/93/ijwh-6-639.PMC4077694.pdf
"Available from http://www.scr.org.sa/files/ file/1eo1lhvt_compressPdf.pd f. Accessed June 9, 2014.",OADS,/arxiv_data1/oa_pdf/f3/93/ijwh-6-639.PMC4077694.pdf
"Available from: http://www.who.int/  healthinfo/paper31.pd f. Accessed January 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/f3/93/ijwh-6-639.PMC4077694.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7e/cb/jpr-7-327.PMC4077695.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 327–338Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  327ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S5688 3The importance of catastrophizing for successful  pharmacological treatment of peripheral  neuropathic pain cory T oth shauna Brady Melinda hatfield Department of clinical  neurosciences, University of calgary,   calgary, aB, canada correspondence : cory Toth   Room 155, University of calgary,   Department of clinical neurosciences,   3330 hospital Drive nW, calgary,   aB, canada, T2n4n1   Tel +1 403 220 8831   Fax +1 403 283 8731   email corytoth@shaw.c aObjective:  Catastrophizing may be a negative predictor of pain-related outcomes.",Non-OADS,/arxiv_data1/oa_pdf/7e/cb/jpr-7-327.PMC4077695.pdf
Adverse events  were  coded using Medical Dictionary for Regulatory Activities ( Med- DRA; http://www.meddra.or g) terminology.,OADS,/arxiv_data1/oa_pdf/7e/cb/jpr-7-327.PMC4077695.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/7e/cb/jpr-7-327.PMC4077695.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/cb/jpr-7-327.PMC4077695.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/41/ndt-10-1155.PMC4077785.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1155–1160Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1155Shor T repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6272 8Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Short Report Y ear: 2014 Volume: 10 Running head verso: Zaninotto et al Running head recto: Verbal fluency improvement in diffuse brain injury DOI: http://dx.doi.org/10.2147/NDT.S62728 Correspondence: Wellingson Silva paiva University of São paulo Medical School,  470 Alves Guimarães St, Ap 93,   São paulo-Sp 05410-000, Brazil T el +55 11 2661 7226 Fax +55 11 2548 6906 email wellingsonpaiva@yahoo.com.b rImprovement of verbal fluency in patients   with diffuse brain injury over time Ana Luiza Zaninotto1 Vinícius Monteiro   de paula Guirado2 Beatriz Baldivia1 Monica Domiano Núñes1 robson Luis   oliveira Amorim2 Manoel Jacobsen T eixeira2 Mara Cristina Souza   de Lucia1 Almir Ferreira de Andrade2 Wellingson Silva paiva2 1Division of psychology, hospital das  Clínicas, 2Division of Neurosurgery,   University of São paulo Medical  School, São paulo, BrazilBackground:  Diffuse axonal injury (DAI), a common cause of neurological sequelae in  patients with traumatic brain injury (TBI), is considered one of the most prevalent forms of  primary neuronal injury in patients with severe TBI.",Non-OADS,/arxiv_data1/oa_pdf/79/41/ndt-10-1155.PMC4077785.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/79/41/ndt-10-1155.PMC4077785.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1160Zaninotto et al  18.,Non-OADS,/arxiv_data1/oa_pdf/79/41/ndt-10-1155.PMC4077785.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/77/ndt-10-1175.PMC4077786.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1175–1181Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1175Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6419 2Correspondence: Li-Wei Chou Department of physical Medicine and  rehabilitation, China Medical University  Hospital, 2 Yuh-Der road,   Taichung 40447, Taiwan Tel +886 4 2205 2121 ext 2381 Fax +886 4 2202 6041 email chouliwe@gmail.comBrain meningioma with initial manifestation   similar to cervical radiculopathy: a case report Yu-Hsuan Huang1,* Chang-Zern Hong2,* Wei-Ting Wu1 Kun-Ta Li3 Li-Wei Chou1,4 ¹Department of physical Medicine  and rehabilitation, China Medical  University Hospital, 2Department  of physical Therapy, Hungkuang  University, 3Department of emergency  Medicine, China Medical University  Hospital, 4school of Chinese Medicine,   College of Chinese Medicine, China  Medical University, Taichung, Taiwan *These authors contributed equally   to this workAbstract:  Meningiomas are the most common benign brain tumors, and are characterized by  slow growth and a long asymptomatic period.",Non-OADS,/arxiv_data1/oa_pdf/55/77/ndt-10-1175.PMC4077786.pdf
"Meningioma accounted for more than a third of all primary central nervous system  tumors reported in the US between 2006 and 2010, where the highest incidence rate  (7.44 per 100,000) of the disease has been recorded.5 Meningiomas usually grow Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Case report Y ear: 2014 Volume: 10 Running head verso: Huang et al Running head recto: Meningioma mimicking cervical radiculopathy DOI: http://dx.doi.org/10.2147/NDT.S64192",Non-OADS,/arxiv_data1/oa_pdf/55/77/ndt-10-1175.PMC4077786.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/55/77/ndt-10-1175.PMC4077786.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1181Meningioma mimicking cervical radiculopathy  23.,Non-OADS,/arxiv_data1/oa_pdf/55/77/ndt-10-1175.PMC4077786.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/3c/jbm-5-099.PMC4077787.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Blood Medicine 2014:5 99–106Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  99Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S6497 6Fluorescence resonance energy transfer-based  real-time polymerase chain reaction method  without Dna extraction for the genotyping of F5,  F2, F12, MThFr, and hFe Jordi Martinez-serra1 Juan robles2 antoni nicolàs3 antonio gutierrez1 T eresa ros1 Juan carlos amat1 regina alemany4 Oliver Vögler4 aina abelló2 aina noguera2 Joan Besalduch1 1Department of hematology,   2Department of clinical analysis,   hospital Universitary son espases,   Palma de Mallorca, spain;  3ecOgen ,   Barcelona,  4Department of cell  Biology, University of the Balearic  islands, Palma de Mallorca, spainAbstract:  Blood samples are extensively used for the molecular diagnosis of many  hematological diseases.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/jbm-5-099.PMC4077787.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/jbm-5-099.PMC4077787.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/3c/jbm-5-099.PMC4077787.pdf
"Upon ex vivo Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> Received 3 April 2014 | Accepted 30 June 2014 | Published 2 July 2014© 2014 Molecular Vision 956Absence of recognition of common melanocytic antigens by T cells  isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada  patient Sébastien Abad,1 Grégoire Wieërs,2 Didier Colau,2 Claude Wildmann,2 Emmanuelle Delair,3 Robin Dhote,1  Antoine P. Brézin,3 Yukata Kawakami,4 Pierre G. Coulie,5 Pierre van der Bruggen2 1Université Paris 13, Sorbonne Paris Cité, Laboratoire de recherche clinique et thérapeutique, Bobigny, France; Service de  Médecine Interne, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France; 2Ludwig Institute for  Cancer Research and de Duve Institute, Université catholique de Louvain, 74 av.",Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
"Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  957nonspecific stimulation, blood CD4 T lymphocytes of VKH  patients secreted slightly more IFN-γ and interleukin (IL)-2  than did cells obtained from control individuals, whereas IL-4  secretion was similar in both groups [ 17].",Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
"Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  958Melan-A, KU-MEL-1, and MAGEA3 were available in  our laboratories.",Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  959(ref.,Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  960were constructed.,Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
"Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  961melanocytic proteins, and we were unable to receive a func - tional clone from other laboratories.",Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  962The recognition of the MAGEA3-derived antigen by  T cells was assessed by measuring the amounts of IFN-γ  released in the supernatant of overnight co-cultures.,Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  963 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
"Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  964with antigen-presenting cells, namely autologous EBV-B  cells that were previously incubated for 20 h with either of  two pools of opsonized bacteria.",Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  965our patient does not support the hypothesis of such a viral  infection.,Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  966 Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  967VKH disease.,Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  968ACKNOWLEDGMENTS We thank Nathalie Krack for her administrative and secre - tarial assistance.,Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
Molecular Vision  2014; 20:956-969 <http://www.molvis.org/molvis/v 20/956> © 2014 Molecular Vision  969with leptomeningeal enhancement.,Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
Cancer  Immun 2013; http://www.cancerimmunity.org/peptide/ .,Non-OADS,/arxiv_data1/oa_pdf/90/42/mv-v20-956.PMC4077848.pdf
"Entrez is intended to be a central  repository of all genomic data and thus cannot be specific to Molecular Vision  2014; 20:947-955 <http://www.molvis.org/molvis/v 20/947> Received 6 September 2014 | Accepted 29 June 2014 | Published 1 July 2014© 2014 Molecular Vision 947Generation of a foveomacular transcriptome Alison Ziesel,1 Steven Bernstein,2 Paul W. Wong1 1Department of Ophthalmology, Emory University, Atlanta GA; 2Department of Opthalmology and Visual Sciences, University of  Maryland, Baltimore MD Purpose:  Organizing molecular biologic data is a growing challenge since the rate of data accumulation is steadily  increasing.",Non-OADS,/arxiv_data1/oa_pdf/41/f0/mv-v20-947.PMC4077849.pdf
"Molecular Vision  2014; 20:947-955 <http://www.molvis.org/molvis/v 20/947> © 2014 Molecular Vision  948any one tissue or developmental state, although information  centered on a single tissue can be potentially extracted.",Non-OADS,/arxiv_data1/oa_pdf/41/f0/mv-v20-947.PMC4077849.pdf
"Molecular Vision  2014; 20:947-955 <http://www.molvis.org/molvis/v 20/947> © 2014 Molecular Vision  949The molecular dynamic scans of screened GDA array  filters were analyzed by Genome Systems using imaging  software specialized for high-density array analysis (Array  Vision; IMAGING Research, St. Catharines, Ontario,  Canada).",OADS,/arxiv_data1/oa_pdf/41/f0/mv-v20-947.PMC4077849.pdf
Molecular Vision  2014; 20:947-955 <http://www.molvis.org/molvis/v 20/947> © 2014 Molecular Vision  950and Gene .,Non-OADS,/arxiv_data1/oa_pdf/41/f0/mv-v20-947.PMC4077849.pdf
Molecular Vision  2014; 20:947-955 <http://www.molvis.org/molvis/v 20/947> © 2014 Molecular Vision  951Identification of the same gene in independent data sources  provides internal experimental confirmation of foveomacular  gene expression status.,Non-OADS,/arxiv_data1/oa_pdf/41/f0/mv-v20-947.PMC4077849.pdf
"Molecular Vision  2014; 20:947-955 <http://www.molvis.org/molvis/v 20/947> © 2014 Molecular Vision  952(46%) of these retinopathic genes in our list of 6,056 foveo - macularly expressed genes.",Non-OADS,/arxiv_data1/oa_pdf/41/f0/mv-v20-947.PMC4077849.pdf
Molecular Vision  2014; 20:947-955 <http://www.molvis.org/molvis/v 20/947> © 2014 Molecular Vision  953samples used to generate our cDNA probe.,Non-OADS,/arxiv_data1/oa_pdf/41/f0/mv-v20-947.PMC4077849.pdf
Molecular Vision  2014; 20:947-955 <http://www.molvis.org/molvis/v 20/947> © 2014 Molecular Vision  954script licensing.,Non-OADS,/arxiv_data1/oa_pdf/41/f0/mv-v20-947.PMC4077849.pdf
14. ftp://ftp.ncbi.nih.gov//genbank/release.notes/gb90.release.notes 15.,Non-OADS,/arxiv_data1/oa_pdf/41/f0/mv-v20-947.PMC4077849.pdf
"Molecular Vision  2014; 20:947-955 <http://www.molvis.org/molvis/v 20/947> © 2014 Molecular Vision  955Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/41/f0/mv-v20-947.PMC4077849.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/4d/opth-8-1199.PMC4077850.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1199–1202Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1199Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6581 0Journal name: Clinical Ophthalmology Journal Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Fujii et al Running head recto: Intravitreal aflibercept injection for AMD DOI: http://dx.doi.org/10.2147/OPTH.S65810 Effect of intravitreal aflibercept injection for  age-related macular degeneration with a retinal  pigment epithelial tear refractory to intravitreal  ranibizumab injection Ayaka Fujii1 Hisanori imai1,2 Michiko Kanai1 Atsushi Azumi1,2  1Department of Ophthalmology,    Kobe Kaisei Hospital, 2Department   of Organ Therapeutics, Division   of Ophthalmology, Kobe University  Graduate school of Medicine,    Kobe, Japan Correspondence: Hisanori imai   Department of Ophthalmology,  Kobe Kaisei Hospital, 3-11-15  shinoharakitamachi, Nada-ku,   Kobe 657-0068, Japan   T el +817 8871 5201   Fax +817 8871 5206   email imai@kobe-kaisei.o rBackground:  The purpose of this study was to evaluate the effects of intravitreal aflibercept  injection for age-related macular degeneration (AMD) with a retinal pigment epithelial (RPE)  tear after intravitreal ranibizumab injection (IVR) which finally became resistant to additional  IVR.",Non-OADS,/arxiv_data1/oa_pdf/89/4d/opth-8-1199.PMC4077850.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/89/4d/opth-8-1199.PMC4077850.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1202Fujii et al  8.,Non-OADS,/arxiv_data1/oa_pdf/89/4d/opth-8-1199.PMC4077850.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/4a/ppa-8-893.PMC4077851.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 893–907Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  893OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5616 0instruments to assess patient satisfaction after  teleconsultation and triage: a systematic review Martina Allemann iseli1 regina Kunz2 eva Blozik1,3 1swiss center for Telemedicine  Medgate, Basel, switzerland ; 2Academy  of swiss insurance Medicine,   University of Basel, Basel, switzerland;   3Department of Primary Medical care,   University Medical center hamburg– eppendorf , Martinistrasse, hamburg,   germany correspondence: eva Blozik   Department of Primary Medical care,   University Medical center   hamburg–eppendorf, Martini strasse  52,  20246 hamburg, germany   Tel +49 40 741 052 400   Fax +49 40 741 053 681   email e.blozik@uke.d eBackground:  Patient satisfaction is crucial for the acceptance, use, and adherence to   recommendations from teleconsultations regarding health care requests and triage services.",Non-OADS,/arxiv_data1/oa_pdf/b0/4a/ppa-8-893.PMC4077851.pdf
Available from: http://www.ahrq.,Non-OADS,/arxiv_data1/oa_pdf/b0/4a/ppa-8-893.PMC4077851.pdf
Available from: http://www.cadth.,Non-OADS,/arxiv_data1/oa_pdf/b0/4a/ppa-8-893.PMC4077851.pdf
"Available from: http://www.nihpromis.org/Documents/ PROMISStandards_Vers2.0_Final.pd f. Accessed October 16, 2013.",OADS,/arxiv_data1/oa_pdf/b0/4a/ppa-8-893.PMC4077851.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b0/4a/ppa-8-893.PMC4077851.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/4a/ppa-8-893.PMC4077851.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/66/vhrm-10-353.PMC4077852.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 353–362Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  353ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S4047 7Update on ranolazine in the management of angina J Nicolás Codolosa1 Subroto Acharjee1 Vincent M Figueredo1,2 1einstein Center for Heart and  Vascular Health, einstein Medical  Center,  2Jefferson Medical College,   Philadelphia, PA, USA Correspondence: Vincent M Figueredo   einstein Medical Center,  5501 Old York   Road, Levy  3232 Philadelphia,   PA 19141, USA   Tel +1 215 456 8991  Fax +1 215 456 3533  email figueredov@einstein.ed uAbstract:  Mortality rates attribu table  to coronary heart disease have declined in recent years,  possibly related to changes in clinical presentation patterns and use of proven secondary preven - tion strategies.",Non-OADS,/arxiv_data1/oa_pdf/8a/66/vhrm-10-353.PMC4077852.pdf
Available from: http://wonder.cdc.gov/mortSQl.,OADS,/arxiv_data1/oa_pdf/8a/66/vhrm-10-353.PMC4077852.pdf
"Available from: https://www.nhlbi.nih.gov/ resources/docs/06a_ip_chtbk.pd f. Accessed May  13, 2014.",OADS,/arxiv_data1/oa_pdf/8a/66/vhrm-10-353.PMC4077852.pdf
"Available from: http://www.fda.gov/NewsEvents/ Newsroom /PressAnnouncements/2006/ucm108587.ht m. Accessed  February  25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8a/66/vhrm-10-353.PMC4077852.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/8a/66/vhrm-10-353.PMC4077852.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/66/vhrm-10-353.PMC4077852.pdf
Available  from: http://clinicaltrials.gov/ct2/show/NCT0153496 2.,Non-OADS,/arxiv_data1/oa_pdf/8a/66/vhrm-10-353.PMC4077852.pdf
Available from: http://clinicaltrials.gov/show/NCT0152265 1.,Non-OADS,/arxiv_data1/oa_pdf/8a/66/vhrm-10-353.PMC4077852.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ott-7-1151.PMC4077853.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1151–1158OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1151Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S5039 4Mapping lymph nodes in cancer management –  role of  99mTc-tilmanocept injection Christoph Tausch Astrid Baege Christoph Rageth Brust-Zentrum, Zürich, Switzerland Correspondence: Christoph Tausch   Brust-Zentrum, Seefeldstrasse  214,  Zürich, Switzerland   Tel +41 44 380 76 60  Fax +41 44 380 76 61  email c.tausch@brust-zentrum.c hAbstract:  Two decades ago, lymphatic mapping of sentinel lymph nodes (SLN) was introduced  into surgical cancer management and was termed sentinel node navigated surgery.",Non-OADS,/arxiv_data1/oa_pdf/fd/02/ott-7-1151.PMC4077853.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fd/02/ott-7-1151.PMC4077853.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/02/ott-7-1151.PMC4077853.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/e2/ppa-8-917.PMC4077854.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 917–923Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  917OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6266 6effect of a structured, active, home-based   cancer-treatment program for the management   of patients on oral chemotherapy s Bordonaro1 F romano1 e lanteri1 F cappuccio1 r indorato2 A Butera2 A D’Angelo3 F Ferraù3 P Tralongo1 1Medical Oncology Unit, Umberto i  hospital, rete Assistenza Oncologica,   siracusa, 2Medical Oncology Unit,    s giovanni di Dio hospital, Agrigento,   3Medical Oncology Unit,    s Vincenzo hospital, Taormina, italy correspondence: Paolo Tralongo   Medical Oncology Unit, Umberto   i hospital, rAO, siracusa, italy   T el +39 9 3172 4542   email tralongo@raosr.i tIntroduction:  The advent of oral chemotherapy agents has had a strong impact on several  aspects of the management of cancer patients, including survival rates, health-care expenditure,  and health-related quality of life.",Non-OADS,/arxiv_data1/oa_pdf/57/e2/ppa-8-917.PMC4077854.pdf
It should Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Bordonaro et al Running head recto: Effect of an active home-based cancer-treatment program DOI: http://dx.doi.org/10.2147/PPA.S62666,Non-OADS,/arxiv_data1/oa_pdf/57/e2/ppa-8-917.PMC4077854.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/57/e2/ppa-8-917.PMC4077854.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/1e/ppa-8-925.PMC4077855.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 925–931Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  925Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S4666 7Bromfenac ophthalmic solution for the treatment  of postoperative ocular pain and inflammation:  safety, efficacy, and patient adherence Rajesh K Rajpal Bryan Ross Sachin D Rajpal Khoa Hoang See Clearly vision Group, McLean,    vA, USAAbstract:  Ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used  by clinicians to manage ocular inflammation and pain following cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/6e/1e/ppa-8-925.PMC4077855.pdf
"With respect to their mechanism of action, in short, NSAIDs  inhibit cyclooxygenase (COX) at the site of inflammation.11 COX inhibitors act upon  the arachidonic acid pathway to inhibit the production of prostaglandins, thereby   reducing inflammation.11–16 Since NSAIDs act at later stages in the arachidonic acid  pathway than corticosteroids, they can achieve similar anti-inflammatory effects without  the adverse events (AEs) common with steroid use (eg, increased intraocular pressure Correspondence: Rajesh Rajpal See Clearly vision Group,   8138 watson St, McLean,   vA 22102, USA email rrajpal@seeclearly.co mJournal name: Patient Preference and Adherence Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Rajpal et al Running head recto: Once-daily bromfenac for ocular inflammation and pain DOI: http://dx.doi.org/10.2147/PPA.S46667",Non-OADS,/arxiv_data1/oa_pdf/6e/1e/ppa-8-925.PMC4077855.pdf
Available from: http://www.ema.europa.eu/ema/index.jsp?curl =pages/ medicines/human/medicines/000818/human_med_000928.,Non-OADS,/arxiv_data1/oa_pdf/6e/1e/ppa-8-925.PMC4077855.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6e/1e/ppa-8-925.PMC4077855.pdf
Available from: http://www.ppdi.com/late- stage-asthma/Adherence-In-Asthma_PPD-White-Paper.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/1e/ppa-8-925.PMC4077855.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/68/opth-8-1187.PMC4077856.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1187–1198Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1187Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4035 0Journal name: Clinical Ophthalmology Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Triantafylla et al Running head recto: Ranibizumab for ocular degeneration DOI: http://dx.doi.org/10.2147/OPTH.S40350 Ranibizumab for the treatment of degenerative  ocular conditions Magdalini Triantafylla1 Horace F Massa2 Doukas Dardabounis1 Zisis Gatzioufas2 vassilios Kozobolis1 Konstantinos ioannakis1 irfan Perente1,3 Georgios D Panos1,2 1Department of Ophthalmology,   University General Hospital of  Alexandroupolis, School of Medicine,   University of Thrace, Alexandroupolis,   Greece; 2Department of  Ophthalmology, Geneva University  Hospitals, Faculty of Medicine,   University of Geneva, Switzerland;   3Beyoglou eye Research and T eaching  Hospital, istanbul University, istanbul,   T urkeyAbstract:  Degenerative ocular conditions, such as age-related macular degeneration, diabetic  retinopathy, retinal vein occlusions, and myopic degeneration, have become a major public  health problem and a leading cause of blindness in developed countries.",Non-OADS,/arxiv_data1/oa_pdf/a6/68/opth-8-1187.PMC4077856.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a6/68/opth-8-1187.PMC4077856.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1198Triantafylla et al  132.,Non-OADS,/arxiv_data1/oa_pdf/a6/68/opth-8-1187.PMC4077856.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/vhrm-10-375.PMC4077857.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 375–388Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  375ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/VHRM.S5762 3epidemiology of stroke in a rural community   in southeastern nigeria Kelechi O enwereji1 Maduaburochukwu c  nwosu1 adesola Ogunniyi2 Paul O nwani1 azuoma l asomugha1 ezinna e enwereji3 1neurology Unit, Department of  Medicine, nnamdi azikiwe University  T eaching Hospital, nnewi, anambra  state, n igeria;  2neurology Unit,   Department of Medicine, University  college Hospital ibadan, Oyo state,   nigeria;  3Department of community  Medicine/ nursing sciences, college of  Medicine, abia state University, Uturu,   abia state, nigeria correspondence: Kelechi O enwereji   neurology Unit, Department of Medicine,  nnamdi azikiwe University Teaching  Hospital, nnewi, anambra state, nigeria   Tel +234 803 386 1317   email doublekay2001@yahoo.co mBackground:  The prevalence and incidence of stroke vary from community to community  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/bb/47/vhrm-10-375.PMC4077857.pdf
"Available at  http://www.ninds.nih.gov/disorders/stroke/detail_stroke.ht m. Accessed  May 8, 2014 .",Non-OADS,/arxiv_data1/oa_pdf/bb/47/vhrm-10-375.PMC4077857.pdf
Available from: http://www.who.int/healthinfo/paper31.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bb/47/vhrm-10-375.PMC4077857.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/bb/47/vhrm-10-375.PMC4077857.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/vhrm-10-375.PMC4077857.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ac/a5/ott-7-1159.PMC4077858.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1159–1168OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1159Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6215 8Clinicopathological and biological significance   of aberrant activation of glycogen synthase  kinase-3 in ovarian cancer Yunfeng Fu1 Xinyu Wang1 Xiaodong cheng1 Feng Ye2 Xing Xie1,2 Weiguo lu1,2 1Department of gynecologic  Oncology, Women’s hospital, school  of Medicine, Zhejiang University,   2Women’s reproduction and health  laboratory of Zhejiang Province,   hangzhou, People’s republic of china correspondence: Weiguo lu   Department of gynecologic Oncology,  Women’s hospital, school of Medicine,  Zhejiang University, Xueshi road #2,  hangzhou 310006, People’s republic   of china   Tel +86 571 8706 1501 ext 1005   Fax +86 571 8706 1878   email lbwg@zju.edu.c n; lwg@hzcnc.co mBackground:  Glycogen synthase kinase-3 (GSK-3) plays an important role in human cancer.",Non-OADS,/arxiv_data1/oa_pdf/ac/a5/ott-7-1159.PMC4077858.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ac/a5/ott-7-1159.PMC4077858.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/a5/ott-7-1159.PMC4077858.pdf
"OncoImmunology 2014; 3:e28697; http://dx.doi.org/10.4161/onci.28697T cell immunosurveillance controls B lymphoma  development Axel Kallies th e wa lter and el iza ha ll in stitute of Medical re search; Parkville, V iC Au stralia Keywords:  immune surveillance, mutations, germinal center, Bcl6, AID, CD8+ T cells we r ecently showed a critical role for t  cells in the immunosurveillance of nascent B cell lymphomas arising from  mutations impacting plasma cell differentiation.",Non-OADS,/arxiv_data1/oa_pdf/f3/4e/onci-3-e28697.PMC4077859.pdf
Semin Diagn Pathol 2011; 28:167-77; PMID:21842702 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/f3/4e/onci-3-e28697.PMC4077859.pdf
Semin Immunol 2011; 23:341-9; PMID:21924923 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f3/4e/onci-3-e28697.PMC4077859.pdf
Nat Med 2014; 20:283-90;  PMID:24487434 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/4e/onci-3-e28697.PMC4077859.pdf
Cancer Cell 2005; 7:445-55; PMID :15894265 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/4e/onci-3-e28697.PMC4077859.pdf
Cancer Cell 2010; 18:568-79; PMID :21156281 ;  http://dx.doi.org/10.1016/j.ccr.2010.10.0307.,OADS,/arxiv_data1/oa_pdf/f3/4e/onci-3-e28697.PMC4077859.pdf
Annu Rev Pathol 2013; 8:79-103; PMID:22974238 ; http://dx.doi.org/10.1146/ annurev-pathol-020712-164004 8.,Non-OADS,/arxiv_data1/oa_pdf/f3/4e/onci-3-e28697.PMC4077859.pdf
Science 2011; 331:1565-70; PMID:21436444 ; http://dx.doi.org/10.1126/ science.1203486 9.,Non-OADS,/arxiv_data1/oa_pdf/f3/4e/onci-3-e28697.PMC4077859.pdf
Curr Opin Hematol 2013; 20:336-44; PMID:23673341 ; http://dx.doi.org/10.1097/ MOH.0b013e3283623d7f 10.,Non-OADS,/arxiv_data1/oa_pdf/f3/4e/onci-3-e28697.PMC4077859.pdf
Cell 2012; 148:739-51; PMID:22341446 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/4e/onci-3-e28697.PMC4077859.pdf
"OncoImmunology 2014; 3:e28782; http://dx.doi.org/10.4161/onci.28782Transplantation-induced cancers Emerging evidence that clonal CMV-specific NK cells   are causal immunogenic factors Abla Achour1,2,3,†, Florence Baychelier1,2,3,†, Michel Marty4, Patrice Debré1,2,3, Didier samu el5, and Vincent Vieillard1,2,3,* 1so rbonne un iversités, uP MC; un iv Paris 06, C r 7; CiMi- Paris; Paris, France; 2iNs er M , u1 135; C iMi- Paris; Paris, France; 3CNr s , erL 8255; C iMi- Paris; Paris, France; 4AP-hP ; Centre  des  in novations  th érapeutiques en  on cologie et  hé matologie;  hô pital  sa int-Louis; Paris, France; 5AP-hP ; Centre hé pato-biliaire ; hô pital Paul-Brousse; iNs erM uMr-s  785;  Villejuif, France; 6uMr-s  785; un iv Paris 10; Villejuif, France †th ese authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/84/96/onci-3-e28782.PMC4077860.pdf
Nat Rev Immunol 2012; 12:239-52; PMID:22437937 ; http://dx.doi.org/10.1038/nri3174 2.,Non-OADS,/arxiv_data1/oa_pdf/84/96/onci-3-e28782.PMC4077860.pdf
Sci Transl Med 2013; 5:208ra145;  PMID :24154599 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/96/onci-3-e28782.PMC4077860.pdf
Eur J Immunol 2012; 42:3141-5; PMID:23255011 ; http://dx.doi.org/10.1002/ eji.201243050 4.,Non-OADS,/arxiv_data1/oa_pdf/84/96/onci-3-e28782.PMC4077860.pdf
Blood 2008; 112:914-5;  PMID:18650467 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/96/onci-3-e28782.PMC4077860.pdf
J Immunol 2014; 192:503-11; PMID:24307732 ; http://dx.doi.org/10.4049/ jimmunol.1301951 7.,Non-OADS,/arxiv_data1/oa_pdf/84/96/onci-3-e28782.PMC4077860.pdf
Cancer Res 2009; 69:3563-9; PMID:19351841 ; http://dx.doi.org/10.1158/0008- 5472.CAN-08-3807 9.,Non-OADS,/arxiv_data1/oa_pdf/84/96/onci-3-e28782.PMC4077860.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/d3/opth-8-1209.PMC4077861.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1209–1212Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1209ShO rt repO rtopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S6160 4Non steroidal anti-inflammatory drugs   in the prevention of cystoid macular edema   after uneventful cataract surgery Correspondence:  Alejandro rodolfo  Allocco Instituto Santa Lucía, Alameda de la  Federación 493, paraná 3100, entre ríos,  Argentina tel/Fax +54 343 4233496 email ale_allocco@outlook.co mNicolás e Quintana* Alejandro r Allocco* Julia A ponce* Mauricio GB Magurno Instituto Santa Lucía, paraná,   Argentina *these authors contributed equally   to this workBackground:  Cystoid macular edema (CME) remains an important complication after  cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/21/d3/opth-8-1209.PMC4077861.pdf
"The most accepted one involves intraocular inflam - mation with prostaglandin (PG) release as the most important factor, which would Journal name: Clinical Ophthalmology Journal Designation: Short Report Y ear: 2014 Volume: 8 Running head verso: Quintana et al Running head recto: NSAIDs for preventing CME after cataract surgery DOI: http://dx.doi.org/10.2147/OPTH.S61604",Non-OADS,/arxiv_data1/oa_pdf/21/d3/opth-8-1209.PMC4077861.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/21/d3/opth-8-1209.PMC4077861.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1212Quintana et al  9.,Non-OADS,/arxiv_data1/oa_pdf/21/d3/opth-8-1209.PMC4077861.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0f/2d/opth-8-1185.PMC4077862.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1185–1186Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1185Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S6619 3evaluating choroidal thickness in diabetic  retinopathy Chee Yee Chan1 thanos D Papakostas2 Demetrios G Vavvas2 1Department of Ophthalmology,    2retina Service, Massachusetts eye  and ear Infirmary, Harvard Medical  School, Boston, MA, USA Correspondence: Chee Yee Chan   Department of Ophthalmology,  Massachusetts Eye and Ear Infirmary,   243 Charles Street, Boston, 02114,   MA, USA tel +1 617 573 3240  Fax +1 617 573 4324   email drchenziyi100@gmail.co mDear editor We read with interest the article by Unsal et al1 and congratulate them on their work  assessing choroidal thickness in patients with diabetic retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/0f/2d/opth-8-1185.PMC4077862.pdf
"However, measurements of choroid thickness have to be cor - rectly drawn and consideration of diurnal variation is required to improve the accuracy  of the results.Journal name: Clinical Ophthalmology Journal Designation: Letter Y ear: 2014 Volume: 8 Running head verso: Chan et al Running head recto: Choroidal thickness in diabetic retinopathy DOI: http://dx.doi.org/10.2147/OPTH.S66193",Non-OADS,/arxiv_data1/oa_pdf/0f/2d/opth-8-1185.PMC4077862.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0f/2d/opth-8-1185.PMC4077862.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1186Chan et al Disclosure All authors contributed to, wrote, or edited this letter.",Non-OADS,/arxiv_data1/oa_pdf/0f/2d/opth-8-1185.PMC4077862.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/73/ott-7-1143.PMC4077863.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1143–1150OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1143Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6416 1integration of multidisciplinary technologies   for real time target visualization and verification  for radiotherapy Wen-chung chang1,* chin-sheng chen2,* hung-chi Tai3 chia-Yuan liu4,5 Yu-Jen chen3 1Department of electrical engineering,   national Taipei University of  T echnology, Taipei, Taiwan;  2graduate  institute of automation T echnology,   national Taipei University of  T echnology, Taipei, Taiwan;   3Department of radiation Oncology,   Mackay Memorial hospital, Taipei,   Taiwan;  4 Department of internal  Medicine, Mackay Memorial hospital,   Taipei, Taiwan; 5Department of  Medicine, Mackay Medical college,   new Taipei city, Taiwan *These authors contributed equally  to this work correspondence:  Yu-Jen chen   Department of radiation Oncology,  Mackay Memorial hospital, 92, section 2,  chung shan north road, Taipei, Taiwan   T el +886 2 2809 4661  Fax +886 2 2808 5952  email chenmdphd@gmail.co m    chia-Yuan liu   Department of internal Medicine, Mackay  Memorial hospital, 92, section 2, chung  shan north road, Taipei, Taiwan   T el +886 2 2809 4661   Fax +886 2 2808 5952   email liu.chiayuan@gmail.co mAbstract:  The current practice of radiotherapy examines target coverage solely from digitally  reconstructed beam’ s eye view (BEV) in a way that is indirectly accessible and that is not in  real time.",Non-OADS,/arxiv_data1/oa_pdf/00/73/ott-7-1143.PMC4077863.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/00/73/ott-7-1143.PMC4077863.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/73/ott-7-1143.PMC4077863.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/03/opth-8-1203.PMC4077864.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1203–1208Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1203Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6252 1Correlation between optic nerve head structural  parameters and glaucomatous visual field indices Kyoichi Mizumoto1 Masahiko gosho2 Masahiro Zako1 1Department of Ophthalmology, aichi  Medical University, nagakute, aichi,   Japan; 2advanced Medical research  Center, aichi Medical University,   nagakute, aichi, Japan Correspondence: Masahiro Zako   Department of Ophthalmology, aichi  Medical University, nagakute,   480-1195 aichi, Japan   T el +81 561 62 3311   Fax +81 561 63 7255   email zako@aichi-med-u.ac.j pAbstract:  We examined associations between optic nerve head structural parameters and  glaucomatous visual field indices.",Non-OADS,/arxiv_data1/oa_pdf/a0/03/opth-8-1203.PMC4077864.pdf
"Overall, these findings indicate Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Mizumoto et al Running head recto: Parameters reflecting glaucomatous visual field indices DOI: http://dx.doi.org/10.2147/OPTH.S62521",Non-OADS,/arxiv_data1/oa_pdf/a0/03/opth-8-1203.PMC4077864.pdf
"The centroid of the optic  disc (Figure 1A, green point) was determined on the scanning  laser ophthalmoscope image using ImageJ 1.46r (Wayne  Rasband National Institutes of Health, http://rsb.info.nih.",OADS,/arxiv_data1/oa_pdf/a0/03/opth-8-1203.PMC4077864.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a0/03/opth-8-1203.PMC4077864.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1208Mizumoto et al ONH, measure the area based on the reference plane paral - lel to the peripapillary retinal surface.",Non-OADS,/arxiv_data1/oa_pdf/a0/03/opth-8-1203.PMC4077864.pdf
OncoImmunology 2014; 3:e28540; http://dx.doi.org/10.4161/onci.28540 ©2014 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Oncoimmunology 2013; 2:e23803; PMID:23734328 ; http://dx.doi.org/10.4161/ onci.23803 2.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Nat Rev Genet 2008; 9:776-88; PMID :18781156 ; http://dx.doi.org/10.1038/ nrg2432 3.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Hum Vaccin Immunother 2012; 8:1694-702; PMID:23111168 ; http://dx.doi.org/10.4161/ hv.22062 4.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Expert Rev Vaccines 2013; 12:1127-37;  PMID:24066796 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Clin Dev Immunol 2010; 2010:169484;  PMID:21197271 ;  http://dx.doi.org/10.1155/2010/169484 7.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Immunol Lett 2007; 111:92-102; PMID:17604849 ;  http://dx.doi.org/10.1016/j.imlet.2007.05.007 10.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Annu Rev Immunol 2011; 29:235-71; PMID:21219185 ; http://dx.doi.org/10.1146/ annurev-immunol-031210-101324 Figure 1.  im pact of electroporation on the outcome of anticancer D nA vaccination.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Nature 2013; 494:361-5;  PMID:23376950 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Annu Rev Immunol 2006; 24:519-40; PMID:16551258 ; http://dx.doi.org/10.1146/ annurev.immunol.23.021704.115825 13.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Front Immunol 2013; 4:438;  PMID:24376443 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Hum Vaccin 2011; 7:811-27; PMID:21817854 ; http://dx.doi.org/10.4161/ hv.7.8.16274 15.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Expert Opin Biol Ther 2008; 8:1645-57;  PMID:18847301 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Vaccine 2007; 25:2064-73;  PMID:17239494 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Hum Gene Ther 2008; 19:1249-60;  PMID:19866489 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Vaccine 2002; 20:3399-408; PMID:12213410 ;  http://dx.doi.org/10.1016/S0264-410X(02)00269-419.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Lab Invest 2004; 84:836-44;  PMID:15197407 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Ejc Suppl 2006; 4:38-44; http://dx.doi.org/10.1016/j.ejcsup.2006.08.005 21.,OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Clin Exp Metastasis 2013; 30:37-45; PMID:22735940 ; http://dx.doi.org/10.1007/ s10585-012-9505-1 24.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Cancer Immunol Immunother 2008; 57:1291-300;  PMID:18259749 ;  http://dx.doi.org/10.1007/s00262-008-0462-0 25.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Nature 2009; 461:282-6; PMID:19741708 ; http://dx.doi.org/10.1038/ nature0829626.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
J Leukoc Biol 2003; 73:339-43;  PMID:12629147 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
Oncoimmunology 2013; 2:e24568;   PMID:23894718 ; http://dx.doi.org/10.4161/ onci.24568 28.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
J Virol 2008; 82:5643-9; PMID:18353952 ; http://dx.doi.org/10.1128/ JVI.02564-07 29.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
J Biotechnol 2004; 110:1-10;  PMID:15099900 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
J Exp Med 1999; 189:169-78; PMID:9874573 ;  http://dx.doi.org/10.1084/jem.189.1.169 ©2014 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/cd/81/onci-3-e28540.PMC4077865.pdf
"OncoImmunology 2014; 3:e28582;   http://dx.doi.org/10.4161/onci.28582A critical role for natural killer cells in dendritic cell- based anticancer immunotherapy Alexander D McLellan Department of Microbiology and im munology; un iversity of ot ago; Dunedin, New Zealand Keywords:  natural killer cell, cancer, melanoma, dendritic cell, immunotherapy Multipronged immunotherapies that activate both t cells and natural killer (NK) cells may result in more robust and  du rable anticancer responses.",Non-OADS,/arxiv_data1/oa_pdf/e3/e7/onci-3-e28582.PMC4077866.pdf
Hum Vaccin Immunother  2012; 8:1141-2;  PMID:22854675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/e7/onci-3-e28582.PMC4077866.pdf
Curr Opin Immunol 2014; 27C:26-32;  PMID:24513968 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/e7/onci-3-e28582.PMC4077866.pdf
Int J Cancer 2001; 94:820-4;   PMID:11745484 ; http://dx.doi.org/10.1002/ijc.1536 4.,Non-OADS,/arxiv_data1/oa_pdf/e3/e7/onci-3-e28582.PMC4077866.pdf
J Leukoc Biol 2013; 94:41-53; PMID:23667165 ;  http://dx.doi.org/10.1189/jlb.12126315.,Non-OADS,/arxiv_data1/oa_pdf/e3/e7/onci-3-e28582.PMC4077866.pdf
Front Immunol 2013; 4:481;  PMID:24391651 ; http://dx.doi.org/10.3389/ fimmu.2013.00481 6.,Non-OADS,/arxiv_data1/oa_pdf/e3/e7/onci-3-e28582.PMC4077866.pdf
J Immunol 2014; 192:2514-21; PMID:24477907 ;  http://dx.doi.org/10.4049/jimmunol.12027978.,Non-OADS,/arxiv_data1/oa_pdf/e3/e7/onci-3-e28582.PMC4077866.pdf
J Immunol 2013; 191:1984-92;  PMID:23858033 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/e7/onci-3-e28582.PMC4077866.pdf
Sci Transl Med 2014; 6:226ra32;  PMID:24598590 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/e7/onci-3-e28582.PMC4077866.pdf
Oncoimmunology 2013; 2:e27058;  PMID:24498564 ;  http://dx.doi.org/10.4161/onci.27058 ©2014 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/e3/e7/onci-3-e28582.PMC4077866.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/08/oajsm-5-151.PMC4077873.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 151–157Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  151ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OAJSM.S6288 5Transtendon rotator-cuff repair of partial- thickness articular surface tears can lead   to medial rotator-cuff failure T om C Woods4 Michael J Carroll1 Atiba A Nelson2 Kristie D More2 Randa Berdusco1 Stephen Sohmer3 Richard S Boorman1,2 Ian KY Lo1,2 1Department of Surgery,  2Sport  Medicine Centre, University of  Calgary, Calgary, AB, Canada;   3Department of Orthopaedics,   University of British Columbia,   Vancouver,  4St Joseph’s Hospital,   Comox, BC, Canada Correspondence: Ian KY Lo   Department of Surgery, University of  Calgary,  3280 Hospital Drive Northwest,  Calgary, AB T2N  4Z6, Canada   Tel +1 403 220 2745  Fax +1 403 210 8197  Email ikylo@ucalgary.c aPurpose:  The purpose of this study was to evaluate clinical and anatomic outcomes of patients  following transtendon rotator-cuff repair of partial articular supraspinatus tendon avulsion  (PASTA) lesions.",Non-OADS,/arxiv_data1/oa_pdf/d7/08/oajsm-5-151.PMC4077873.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/d7/08/oajsm-5-151.PMC4077873.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/08/oajsm-5-151.PMC4077873.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/ec/tcrm-10-485.PMC4077874.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 485–492Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  485Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/TCRM.S3698 3icosapent ethyl for the treatment of severe  hypertriglyceridemia Hassan Fares1 Carl J Lavie2,3 James J DiNicolantonio4 James H O’Keefe5 Richard v Milani2 1Department of Hospital Medicine,   Ochsner Medical Center,   New Orleans, LA, 2Department  of Cardiovascular Diseases, John  Ochsner Heart and vascular institute,   Ochsner Clinical School, University  of Queensland School of Medicine,   New Orleans, LA, 3Department of  Preventive Medicine, Pennington  Biomedical Research Center, Louisiana  State University System, Baton Rouge,   LA, 4Mid America Heart institute at  Saint Luke’s Hospital, Kansas City,   MO, 5Mid America Heart institute,   University of Missouri–Kansas City,   Kansas City, MO, USA Correspondence: Carl J Lavie   Cardiac Rehabilitation, exercise  Laboratories, John Ochsner Heart and  vascular institute, Ochsner Clinical  School – The University of Queensland  School of Medicine, 1514 Jefferson  Highway, New Orleans, LA,   USA 70121-2483   Tel +1 504 842 1281   Fax +1 504 842 5875   email clavie@ochsner.or gAbstract:  Hypertriglyceridemia is a highly prevalent lipid abnormality and it is associated  with atherosclerosis, with a growing body of evidence linking elevated triglycerides (TGs) with  cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/00/ec/tcrm-10-485.PMC4077874.pdf
Available from: http://epadruginitiative.com/press/ fda-puts-patients-at-risk .,Non-OADS,/arxiv_data1/oa_pdf/00/ec/tcrm-10-485.PMC4077874.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/00/ec/tcrm-10-485.PMC4077874.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/ec/tcrm-10-485.PMC4077874.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/97/ppa-8-909.PMC4077875.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 909–915Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  909OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6278 0Associations between the 2007 Medicare  reimbursement reduction for bone mineral  density testing and osteoporosis drug therapy  patterns of female Medicare beneficiaries sun Jung Kim1,2 Joo hun lee3 sulgi Kim4 shunichi nakagawa5 heather Bertelson6 Julia lam7 Ji Won Y oo6,7 1Department of Public health, 2institute of  health services research, Yonsei University  college of Medicine, 3Department of Media  and communication, hanyang University college  of social sciences, seoul, republic of Korea;  4Department of epidemiology and Biostatistics, case  Western reserve University, cleveland, Oh, UsA;  5Department of Medicine, college of Physicians  and surgeons, columbia University, new Y ork, nY,  UsA; 6Department of internal Medicine, Aurora  health care, Milwaukee, Wi, UsA; 7Department  of Medicine, University of Wisconsin school of  Medicine and Public health, Madison, Wi, UsAObjective:  To examine how drug therapy patterns for osteoporosis have changed after the  Medicare Physician Fee Schedule (MPFS) reimbursement reduction in 2007, in relation to  follow-up bone mineral density (BMD) testing status.",Non-OADS,/arxiv_data1/oa_pdf/8c/97/ppa-8-909.PMC4077875.pdf
Or use: http://dvpr.es/1kJFC1 LVideo abstract Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Kim et al Running head recto: BMD testing and osteoporosis drug therapy patterns DOI: http://dx.doi.org/10.2147/PPA.S62780,Non-OADS,/arxiv_data1/oa_pdf/8c/97/ppa-8-909.PMC4077875.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/8c/97/ppa-8-909.PMC4077875.pdf
Available from: http://nof.org/hcp/clinicians-guide.,Non-OADS,/arxiv_data1/oa_pdf/8c/97/ppa-8-909.PMC4077875.pdf
Available from: http://www.cms.gov/apps/physician- fee-schedule/license-agreement.aspx.,Non-OADS,/arxiv_data1/oa_pdf/8c/97/ppa-8-909.PMC4077875.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f6/f6/tcrm-10-479.PMC4077876.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 479–484Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  479ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S6235 1Cost-effectiveness analysis on the use   of rFsh + rlh for the treatment of anovulation   in hypogonadotropic hypogonadal women enrico Papaleo1 Carlo alviggi2 giorgio lorenzo Colombo3,4 Claudio Pisanelli5,6 Claudio Ripellino7 salvatore longobardi8 Pier luigi Canonico9 1Centro scienze della n atalità,   gynecological-Obstetrics  Department, san Raffaele hospital,   Vita-salute san Raffaele, Milan, italy;  2Department of n euroscience,   Reproductive sciences and  Odontostomatology, University  “Federico ii” of naples, naples,   italy; 3Department of Drug sciences,   University of Pavia, Pavia, italy; 4saVe  studi analisi Valutazioni economiche,   Milan, italy; 5aCO san Filippo neri,   Rome, italy; 6società italiana Di  Farmacia Ospedaliera, Milan, italy  7CsD Medical Research srl, Milan,   italy; 8Medical Department, Merck  serono spa, Rome, italy 9Department  of Pharmaceutical sciences, University  of Piemonte Orientale, novara, italy Correspondence: Claudio Ripellino   CsD Medical Research srl,   Viale Jenner n °53, 20159, Milan, italy   Tel +39 02 6977 0279  Fax +39 02 6901 0325  email claudio.ripellino@cegedim.co mBackground:  Hypogonadotropic hypogonadal women are characterized by ovarian functionality  deficiency, caused by low concentrations of follicle-stimulating hormone (FSH) and luteiniz - ing hormone (LH).",Non-OADS,/arxiv_data1/oa_pdf/f6/f6/tcrm-10-479.PMC4077876.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/f6/f6/tcrm-10-479.PMC4077876.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/f6/tcrm-10-479.PMC4077876.pdf
"Available from: http://ej-endocrinology.org/gnrh.htm l. Accessed   September  13, 2013.",Non-OADS,/arxiv_data1/oa_pdf/f6/f6/tcrm-10-479.PMC4077876.pdf
Available from: http://ajplegacy.physiology.,Non-OADS,/arxiv_data1/oa_pdf/f6/f6/tcrm-10-479.PMC4077876.pdf
"Available  from: http://www.codifa.i t. Accessed July  25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/f6/f6/tcrm-10-479.PMC4077876.pdf
Coral Reefs 2009; 28:867-70; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Can J  Zool  2006 ; 84:322-56; http://dx.doi.org/10.1139/ z06-032 4.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Facies  1998 ;  38:1-88; http://dx.doi.org/10.1007/BF02537358 5.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Geobiology  2010 ;  8:191-6; PMID:20345891 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
BMC Evol  Biol 2011 ; 11:238; PMID:21838889 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Adv Exp Med Biol  2007 ; 607:111-8; PMID:17977463 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Dev Cell  2004 ; 6:463- 77; PMID:15068787 ; http://dx.doi.org/10.1016/ S1534-5807(04)00099-1 10.,OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Cell Death  Differ  2005 ; 12(Suppl 2 ):1535 -41; PMID:16247501 ;  http://dx.doi.org/10.1038/sj.cdd.4401728 11.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Nat Cell Biol  2007 ; 9:1102 -9; PMID:17909521 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Proc Biol Sci 2007 ; 274:3079 -85; PMID:17925275 ;  http://dx.doi.org/10.1098/rspb.2007.0711 15.,OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Autophagy  2009 ; 5:211-6; PMID:19066451 ;  http://dx.doi.org/10.4161/auto.5.2.740516.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Dev Cell  2003 ; 5:539- 45; PMID:14536056 ; http://dx.doi.org/10.1016/ S1534-5807(03) 00296-X 17.,OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Cell 2007 ; 130:165- 78; PMID:17632063 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Autophagy  2012 ; 8:445- 544; PMID:22966490 ; http://dx.doi.org/10.4161/ auto.19496 19.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Genome Biol  2011 ; 12:226; PMID:21867568 ;  http://dx.doi.org/10.1186/gb-2011-12-7-226 20.,OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
Mol Biol Evol  2000 ; 17:540-52;  PMID:10742046 ; http://dx.doi.org/10.1093/ oxfordjournals.molbev.a026334,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/auto-10-408.PMC4077880.pdf
"10-13 *Correspondence to: Noboru Mizushima; Email: nmizu@m.u-tokyo.ac.jp Submitted: 12/03/2012; Revised: 11/20/2013; Accepted: 11/26/2013http://dx.doi.org/10.4161/auto.27344Expression of the autophagy substrate SQSTM1/ p62 is restored during prolonged starvation  depending on transcriptional upregulation and  autophagy-derived amino acids Mayurbhai h imatbhai s ahani,1,2 eisuke i takura,1,† and Noboru Mizushima1,2,* 1Department of Physiology and c ell Biology; Tokyo Medical and Dental University; Tokyo, Japan; 2Department of Biochemistry and Molecular Biology; Graduate s chool   and Faculty of Medicine; University of Tokyo; Tokyo, Japan †current affiliation: MR c Laboratory of Molecular Biology; c ambridge, UK Keywords:  SQSTM1/p62, amino acid, transcription Abbreviations:  Baf, bafilomycin A1; CHX, cycloheximide; CMV, cytomegalovirus; CQ, chloroquine; DMEM, Dulbecco’s  modified Eagle’s medium; GFP, green fluorescent protein; KO, knockout; MAP1LC3 (LC3), microtubule-associated protein  1 light chain 3; LIR, LC3-interacting region; MEF, mouse embryonic fibroblast; MTORC1, mechanistic target of rapamycin  complex 1; NFE2L2/Nrf2, nuclear factor, erythroid 2-like 2; NFKB/NF κB, nuclear factor of kappa light polypeptide gene  enhancer in B-cells; PBS, phosphate-buffered saline; RB1CC1/FIP200, RB1-inducible coiled-coil 1; SQSTM1, sequestosome 1 sQsTM1/p62 (sequestosome 1) is a multifunctional signaling molecule, involved in a variety of cellular pathways.",Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Nature  2006; 443:780-6;  PMID:17051204 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Cell 2008 ; 132:27-42; PMID:18191218 ;  http://dx.doi.org/10.1016/j.cell.2007.12.018 3.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Cell 2011 ; 147:728-41;  PMID:22078875 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
FEBS Lett  2010 ; 584:1379 -85; PMID:20083108 ;  http://dx.doi.org/10.1016/j.febslet.2010.01.018 6.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Autophagy   2011 ; 7:279-96; PMID:21189453 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Annu Rev Biochem  2011 ; 80:125-56; PMID :21548784 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Cell Biol 2005 ; 171:603-14;  PMID:16286508 ; http://dx.doi.org/10.1083/ jcb.200507002,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Biol Chem 2007 ; 282:24131 -45;  PMID:17580304 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Biomed Biotechnol 2006; 2006:62079;  PMID:17047309; http://dx.doi.org/10.1155/ JBB/2006/62079 11.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Cell 2009 ;  137:1001 -4; PMID:19524504 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Pharmacol Res  2012 ; 66:457-62; PMID:22841931 ;  http://dx.doi.org/10.1016/j.phrs.2012.07.004 14.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Cell Biol  2011 ; 192:17-27; PMID:21220506 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Autophagy  2012 ; 8:445- 544; PMID:22966490 ; http://dx.doi.org/10.4161/ auto.19496 16.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Cell 2010 ; 140:313- 26; PMID:20144757 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Cell 2007 ; 131:1149 -63; PMID:18083104 ;  http://dx.doi.org/10.1016/j.cell.2007.10.035 18.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Mol Cell Biol  2010 ; 30:3275 -85; PMID:20421418 ;  http://dx.doi.org/10.1128/MCB.00248-10 20.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Biol Chem 2008 ;  283:22847 -57; PMID:18524774 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Cell 2012 ; 151:1256 -69;  PMID:23217709 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Nature  2010 ;  465:942-6; PMID:20526321 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Biol Chem 2009 ; 284:8023 -32;  PMID:19150980 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Autophagy   2011 ; 7:188-204; PMID:21107021 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Biol Chem  2000 ; 275:16023 -9; PMID:10821856 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Biol Chem 2010 ; 285:22576 -91;  PMID:20452972 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Oncogene  2003 ; 22:2322 -33; PMID:12700667 ;  http://dx.doi.org/10.1038/sj.onc.1206325 29.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Nutr  Biochem  2012 ; 23:994-1006 ; PMID:21937211 ;  http://dx.doi.org/10.1016/j.jnutbio.2011.05.006 30.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Biol Chem 2012 ;  287:19687 -98; PMID:22518844 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
EMBO J 2012 ; 31:1095 -108;  PMID:22343943 ; http://dx.doi.org/10.1038/ emboj.2012.32 32.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Science  2011 ; 332:1429 - 33; PMID:21617040 ; http://dx.doi.org/10.1126/ science.1204592 33.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Cell Sci  2005 ; 118:2545 -55; PMID :15944395 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Cytokine   2011 ; 54:6- 19; PMID:21257317 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Temporal orchestration of  circadian autophagy rhythm by C/EBP β. EMBO J  2011 ; 30:4642 -51; PMID:21897364 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Nucleic  Acids Res 2013 ; 41:7683 -99; PMID:23804767 ;  http://dx.doi.org/10.1093/nar/gkt563 37.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Biol Chem  2005 ; 280:31582 -6; PMID:16027116 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Trends Biochem Sci 2012 ; 37:230- 6; PMID:22424619 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Mol Cell  2011 ; 44:134- 46; PMID:21981924 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Autophagy  2010 ; 6:784-93; PMID:20574168 ;  http://dx.doi.org/10.4161/auto.6.6.12510 43.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
J Cell Biol 2006 ; 175:121- 33; PMID :17015619 ; http://dx.doi.org/10.1083/ jcb.200604129 44.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
Nature  2004 ; 432:1032 - 6; PMID:15525940 ; http://dx.doi.org/10.1038/ nature03029 45.,Non-OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
FEBS Lett   2006 ; 580:2623 -9; PMID:16647067 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/91/auto-10-431.PMC4077882.pdf
"1 *Correspondence to: Gábor Juhász; Email: szmrt@elte.hu Submitted: 07/17/2013; Revised: 11/26/2013; Accepted: 12/05/2013http://dx.doi.org/10.4161/auto.27442Atg17/FIP200 localizes to perilysosomal Ref(2)P  aggregates and promotes autophagy   by activation of Atg1 in Drosophila Péter Nagy,† Manuéla Kárpáti,† Ágnes Varga, Karolina Pircs, Zsolt Venkei,‡ szabolcs Takáts, Kata Varga, Balázs Érdi,§   Krisztina h egedűs, and Gábor Juhász* Department of a natomy, c ell and Developmental Biology; e ötvös Loránd University; Budapest, h ungary †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Nature 2008; 451:1069-75;   PMID:18305538 ; http://dx.doi.org/10.1038/ nature066392.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Autophagy  2012 ; 8:1875 -6; PMID:22874642 ;  http://dx.doi.org/10.4161/auto.215443.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Mol Biol Cell  2009 ; 20:1981 - 91; PMID:19211835 ; http://dx.doi.org/10.1091/ mbc.E08-12-1248,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Nat Cell Biol  2011 ; 13:453-60; PMID:21394080 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Science  2011 ; 334:678- 83; PMID:22053050 ; http://dx.doi.org/10.1126/ science.1207056 6.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Nature  2010 ;  465:942-6; PMID:20526321 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Dev Cell  2003 ; 5:539- 45; PMID:14536056 ; http://dx.doi.org/10.1016/ S1534-5807(03) 00296-X 8.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Cell 2011 ; 147:728-41;  PMID:22078875 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
J Cell Sci 2011 ; 124:161- 70; PMID:21187343 ; http://dx.doi.org/10.1242/ jcs.064576 10.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Genes Dev  2007 ; 21:3061 -6; PMID:18056421 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Trends Biochem Sci 2012 ; 37:230- 6; PMID:22424619 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
J Cell Biol 2008 ;  180:1065 -71; PMID:18347073 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Cell 2007 ; 131:1149 -63; PMID:18083104 ;  http://dx.doi.org/10.1016/j.cell.2007.10.035 15.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
J Cell Biol 2008 ; 181:497- 510; PMID:18443221 ; http://dx.doi.org/10.1083/ jcb.200712064 16.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Mol Biol Cell  2009 ; 20:1992 -2003 ;  PMID:19225151 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Curr Opin Cell Biol  2010 ; 22:132-9; PMID:20056399 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Mol Cell Biol   2009 ; 29:157-71; PMID :18936157 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Autophagy   2012 ; 8:1124 -35; PMID:22562043 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Autophagy  2012 ; 8:623-36;  PMID:22330894 ; http://dx.doi.org/10.4161/ auto.19081 21.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Mol Biol Cell  2009 ; 20:2004 -14; PMID :19225150 ;  http://dx.doi.org/10.1091/mbc.E08-12-1250 22.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Curr Biol  2007 ; 17:1- 11; PMID:17208179 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
PLoS One  2012 ; 7:e44214 ;  PMID:22952930 ; http://dx.doi.org/10.1371/ journal.pone.0044214 25.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
J Cell Biol  2011 ; 192:17-27; PMID:21220506 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Genes Cells  2007 ; 12:209-18; PMID:17295840 ;  http://dx.doi.org/10.1111/j.1365-2443.2007.01050.x 27.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Autophagy   2010 ; 6:764-76; PMID:20639694 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
EMBO  Rep 2007 ; 8:360-5; PMID:17347671 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Autophagy  2011 ; 7:1212 -21; PMID:21795849 ;  http://dx.doi.org/10.4161/auto.7.10.16660 30.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Dev Cell   2004 ; 7:179-92; PMID :15296715 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Cell 2007 ; 131:1137-48; PMID:18083103 ;  http://dx.doi.org/10.1016/j.cell.2007.10.048 32.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
J Cell Biol 2008 ; 181:655- 66; PMID:18474623 ; http://dx.doi.org/10.1083/ jcb.200712051 34.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
J Cell Biol 1999 ; 147:435- 46; PMID:10525546 ; http://dx.doi.org/10.1083/ jcb.147.2.435 35.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
J Cell Biol 2012 ; 198:219-33; PMID:22826123 ;  http://dx.doi.org/10.1083/jcb.201202061 36.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Proc Natl Acad Sci U S A  2013 ; 110:5486 -91; PMID:23509291 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
J Proteome Res  2009 ; 8:5253 -63; PMID:19807128 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Autophagy  2013 ; 9:1201 - 13; PMID:23819996 ; http://dx.doi.org/10.4161/ auto.24811 39.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
EMBO J 2012 ; 31:3691 -703; PMID:22885598 ;  http://dx.doi.org/10.1038/emboj.2012.225 41.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Cell Death Differ 2013 ; 20:43-8; PMID:22705847 ;  http://dx.doi.org/10.1038/cdd.2012.73 42.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
J Biol Chem 2000 ;  275:25840 -9; PMID:10837477 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Cell  2010 ; 141:536-48; PMID:20434990 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
Genes Dev 2008 ; 22:3292 - 307; PMID:19056884 ; http://dx.doi.org/10.1101/ gad.1734608 45.,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
PLoS Genet  2013 ; 9:e1003664 ; PMID:23950728 ;  http://dx.doi.org/10.1371/journal.pgen.1003664,OADS,/arxiv_data1/oa_pdf/5a/c5/auto-10-453.PMC4077884.pdf
"As the OS are renewed from  *Correspondence to: Debasish Sinha; Email: Debasish@jhmi.edu Submitted: 07/18/2013; Revised: 10/31/2013; Accepted: 01/14/2014http://dx.doi.org/10.4161/auto.27292Lysosomal-mediated waste clearance   in retinal pigment epithelial cells is regulated   by CRYBA1/ βA3/A1-crystallin   via V-ATPase-MTORC1 signaling Mallika Valapala,1 christine Wilson,1 stacey h ose,1 imran A Bhutto,1 Rhonda Grebe,1 Aling Dong,1 seth Greenbaum,1   Limin Gu,1,2 samhita s engupta,1 Marisol c ano,1 sean h ackett,1 Guotong Xu,2 Gerard A Lutty,1 Lijin Dong,3 Yuri s ergeev,3   James T h anda,1 Peter c ampochiaro,1 eric Wawrousek,3 J samuel Zigler, Jr,1 and Debasish s inha1,* 1Wilmer e ye institute; Johns h opkins University s chool of Medicine; Baltimore, MD U sA; 2Department of Ophthalmology of s hanghai Tenth People’s h ospital   and Tongji e ye institute; Tongji University s chool of Medicine; s hanghai, c hina; 3National e ye institute; National i nstitutes of h ealth; Bethesda, MD U sA Keywords:  autophagy, β A3/A1-crystallin, lysosomes, MTORC1, phagocytosis, retinal pigment epithelium, retinal function,  V-ATPase Abbreviations:  AKT, protein kinase B; ATP6V0A1, a1 subunit of V0-ATPase; cKO, conditional knockout; CRYBA1, crystallin,  beta A1; Cryba1fl/fl, mice homozygous for a “floxed” allele of the Cryba1  gene; CTSD, cathepsin D; ERG, electroretinography;  GFP, green fluorescent protein; HEXA, hexosaminidase A (alpha polypeptide); LAMP1, lysosomal-associated membrane protein-1;  LC3, microtubule-associated protein 1 light chain 3; MTORC1, mechanistic target of rapamycin, complex 1; OS, outer segments;  PI3K, phosphoinositide 3-kinase; PLIN2, perilipin 2; RPE, retinal pigment epithelium; RPTOR, raptor; SQSTM1, sequestosome  1; TEM, transmission electron microscopy; V-ATPase, vacuolar-type H+-ATPase; XMEA, x-linked myopathy with excessive  autophagy; YFP, yellow fluorescent protein in phagocytic cells, including the retinal pigment epithelium (RP e), acidic compartments of the endolysosomal system  are regulators of both phagocytosis and autophagy, thereby helping to maintain cellular homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
"62 The possible interaction between CRYBA3 and the V-ATPase  monomer was tested using an interactive protein docking and molecular superposition program Hex Protein Docking, version 6.3 (http://hex.loria.fr/manual63/hex_manual.pdf).",OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Physiol Rev 2005; 85:845-81;  PMID :15987797 ; http://dx.doi.org/10.1152/ physrev.00021.2004 2.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Curr Mol Med   2010 ; 10:802-23; PMID:21091424 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Physiology (Bethesda)   2010 ; 25:8-15; PMID:20134024 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Am J Pathol  2013 ; 182:612-22; PMID:23369575 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Autophagy  2013 ; 9:973-84; PMID:23590900 ;  http://dx.doi.org/10.4161/auto.24546 6.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
EMBO J 2011 ; 30:3481 -500; PMID:21878991 ;  http://dx.doi.org/10.1038/emboj.2011.2867.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Cell Struct Funct   2003 ; 28:455-63; PMID:14745137 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Annu Rev Physiol 2012 ; 74:69-86;  PMID:22335796 ; http://dx.doi.org/10.1146/ annurev-physiol-012110-142317 9.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Biochemistry  2010 ;  49:4715 -23; PMID:20450191 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
J Cell Sci 2011 ;  124:523-31; PMID:21266465 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
EMBO J 2011 ; 30:3242 - 58; PMID:21804531 ; http://dx.doi.org/10.1038/ emboj.2011.257 14.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Science  2011 ; 334:678- 83; PMID:22053050 ; http://dx.doi.org/10.1126/ science.1207056 15.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Exp Gerontol  2005 ; 40:622- 33; PMID:16125351 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Nat Commun  2013 ; 4:1629 ;  PMID:23535650 ; http://dx.doi.org/10.1038/ ncomms2624 19.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Cell Tissue Res 1998 ; 294:309-21; PMID:9799447 ;  http://dx.doi.org/10.1007/s004410051181 22.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
PLoS One  2013 ; 8:e63061 ;  PMID:23704888 ; http://dx.doi.org/10.1371/ journal.pone.0063061 23.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Proc Natl Acad Sci U S A 2012 ; 109:8145 - 8; PMID:22566632 ; http://dx.doi.org/10.1073/ pnas.1121101109 24.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
J  Biol Chem  2008 ; 283:25091 -102; PMID:18606814 ;  http://dx.doi.org/10.1074/jbc.M80298120025.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Exp Eye Res 2011 ; 93:937-46;  PMID:22056912 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Antioxid Redox Signal  2012 ; 17:766-74; PMID:22098160 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Science  2003 ; 299:1400 - 3; PMID:12610307 ; http://dx.doi.org/10.1126/ science.1080106 29.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Arch Histol Cytol 2001 ;  64:233-46; PMID:11575420 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
FASEB J   2010 ; 24:3052 -65; PMID:20375270 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Cell 2010 ; 140:313- 26; PMID:20144757 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Cell 2008 ; 133:916- 27; PMID:18510934 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Autophagy  2012 ; 8:445- 544; PMID:22966490 ; http://dx.doi.org/10.4161/ auto.19496 36.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Cell 2013 ; 154:365-76;  PMID:23870125 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
PLoS One  2013 ; 8:e69563 ;  PMID:23922739 ; http://dx.doi.org/10.1371/ journal.pone.0069563 39.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Hum Mol Genet 2012 ;  21:5159 -73; PMID:22949512 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Nat Cell Biol  2011 ; 13:453-60; PMID:21394080 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Cell Death Dis 2011 ;  2:e217; PMID:21993393 ; http://dx.doi.org/10.1038/ cddis.2011.100 43.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Cell 2010 ; 141:290- 303; PMID:20381137 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Cell 2010 ;  141:1146 -58; PMID:20541250 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Acta Neuropathol  2013 ; 125:439-57;  PMID:23315026 ; http://dx.doi.org/10.1007/ s00401-012-1073-6 48.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Exp Neurol   1981 ; 71:295-306; PMID:7004885 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Science  2008 ; 320:1496 - 501; PMID:18497260 ; http://dx.doi.org/10.1126/ science.1157535 51.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Nature  2010 ;  465:942-6; PMID:20526321 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Ann Neurol  1988 ; 23:258- 65; PMID:2897824 ; http://dx.doi.org/10.1002/ ana.410230308 55.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Int J Biochem Cell Biol 2004 ; 36:2392 -404;  PMID :15325580 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Science  2004 ;  306:990-5; PMID :15528435 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Cell Mol Life Sci 2004 ; 61:1439 - 54; PMID :15197469 ; http://dx.doi.org/10.1007/ s00018-004-4012-4 60.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Front Biosci   2008 ; 13:718-36; PMID:17981582 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Mol Cell Neurosci  2008 ; 37:85- 95; PMID:17931883 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Bioinformatics  2010 ;  26:2398 -405; PMID:20685958 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Biochemistry  2000 ; 39:15799 - 806; PMID:11123905 ; http://dx.doi.org/10.1021/ bi001882h 65.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Exp Eye Res 2004 ; 79:377- 83; PMID :15669142 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Proc Natl Acad Sci U S A 2003 ; 100:6481 - 6; PMID:12743369 ; http://dx.doi.org/10.1073/ pnas.1130432100 67.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Transgenic Res  2012 ; 21:1033 -42;  PMID:22427112 ; http://dx.doi.org/10.1007/ s11248-012-9608-0 68.,Non-OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Proc Natl Acad Sci U S A  2006 ; 103:11300 -5; PMID:16849425 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
Methods Mol Biol   2008 ; 432:229-41; PMID:18370022 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/b7/auto-10-480.PMC4077886.pdf
"Finally, the concentrations of protein-bound oxidized amino acids were measured in plasma samples from classicbasic research http://www.kidney-international.org &2014 International Society of Nephrology Correspondence: James A. Shayman, Department of Internal Medicine, 1150 West Medical Center Drive, Ann Arbor, Michigan 48109-0676, USA.E-mail: jshayman@umich.edu Received 18 March 2013; revised 4 November 2013; accepted 14 November 2013; published online 8 January 2014 58 Kidney International (2014) 86,5 8 – 6 6",Non-OADS,/arxiv_data1/oa_pdf/78/f3/ki2013520a.PMC4077934.pdf
Relation of plasma 3-nitrotyrosine levels and lyso-Gb3 concentration in Fabry patient plasma Supplementary material is linked to the online version of the paper at http://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/78/f3/ki2013520a.PMC4077934.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 66 Kidney International (2014) 86,5 8 – 6 6basic research L Shu et al.",Non-OADS,/arxiv_data1/oa_pdf/78/f3/ki2013520a.PMC4077934.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease273 http://e-aair.orgThe prevalence of allergic rhinitis (AR) in the general popula - tion is increasing and currently estimated to be approximately  10-25%.1,2 Although AR is not associated with a risk of death, the  disorder can have a considerable effect on a patient’s quality of  life.",Non-OADS,/arxiv_data1/oa_pdf/01/1d/aair-6-273.PMC4077952.pdf
"This im - plies that although many ENT specialists now agree with the ef - ficacy of SIT, they are concerned about the safety issues of this This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/1d/aair-6-273.PMC4077952.pdf
2014 July;6(4):273-275. http://dx.doi.org/10.4168/aair.2014.6.4.273 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/01/1d/aair-6-273.PMC4077952.pdf
"Rhee Volume 6, Number 4, July 2014274 http://e-aair.org Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/01/1d/aair-6-273.PMC4077952.pdf
2014 July;6(4):273-275. http://dx.doi.org/10.4168/aair.2014.6.4.273 Allergy Asthma Immunol Res.,Non-OADS,/arxiv_data1/oa_pdf/01/1d/aair-6-273.PMC4077952.pdf
"2014 July;6(4):273-275. http://dx.doi.org/10.4168/aair.2014.6.4.273therapy, especially those of SCIT.",Non-OADS,/arxiv_data1/oa_pdf/01/1d/aair-6-273.PMC4077952.pdf
275 http://e-aair.orgSIT in Allergic Rhinitis AAIR Allergy Asthma Immunol Res.,Non-OADS,/arxiv_data1/oa_pdf/01/1d/aair-6-273.PMC4077952.pdf
2014 July;6(4):273-275. http://dx.doi.org/10.4168/aair.2014.6.4.273 Allergy Asthma Immunol Res.,Non-OADS,/arxiv_data1/oa_pdf/01/1d/aair-6-273.PMC4077952.pdf
2014 July;6(4):273-275. http://dx.doi.org/10.4168/aair.2014.6.4.273REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/01/1d/aair-6-273.PMC4077952.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease276 http://e-aair.orgINTRODUCTION Atopic dermatitis (AD) is one of the most common chronic in - flammatory skin diseases, characterized by xerosis, eczematous  skin lesions, pruritus, immunodysregulation, epidermal barrier  dysfunction and IgE-mediated sensitization to food and envi - ronmental allergens.1 Our understanding of the disease patho - genesis of AD has increased, and it is clear that no single defect  accounts for the array of clinical features associated with AD.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
"Key Words:  Atopic dermatitis; barrier repair therapy; skin barrierThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
"2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 AAIR 277 http://e-aair.orgbarrier function, indicated by an increased transepidermal wa - ter loss (TEWL) and decreased water-binding capacity due main - ly to altered levels of inter/intracellular components in the SC.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 278 http://e-aair.orgA recent study by Kim et al .,OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
"2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 AAIR 279 http://e-aair.orgPAR-2 and trypsin have been observed in the lesional skin of  patients with AD, and PAR-2 agonist peptides induce pruritus  in patients with AD.34 PAR-2 in the skin is involved in pruritus  via the transient receptor potential vanilloid receptor (TRPV1)  inflammation, and thymic stromal lymphopoietin (TSLP) acti - vation, implying that PAR-2 antagonists represent potentially  useful therapeutics for treating AD (Fig.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
"2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 280 http://e-aair.orgcoexist in some patients with AD, resulting in a more severe de - fect in the skin barrier.13 The proteolytic activity from various contact allergens and  aeroallergens are considered important factors in the initiation  and aggravation of AD.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
"2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 AAIR 281 http://e-aair.orgproves paracellular permeability.48 Recent analysis of AD skin  lesions showed increased PPAR γ expression in keratinocytes  and in infiltrating T cells and monocytes.49 PPARγ plays a criti - cal role in the regulation of genes involved in cellular prolifera - tion, in specific components of the Th2 inflammatory pathway  and in maintenance of the skin barrier.45 Systemic treatment with  a PPARγ agonist, rather than with topical treatment, decreased  the amount of surface area affected, the severity of lesions and  the number of flares in patients with severe AD.50 Therefore,  PPARs and their corresponding ligands are potential therapeutic  targets for treating AD.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
"2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 282 http://e-aair.orgcytokine production.67 In addition, a suberythemal dose of UVB  on the skin exerts beneficial effects on the SC barrier function  by activating the cutaneous vitamin D system.68,69 In addition,  UV initiates endoplasmic reticulum (ER) stress responses in - cluding downstream activation of the transcription factor, NF- κB.70 In the epidermis, ER stress increases human cathelicidin  antimicrobial peptide (CAMP) expression, which stimulates in - nate immunity.71 A recent study suggested that UV radiation  enhances cortisol activity in a waveband-dependent manner,  and cortisol production protects and/or restores epidermal  barrier homeostasis.72 In fact, most patients affected by AD im - prove during the sunny summer season, and artificial UV radi - ation, including psoralen-UVA and narrow-band UVB, is fre - quently utilized in the treatment of AD.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 AAIR 283 http://e-aair.orgpathomechanisms and potential treatments for AD.,OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 284 http://e-aair.orgAD treatment (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
"2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 AAIR 285 http://e-aair.orgMangan NE, Callanan JJ, Kawasaki H, Shiohama A, Kubo A, Sund - berg JP , Presland RB, Fleckman P , Shimizu N, Kudoh J, Irvine AD,  Amagai M, McLean WH.",OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 286 http://e-aair.orgmunol 2010;125:160-9.e1-5.,Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
2014 July;6(4):276-287. http://dx.doi.org/10.4168/aair.2014.6.4.276 AAIR 287 http://e-aair.org75.,Non-OADS,/arxiv_data1/oa_pdf/be/d8/aair-6-276.PMC4077953.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease288 http://e-aair.orgINTRODUCTION Leukotrienes are lipid mediators generated from arachidonic  acid through the 5-lipoxygenase (5-LO) pathway.",Non-OADS,/arxiv_data1/oa_pdf/39/4e/aair-6-288.PMC4077954.pdf
"Key Words:  Leukotrienes; 5-lipoxygenase; asthma; AERDThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/4e/aair-6-288.PMC4077954.pdf
2014 July;6(4):288-295. http://dx.doi.org/10.4168/aair.2014.6.4.288 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/39/4e/aair-6-288.PMC4077954.pdf
"2014 July;6(4):288-295. http://dx.doi.org/10.4168/aair.2014.6.4.288 289 http://e-aair.orgthe microenvironment and intracellular phosphorylation  events, with mechanisms that can respectively enhance and  limit the expression and function of the critical metabolic en - zymes dependent on context.",Non-OADS,/arxiv_data1/oa_pdf/39/4e/aair-6-288.PMC4077954.pdf
"2014 July;6(4):288-295. http://dx.doi.org/10.4168/aair.2014.6.4.288 290 http://e-aair.orgsue edema induced by IgE-dependent passive cutaneous ana - phylaxis.30 Thus, at least two GPCRs (CysLT 2R and GPR17)  dampen CysLT 1R function by direct physical interactions.",Non-OADS,/arxiv_data1/oa_pdf/39/4e/aair-6-288.PMC4077954.pdf
"2014 July;6(4):288-295. http://dx.doi.org/10.4168/aair.2014.6.4.288 291 http://e-aair.orgasthma does not correlate with the numbers of CysLT 1R- or  CysLT 2R- expressing cells in bronchial biopsies.60 It is tempting  to speculate that non-classical receptors, such as GPR99, may  account for a component of the end organ responsiveness to  cys-LTs (particularly to LTE 4) observed in AERD.",Non-OADS,/arxiv_data1/oa_pdf/39/4e/aair-6-288.PMC4077954.pdf
2014 July;6(4):288-295. http://dx.doi.org/10.4168/aair.2014.6.4.288 292 http://e-aair.orgedly amplifies the recruitment of eosinophils to the airways of  sensitized mice challenged with low-dose OVA.,Non-OADS,/arxiv_data1/oa_pdf/39/4e/aair-6-288.PMC4077954.pdf
"2014 July;6(4):288-295. http://dx.doi.org/10.4168/aair.2014.6.4.288 293 http://e-aair.orgP , Drazen JM.",Non-OADS,/arxiv_data1/oa_pdf/39/4e/aair-6-288.PMC4077954.pdf
2014 July;6(4):288-295. http://dx.doi.org/10.4168/aair.2014.6.4.288 294 http://e-aair.orgleukotriene D4.,Non-OADS,/arxiv_data1/oa_pdf/39/4e/aair-6-288.PMC4077954.pdf
2014 July;6(4):288-295. http://dx.doi.org/10.4168/aair.2014.6.4.288 295 http://e-aair.org1993;6:1468-73.,Non-OADS,/arxiv_data1/oa_pdf/39/4e/aair-6-288.PMC4077954.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease296 http://e-aair.orgINTRODUCTION Allergic rhinitis (AR) is a common inflammatory disease of the  nasal mucosa that results from seasonal or perennial responses  to allergens.",Non-OADS,/arxiv_data1/oa_pdf/c7/27/aair-6-296.PMC4077955.pdf
"Key Words:  Allergic rhinitis; specific immunotherapy; data collection; Chinese otolaryngologistsThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/27/aair-6-296.PMC4077955.pdf
2014 July;6(4):296-303. http://dx.doi.org/10.4168/aair.2014.6.4.296 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/c7/27/aair-6-296.PMC4077955.pdf
"2014 July;6(4):296-303. http://dx.doi.org/10.4168/aair.2014.6.4.296 297 http://e-aair.orgMATERIALS AND METHODS We designed and distributed a questionnaire to 800 ENT spe - cialists in January and February of 2011 who were working in 18  provinces and municipalities representative of 4 different geo - graphical regions (east, south-central, west, and north) in Chi - na.",OADS,/arxiv_data1/oa_pdf/c7/27/aair-6-296.PMC4077955.pdf
"2014 July;6(4):296-303. http://dx.doi.org/10.4168/aair.2014.6.4.296 298 http://e-aair.org(32.1%), and then single pollen (22.1%).",OADS,/arxiv_data1/oa_pdf/c7/27/aair-6-296.PMC4077955.pdf
2014 July;6(4):296-303. http://dx.doi.org/10.4168/aair.2014.6.4.296 299 http://e-aair.org(Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/27/aair-6-296.PMC4077955.pdf
2014 July;6(4):296-303. http://dx.doi.org/10.4168/aair.2014.6.4.296 300 http://e-aair.orgquestionnaire.,Non-OADS,/arxiv_data1/oa_pdf/c7/27/aair-6-296.PMC4077955.pdf
"2014 July;6(4):296-303. http://dx.doi.org/10.4168/aair.2014.6.4.296 301 http://e-aair.orgtechnological advances in SIT; however, relevant and current  studies are still limited in China.",Non-OADS,/arxiv_data1/oa_pdf/c7/27/aair-6-296.PMC4077955.pdf
"2014 July;6(4):296-303. http://dx.doi.org/10.4168/aair.2014.6.4.296 302 http://e-aair.orgDY, Wickman M, Yawn BP , Yorgancioglu A, Yusuf OM, Zar H, An - nesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Boucha - rd J, Burney P , Busse WW, Chan-Yeung M, Chavannes NH, Chuchal - in A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C,  Johnston SL, Keith PK, Kemp JP , Klossek JM, Larenas-Linnemann  D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Nigge - mann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP , Potter  P , Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D; World  Health Organization; GA2LEN; AllerGen.",Non-OADS,/arxiv_data1/oa_pdf/c7/27/aair-6-296.PMC4077955.pdf
2014 July;6(4):296-303. http://dx.doi.org/10.4168/aair.2014.6.4.296 303 http://e-aair.orglergen cluster immunotherapy in a clinical practice.,Non-OADS,/arxiv_data1/oa_pdf/c7/27/aair-6-296.PMC4077955.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease304 http://e-aair.orgINTRODUCTION Anaphylaxis is a possibly fatal allergic reaction with a rapid on - set.1 It is the most severe form of allergic reactions and should be  considered a medical emergency.",Non-OADS,/arxiv_data1/oa_pdf/ed/19/aair-6-304.PMC4077956.pdf
"Key Words:  Anaphylaxis; food; tryptase; shrimpThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/19/aair-6-304.PMC4077956.pdf
2014 July;6(4):304-309. http://dx.doi.org/10.4168/aair.2014.6.4.304 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/ed/19/aair-6-304.PMC4077956.pdf
2014 July;6(4):304-309. http://dx.doi.org/10.4168/aair.2014.6.4.304 305 http://e-aair.organaphylaxis.,Non-OADS,/arxiv_data1/oa_pdf/ed/19/aair-6-304.PMC4077956.pdf
2014 July;6(4):304-309. http://dx.doi.org/10.4168/aair.2014.6.4.304 306 http://e-aair.orgase by an examination of the areas under the respective ROC  curves.,OADS,/arxiv_data1/oa_pdf/ed/19/aair-6-304.PMC4077956.pdf
2014 July;6(4):304-309. http://dx.doi.org/10.4168/aair.2014.6.4.304 307 http://e-aair.orgDelta-tryptase and tryptase ratio values among the 3 groups The delta-tryptase and tryptase ratio were calculated.,OADS,/arxiv_data1/oa_pdf/ed/19/aair-6-304.PMC4077956.pdf
2014 July;6(4):304-309. http://dx.doi.org/10.4168/aair.2014.6.4.304 308 http://e-aair.orgThe most common presentation of anaphylaxis in our study  was cutaneous manifestation.,Non-OADS,/arxiv_data1/oa_pdf/ed/19/aair-6-304.PMC4077956.pdf
2014 July;6(4):304-309. http://dx.doi.org/10.4168/aair.2014.6.4.304 309 http://e-aair.orgphylaxis in children and adults.,Non-OADS,/arxiv_data1/oa_pdf/ed/19/aair-6-304.PMC4077956.pdf
Available from: http://www.phadia.com/ da/Products/Allergy-testing-products/ImmunoCAP-Assays/Im -munoCAP-Tryptase/.,Non-OADS,/arxiv_data1/oa_pdf/ed/19/aair-6-304.PMC4077956.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease310 http://e-aair.orgINTRODUCTION Chronic sinusitis is an inflammatory disease of the nose and  sinus mucosa caused by a disturbance of ventilation and nasal  cavity drainage.1 In addition, paranasal sinusitis (due to sino - mucosal damage and ciliary dysfunction) results in an inflam - mation that lasts longer than three months.2 Chronic sinusitis is  a common upper airway inflammatory condition with a preva - lence of 10.1% in the general population in the USA.3 Nasal pol - yps are smooth, grapelike structures caused by inflamed nasal  mucosa.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/aair-6-310.PMC4077957.pdf
"Key Words:  Bronchial hyperresponsiveness; computed tomography; nasal polyp; pulmonary function test; sinusitisThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/aair-6-310.PMC4077957.pdf
2014 July;6(4):310-315. http://dx.doi.org/10.4168/aair.2014.6.4.310 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/ba/24/aair-6-310.PMC4077957.pdf
"2014 July;6(4):310-315. http://dx.doi.org/10.4168/aair.2014.6.4.310 311 http://e-aair.orglower airway diseases are different manifestations of one patho - logic process.8 Studies dealing with associations of the upper and lower re - spiratory airways have mainly focused on rhinosinusitis patients  with lung disease6,12,13; however, the potential effect of upper  airway pathology on normal lower airways has not been evalu - ated.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/aair-6-310.PMC4077957.pdf
"2014 July;6(4):310-315. http://dx.doi.org/10.4168/aair.2014.6.4.310 312 http://e-aair.orgComparison of clinical characteristics according to co-morbid  sinusitis and nasal polyp The group suspicious of sinusitis on CT showed male predom - inance (78.5% vs 54.8%, P<0.001) and was significantly older  than the non-sinusitis control group (52.0 ±0.6 years vs 44.3 ± 2.0 years, P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/ba/24/aair-6-310.PMC4077957.pdf
2014 July;6(4):310-315. http://dx.doi.org/10.4168/aair.2014.6.4.310 313 http://e-aair.orgSubgroup analysis according to the severity of CT finding of  sinusitis in subjects without BHR also revealed a linear trend of  decreased FEV1 and FEV1/FVC ( P=0.022).,Non-OADS,/arxiv_data1/oa_pdf/ba/24/aair-6-310.PMC4077957.pdf
"2014 July;6(4):310-315. http://dx.doi.org/10.4168/aair.2014.6.4.310 314 http://e-aair.orggold standard for the radiographic delineation of sinus disease28,29  and CT findings are a key component in severity staging systems  for chronic sinusitis.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/aair-6-310.PMC4077957.pdf
2014 July;6(4):310-315. http://dx.doi.org/10.4168/aair.2014.6.4.310 315 http://e-aair.org18.,Non-OADS,/arxiv_data1/oa_pdf/ba/24/aair-6-310.PMC4077957.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease316 http://e-aair.orgINTRODUCTION With ageing, there is an increasing overlap of asthma and  chronic obstructive pulmonary disease (COPD), such that many  older patients with obstructive airway disease (OAD) have fea - tures of both asthma and COPD, termed asthma-COPD overlap  syndrome.1 Hardin et al .",Non-OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
"Key Words:  Ageing; C-reactive protein; interleukin-6; asthma; obstructive airway disease; comorbidityThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
2014 July;6(4):316-324. http://dx.doi.org/10.4168/aair.2014.6.4.316 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
"2014 July;6(4):316-324. http://dx.doi.org/10.4168/aair.2014.6.4.316 317 http://e-aair.orgincreases with age, it is unclear whether systemic inflammation is  also a feature of this condition, and if so, which markers are in - volved in and what are the clinical correlates of these markers.",Non-OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
2014 July;6(4):316-324. http://dx.doi.org/10.4168/aair.2014.6.4.316 318 http://e-aair.orgfunction with post bronchodilator FEV1/FVC ≥70% and post- bronchodilator FEV1 >80% of predicted.,Non-OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
"2014 July;6(4):316-324. http://dx.doi.org/10.4168/aair.2014.6.4.316 319 http://e-aair.orgwere natural log transformed and reciprocal square roots trans - formed to normality, respectively.",OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
2014 July;6(4):316-324. http://dx.doi.org/10.4168/aair.2014.6.4.316 320 http://e-aair.orgTable 4.,Non-OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
"2014 July;6(4):316-324. http://dx.doi.org/10.4168/aair.2014.6.4.316 321 http://e-aair.orgAssociations between systemic inflammation mediators and  clinical characteristics In univariate regression, serum CRP level (LN CRP) was as - sociated with BMI (Coef.",OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
"2014 July;6(4):316-324. http://dx.doi.org/10.4168/aair.2014.6.4.316 322 http://e-aair.orgTherefore, this study provides novel data in relation to this pa - tient population.",Non-OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
"2014 July;6(4):316-324. http://dx.doi.org/10.4168/aair.2014.6.4.316 323 http://e-aair.orgfuture studies measurement a panel of biomarkers is suggest - ed.40 Moreover, to investigate the predictors for developing asth - ma-COPD overlap syndrome and prognostic role of systemic in - flammation in OAD, a longitudinal study will be valuable.",Non-OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
2014 July;6(4):316-324. http://dx.doi.org/10.4168/aair.2014.6.4.316 324 http://e-aair.orgly.,Non-OADS,/arxiv_data1/oa_pdf/0d/6b/aair-6-316.PMC4077958.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease325 http://e-aair.orgINTRODUCTION Periplaneta americana  (American cockroach) has a predilec - tion for a tropical climate.1 They inhabit households, offices, and  restaurants and are a major source of inhalant indoor allergens.2,3  Exposure to cockroach (CR) allergens cause sensitization to al - lergic diseases, especially among atopic subjects.4,5 The sensi - tized subjects develop a Th2-immune response bias with spe - cific Th2-cell proliferation and cytokine production that medi - ate class switching of specific B cells to IgE-committed B cells.",Non-OADS,/arxiv_data1/oa_pdf/80/0e/aair-6-325.PMC4077959.pdf
"Key Words:  American cockroach; B-cell epitope; hybridoma; Per a 1; Periplaneta americana , mimotopeThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/0e/aair-6-325.PMC4077959.pdf
2014 July;6(4):325-332. http://dx.doi.org/10.4168/aair.2014.6.4.325 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/80/0e/aair-6-325.PMC4077959.pdf
2014 July;6(4):325-332. http://dx.doi.org/10.4168/aair.2014.6.4.325 326 http://e-aair.orgno.,Non-OADS,/arxiv_data1/oa_pdf/80/0e/aair-6-325.PMC4077959.pdf
2014 July;6(4):325-332. http://dx.doi.org/10.4168/aair.2014.6.4.325 327 http://e-aair.orgonly to the homologous antigen and the P .,Non-OADS,/arxiv_data1/oa_pdf/80/0e/aair-6-325.PMC4077959.pdf
"2014 July;6(4):325-332. http://dx.doi.org/10.4168/aair.2014.6.4.325 328 http://e-aair.orgIgE reactivity of the Per a 1.0105 epitope The procedure of competitive ELISA was performed with  modification to validate the IgE reactivity of the Per a 1.0105  epitope.17 The amplified rPer a 1.0105-specific MAb mimotopic  phages and irrelevant phage (background control) at various  amounts (108, 109, 1010, 1011, and 1012 pfu) were mixed individu - ally with pooled CR allergic patient sera (5 patients).",Non-OADS,/arxiv_data1/oa_pdf/80/0e/aair-6-325.PMC4077959.pdf
2014 July;6(4):325-332. http://dx.doi.org/10.4168/aair.2014.6.4.325 329 http://e-aair.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/80/0e/aair-6-325.PMC4077959.pdf
2014 July;6(4):325-332. http://dx.doi.org/10.4168/aair.2014.6.4.325 330 http://e-aair.orgnot inhibit the binding of the IgE in patient-pooled sera to the  native Per a 1 and indicated that the MAb-specific Per a 1 epit - ope was not an IgE- inducing epitope.,Non-OADS,/arxiv_data1/oa_pdf/80/0e/aair-6-325.PMC4077959.pdf
2014 July;6(4):325-332. http://dx.doi.org/10.4168/aair.2014.6.4.325 331 http://e-aair.orgmotopic peptide is REVLQKNFAKGV which is matched with  the amino acids 99QDLLQNLRDKGV110 of the Per a 1.0105.,OADS,/arxiv_data1/oa_pdf/80/0e/aair-6-325.PMC4077959.pdf
"2014 July;6(4):325-332. http://dx.doi.org/10.4168/aair.2014.6.4.325 332 http://e-aair.orgP , Mitchell H, McNiff-Mortimer K, Lynn H, Ownby D, Malveaux F .",Non-OADS,/arxiv_data1/oa_pdf/80/0e/aair-6-325.PMC4077959.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease333 http://e-aair.orgINTRODUCTION Asthma is a common respiratory disease characterized by re - versible airway obstruction, bronchial hyperresponsiveness,  and respiratory symptoms resulting from chronic airway in - flammation.",Non-OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
"Key Words:  Asthma; epistasis; polymorphism; monocyte chemoattractant proteinsThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
2014 July;6(4):333-340. http://dx.doi.org/10.4168/aair.2014.6.4.333 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
"2014 July;6(4):333-340. http://dx.doi.org/10.4168/aair.2014.6.4.333 334 http://e-aair.orgFurthermore, MCP-1 might play an important role in allergic  responses via induction of mast cell activation and release of  leukotriene C4 into the airway, which directly induces airway  hyperresponsiveness.8 MCP-3 may play an important role in  macrophage recruitment in children with upper respiratory vi - ral infections.3 RANTES and MCP-3 mRNA was significantly el - evated in bronchial mucosa of atopic asthma, and associated  with significantly increased numbers of bronchial mucosal eo - sinophils.9 The expressions of MCP-3 in bronchial mucosa were  also observed together with eosinophilic cytokines such as IL-5  GM-CSF , and IL-13 in both atopic and nonatopic asthma.10  All three human MCP  genes are located on chromosome 17q  11.2-q12.",Non-OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
2014 July;6(4):333-340. http://dx.doi.org/10.4168/aair.2014.6.4.333 335 http://e-aair.orgthe standard 5% level.,Non-OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
2014 July;6(4):333-340. http://dx.doi.org/10.4168/aair.2014.6.4.333 336 http://e-aair.orgble 6; Fig.,Non-OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
"2014 July;6(4):333-340. http://dx.doi.org/10.4168/aair.2014.6.4.333 337 http://e-aair.orgstatus) than its single effect (main effect, 0.52% vs 0.64%, re - spectively, MCP1-2518G >A versus MCP2+46A >C) for a sub - ject’s status (asthma or normal).",Non-OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
2014 July;6(4):333-340. http://dx.doi.org/10.4168/aair.2014.6.4.333 338 http://e-aair.orgmodel between asthma and control.,Non-OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
2014 July;6(4):333-340. http://dx.doi.org/10.4168/aair.2014.6.4.333 339 http://e-aair.orgtra-combination and asthma indicates that linkage disequilib - ria did not affect the process of detecting gene – gene interac - tions.,OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
ORCID Choon-Sik Park http://orcid.org/0000-0003-2977-0255REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
2014 July;6(4):333-340. http://dx.doi.org/10.4168/aair.2014.6.4.333 340 http://e-aair.orgchallenge testing-1999.,OADS,/arxiv_data1/oa_pdf/4e/f8/aair-6-333.PMC4077960.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease341 http://e-aair.orgINTRODUCTION The global prevalence, morbidity, mortality and economic  cost associated with asthma have been on the rise, increasing  nearly 50% every decade.1,2 Asthma is most often first diagnosed  in childhood and acute asthmatic responses are one of the most  common causes of emergency room visits in children.3 Cur - rently, most common treatment options provide only tempo - rary relief to alleviate symptoms while sustained relief requires  long-term interventions that include medication and lifestyle  modifications.",Non-OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
"Key Words:  Asthma; vaccines; listeria monocytogenes ; immune system; newborn; Extrinsic allergicThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
2014 July;6(4):341-349. http://dx.doi.org/10.4168/aair.2014.6.4.341 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
"2014 July;6(4):341-349. http://dx.doi.org/10.4168/aair.2014.6.4.341 342 http://e-aair.orggies offer an even more effective approach that could lead to  protection from asthma.6 The processes leading to clinically symptomatic asthma have  been shown to begin early in life7,8 and therefore, attempts to  prevent asthma would likely be most effective if initiated peri - natally.",Non-OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
"2014 July;6(4):341-349. http://dx.doi.org/10.4168/aair.2014.6.4.341 343 http://e-aair.orgSubsequently, anesthetized mice were challenged intranasally  (i.n.)",Non-OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
"2014 July;6(4):341-349. http://dx.doi.org/10.4168/aair.2014.6.4.341 344 http://e-aair.orgsequent allergen exposure; “Ctrl” – immunization with NaCl  followed by allergen exposure; “ Lm” – immunization with Lm  ∆(trpS actA )/pSP0, followed by allergen exposure; “ LmOVA” –  immunization with Lm ∆(trpS actA )/pSP0-PS hlyOVA, followed  by allergen exposure; “HK LmOVA” – immunization with HK Lm  ∆(trpS actA )/pSP0-PS hly-OVA, followed by allergen exposure.",Non-OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
"2014 July;6(4):341-349. http://dx.doi.org/10.4168/aair.2014.6.4.341 345 http://e-aair.orgperiments, bronchoalveolar lavages (BAL) were obtained by 3  sequential introductions and aspiration of 1 mL sterile PBS each.",Non-OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
"2014 July;6(4):341-349. http://dx.doi.org/10.4168/aair.2014.6.4.341 346 http://e-aair.orgLmOVA, and HK LmOVA groups in comparison to the control  group and showed the highest statistical significance in the  LmOVA groups.",OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
2014 July;6(4):341-349. http://dx.doi.org/10.4168/aair.2014.6.4.341 347 http://e-aair.orgrameters associated with HP .,OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
"2014 July;6(4):341-349. http://dx.doi.org/10.4168/aair.2014.6.4.341 348 http://e-aair.orging of HP in neonatally vaccinated mice suggests, again, that  early life Lm immunization appears to induce a balanced im - mune response, rather than a simple Th2/Th1 shift.",Non-OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
2014 July;6(4):341-349. http://dx.doi.org/10.4168/aair.2014.6.4.341 349 http://e-aair.org15.,Non-OADS,/arxiv_data1/oa_pdf/e1/28/aair-6-341.PMC4077961.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease350 http://e-aair.orgINTRODUCTION Immunoglobulin E (IgE) is a monomeric antibody that has  been implicated in immune responses to helminth infections.1  High total serum IgE levels are a clinical characteristic of asth - ma and atopy in western communities2 and have also been as - sociated with a number of environmental and genetic risk fac - tors.3 Twin registry studies have consistently shown a signifi - cant genetic component to serum IgE variation across individ - uals in all age groups, with cord blood, infants, children and  adults levels having heritability ranging from 30% to 70%.4,5 Can - didate gene associated studies have also shown that genetic  variants in a number of genes, particularly in interleukin (IL)-4/ IL-13 signal pathway genes, were associated with IgE levels.6-8 IL-13 and IL-4, which are essential for IgE synthesis, share a  common signalling pathway in binding to a heterodimer of the  IL-4 receptor α and either the common γ-chain (for binding Maternal Genetic Variants of IL4/IL13 Pathway Genes on IgE With  “Western or Eastern Environments/Lifestyles”  Guicheng Zhang,1,5* Siew-Kim Khoo,1 Mika J Mäkelä,2 Pierre Candelaria,1 Catherine M Hayden,1 Leena von Hertzen,2  Tiina Laatikainen,3 Erkki Vartiainen,3 Jack Goldblatt,1,4 Tari Haahtela,2 Peter N LeSouëf1 1School of Paediatrics and Child Health, University of Western Australia, Australia 2Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland 3National Institute for Health and Welfare, Department of Chronic Disease Prevention, Helsinki, Finland 4Genetic Services of WA, King Edward Memorial Hospital, Perth, Australia 5School of Public Health, Curtin University, Perth, Australia IL-4 and IL-13) or the IL-13 receptor α chain (exclusive for IL- 13).9 By phosphorylation of the transcriptional regulator of sig - nal transducer and activator of transcription 6 (STAT6), intra - cellular signalling of IL4/IL-13 pathway penetrates the nucleus  and activates the transcription of target genes inducing IgG  switching to IgE.10 Several functionally important genetic vari - ants in the IL-4 /IL-13  pathway genes should have an influence  on serum IgE levels in view of the critical role of the IL-4/IL-13  pathway in promotion of production of IgE.",Non-OADS,/arxiv_data1/oa_pdf/b9/26/aair-6-350.PMC4077962.pdf
"Key Words:  Allergy; IgE; IL-4; IL-13; maternal genetic effectsThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/26/aair-6-350.PMC4077962.pdf
2014 July;6(4):350-356. http://dx.doi.org/10.4168/aair.2014.6.4.350 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/b9/26/aair-6-350.PMC4077962.pdf
"2014 July;6(4):350-356. http://dx.doi.org/10.4168/aair.2014.6.4.350 351 http://e-aair.orgpreviously reported the associations of those genetic variants  with IgE.11-13 Maternal genetic variants may determine the prenatal envi - ronment and thus play a role in the development of health con - ditions in their offspring, particularly for diseases with onset  early in life.14,15 Many prenatal factors have been associated with  IgE levels later in life.16,17 It is, therefore, conceivable that mater - nal genetic variants may have an influence on IgE levels in school- age children, particularly for genes in the IL-4/IL-13  pathway,  as there is evidence that cord blood IgE was a predictor for al - lergy and asthma later in life.18,19 However, no reported studies  have investigated the effects of maternal genetic variants in IL4/ IL13  pathway genes on IgE levels in children.",Non-OADS,/arxiv_data1/oa_pdf/b9/26/aair-6-350.PMC4077962.pdf
"Ten sin - gle nucleotide polymorphisms (SNPs) in IL-4 , IL-4Ra , IL-13,  and  STAT6  were selected and genotyped based on their functional  importance and evidence of associations with asthma and IgE.25  Genotyping of candidate polymorphisms was performed using  iPLEXTM Assay on the MassARRAY® system (Sequenom, San  Diego, CA, USA) according to manufacturer’s instructions  (http://www.sequenom.com).",OADS,/arxiv_data1/oa_pdf/b9/26/aair-6-350.PMC4077962.pdf
"2014 July;6(4):350-356. http://dx.doi.org/10.4168/aair.2014.6.4.350 352 http://e-aair.orgage disequilibrium with the SNPs of IL-4  -33 in the IL-4  gene  and IL-13  130 in the IL-13  gene, respectively, therefore only the  results of IL-4  -33 and IL-13  130 were reported.",Non-OADS,/arxiv_data1/oa_pdf/b9/26/aair-6-350.PMC4077962.pdf
2014 July;6(4):350-356. http://dx.doi.org/10.4168/aair.2014.6.4.350 353 http://e-aair.orgpared to those whose mothers were AG (n =49; mean: 61.7; 95%  CI: 42.3-89.7 kU/L).,Non-OADS,/arxiv_data1/oa_pdf/b9/26/aair-6-350.PMC4077962.pdf
"2014 July;6(4):350-356. http://dx.doi.org/10.4168/aair.2014.6.4.350 354 http://e-aair.orgber of children at home, parents’ education, residential suburb  housing, passive smoking, farm exposure in the first year of life,  farm animal exposure, cat and dog exposure were investigated  for associations with serum IgE levels in children.",Non-OADS,/arxiv_data1/oa_pdf/b9/26/aair-6-350.PMC4077962.pdf
2014 July;6(4):350-356. http://dx.doi.org/10.4168/aair.2014.6.4.350 355 http://e-aair.orgis a stronger predictor for offspring’s susceptibility compared to  paternal history.28 This evidence and our findings all point to  epigenetic influences29 that warrant more studies.,Non-OADS,/arxiv_data1/oa_pdf/b9/26/aair-6-350.PMC4077962.pdf
2014 July;6(4):350-356. http://dx.doi.org/10.4168/aair.2014.6.4.350 356 http://e-aair.orgasthma and allergy on Karelia.,OADS,/arxiv_data1/oa_pdf/b9/26/aair-6-350.PMC4077962.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease357 http://e-aair.orgINTRODUCTION Main goal of asthma treatment in children is to achieve and  maintain disease control in all aspects of the clinical spectrum  including symptoms, activity limitations, use of rescue broncho - dilators and lung function.1 Adequate therapeutic plan which  depends on correct assessment of control in children is vital to  decrease morbidity and to inhibit remodeling at this period of  life.2 The only asthma control measure validated into Turkish was  the Asthma Control Test for children (C-ACT) which is suitable  for use in children aged 4 years and above.3,4 However, there was  no questionnaire for evaluation of asthma control in Turkish  children younger than 4 years.",Non-OADS,/arxiv_data1/oa_pdf/0f/8b/aair-6-357.PMC4077963.pdf
"Key Words:  Asthma; preschool; questionnaireThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/8b/aair-6-357.PMC4077963.pdf
2014 July;6(4):357-361. http://dx.doi.org/10.4168/aair.2014.6.4.357 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/0f/8b/aair-6-357.PMC4077963.pdf
2014 July;6(4):357-361. http://dx.doi.org/10.4168/aair.2014.6.4.357 358 http://e-aair.orgStudy design This was a cohort study and it was approved by the Ethical  Board of Celal Bayar University.,Non-OADS,/arxiv_data1/oa_pdf/0f/8b/aair-6-357.PMC4077963.pdf
2014 July;6(4):357-361. http://dx.doi.org/10.4168/aair.2014.6.4.357 359 http://e-aair.orgtrolled asthma according to TRACK score ( P=0.02 and P<0.001  respectively).,Non-OADS,/arxiv_data1/oa_pdf/0f/8b/aair-6-357.PMC4077963.pdf
"2014 July;6(4):357-361. http://dx.doi.org/10.4168/aair.2014.6.4.357 360 http://e-aair.orgHowever, none of the previous research had enrolled preschool  children with asthma.",Non-OADS,/arxiv_data1/oa_pdf/0f/8b/aair-6-357.PMC4077963.pdf
Available  from: http://www.ginasthma.org/documents/6.,Non-OADS,/arxiv_data1/oa_pdf/0f/8b/aair-6-357.PMC4077963.pdf
2014 July;6(4):357-361. http://dx.doi.org/10.4168/aair.2014.6.4.357 361 http://e-aair.org16.,Non-OADS,/arxiv_data1/oa_pdf/0f/8b/aair-6-357.PMC4077963.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease362 http://e-aair.orgINTRODUCTION Angioedema without urticaria is an uncommon skin disease  with a prevalence of 1.6%-2.2% and has been classified as either  hereditary or acquired.1 Angioedema can be further stratified  according to the mediators that induce vascular leakage: brady - kinin, histamine, various factor-mediated, and idiopathic an - gioedema, which is a poorly understood syndrome.2,3 Angio - edema with eosinophilia (AE) can be classified to idiopathic  angioedema.",Non-OADS,/arxiv_data1/oa_pdf/47/00/aair-6-362.PMC4077964.pdf
"Key Words:  Angioedema; eosinophilia; anti-IgE antibodyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/00/aair-6-362.PMC4077964.pdf
2014 July;6(4):362-365. http://dx.doi.org/10.4168/aair.2014.6.4.362 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/47/00/aair-6-362.PMC4077964.pdf
2014 July;6(4):362-365. http://dx.doi.org/10.4168/aair.2014.6.4.362 363 http://e-aair.organd treatment outcomes were also noted.,Non-OADS,/arxiv_data1/oa_pdf/47/00/aair-6-362.PMC4077964.pdf
2014 July;6(4):362-365. http://dx.doi.org/10.4168/aair.2014.6.4.362 364 http://e-aair.orgtients had a history of recurrent attacks and could be classified  as EAE.,Non-OADS,/arxiv_data1/oa_pdf/47/00/aair-6-362.PMC4077964.pdf
ORCID Hae-Sim Park http://orcid.org/0000-0003-2614-0303 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/47/00/aair-6-362.PMC4077964.pdf
2014 July;6(4):362-365. http://dx.doi.org/10.4168/aair.2014.6.4.362 365 http://e-aair.org63.,Non-OADS,/arxiv_data1/oa_pdf/47/00/aair-6-362.PMC4077964.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease366 http://e-aair.orgINTRODUCTION Chronic granulomatous disease (CGD) is a rare genetic dis - ease with a prevalence of 1/200,000-250,000 characterized by  recurrent life-threatening bacterial or fungal infection and  granuloma formation.1 The pathophysiology of CGD is the in - activation or a defect of the nicotinamide adenine dinucleotide  phosphate (NADPH) oxidase (phox) complex and a failure of  production of superoxide anions.",Non-OADS,/arxiv_data1/oa_pdf/d2/9d/aair-6-366.PMC4077965.pdf
"Key Words:  Chronic granulomatous disease; immunodeficiency; CYBB gene; mutationThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/9d/aair-6-366.PMC4077965.pdf
2014 July;6(4):366-369. http://dx.doi.org/10.4168/aair.2014.6.4.366 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/d2/9d/aair-6-366.PMC4077965.pdf
2014 July;6(4):366-369. http://dx.doi.org/10.4168/aair.2014.6.4.366 367 http://e-aair.orgnot show response.,Non-OADS,/arxiv_data1/oa_pdf/d2/9d/aair-6-366.PMC4077965.pdf
2014 July;6(4):366-369. http://dx.doi.org/10.4168/aair.2014.6.4.366 368 http://e-aair.orgto treat pneumonia and suspected fungal osteomyelitis.,Non-OADS,/arxiv_data1/oa_pdf/d2/9d/aair-6-366.PMC4077965.pdf
2014 July;6(4):366-369. http://dx.doi.org/10.4168/aair.2014.6.4.366 369 http://e-aair.org127:1319-26.,Non-OADS,/arxiv_data1/oa_pdf/d2/9d/aair-6-366.PMC4077965.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease370 http://e-aair.orgINTRODUCTION Wheat-dependent exercise-induced anaphylaxis (WDEIA) is  a rare but potentially severe food allergy characterized by ana - phylactic reactions that range from urticaria to respiratory, gas - trointestinal or cardiovascular symptoms that occur 1 to 4 hours  after the ingestion of wheat, followed by physical exercise.1 Wheat  allergens (especially omega-5 gliadin) play an important role in  the elicitation of WDEIA.2 Cofactors such as aspirin, alcohol in - take, infections, stress or female sex hormones/menstruation  can substitute for or synergize with exercise to instigate the im - mediate-type hypersensitivity reaction after the ingestion of  wheat.3 We present an unusual case of a 51-year-old patient  who developed exercise-induced anaphylaxis with a 10 to 24  hour delayed onset after wheat ingestion.",Non-OADS,/arxiv_data1/oa_pdf/cb/28/aair-6-370.PMC4077966.pdf
"Key Words:  Wheat-dependent exercise-induced anaphylaxis; chronic gastroenteritis; superior mesenteric artery syndromeThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/28/aair-6-370.PMC4077966.pdf
2014 July;6(4):370-372. http://dx.doi.org/10.4168/aair.2014.6.4.370 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/cb/28/aair-6-370.PMC4077966.pdf
2014 July;6(4):370-372. http://dx.doi.org/10.4168/aair.2014.6.4.370 371 http://e-aair.orgperiodical abdominal distention and vomit.,Non-OADS,/arxiv_data1/oa_pdf/cb/28/aair-6-370.PMC4077966.pdf
2014 July;6(4):370-372. http://dx.doi.org/10.4168/aair.2014.6.4.370 372 http://e-aair.org2.,Non-OADS,/arxiv_data1/oa_pdf/cb/28/aair-6-370.PMC4077966.pdf
"Analyses performed using ReviewManager 5.2 (available at:http://tech.cochrane.org/ revman/download ).CIconﬁ- dence interval, DZP diazepam, IVintravenous, PHT phenytoin, VPA valproic acid Table 2 Non-randomized comparative studies evaluating intravenous valproate monotherapy in the treatment of SE References N Patients Type of SE Dose regimen Tripathi et al.",OADS,/arxiv_data1/oa_pdf/d6/f8/40263_2014_Article_167.PMC4078236.pdf
"INTRODUCTION The National Consortium on Alcohol and NeuroDevelopment in Adolescence (N-CANDA;http://ncanda.org/), funded by the NationalInstitute on Alcohol Abuse and Alcoholism, is aconsortium tasked with investigating the extent towhich structural and functional de ﬁcits in neurode- velopmental maturation are caused or exacerbatedby adolescent alcohol use.",Non-OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
All software tools and docu-mentation materials created by us are also freely avail-able at http://nitrc.org/projects/ncanda-datacore/.,OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
"Based on these insights, we implemented N-CANDA ’s data collection, transmission, and inte- gration system using a networked Subversion(https://subversion.apache.org/) repository and amoderate number of custom Perl and Pythonscripts.",OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
"5 For central data management, we chose the Research Electronic Data Capture (REDCap; http://project-redcap.org/) system 6for its web-based Open Access Scan to access more free content 758 Rohl ﬁng T, et al .J Am Med Inform Assoc 2014; 21:758–762.",OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
"Second, Subversion provides networked operation over a secure, encrypted link (HTTPS; via an Apache web server,http://apache.org/), error handling, and access control, without any custom software components.",Non-OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
"This eliminates the possibility thatresearch assistants will miss or accidentally overwrite ﬁles when preparing to submit data and simpli ﬁes the transmission process to the degree that simply clicking an ‘Upload ’desktop icon per- forms the entire upload procedure.Table 1 Data captured by the N-CANDA data collection laptops; the ‘data conversion ’steps are automatically executed by the consortium server running Linux, with no user interaction Instrument Data collection Data conversion Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA).1Depending on the age of the subject, the interview is conducted either with the subject directly (‘SSAGA (Youth) ’) or with a parent ( ‘SSAGA (Parent) ’)Legacy survey implemented with the Blaise computer-assisted interviewing system (http://www.blaise.com/)Proprietary database format; raw data records extracted using Blaise ’s‘Manipula ’tool, running in batch mode using the ‘Wine ’Windows Emulator (http://winehq.org).",Non-OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
"Stroop Match-to-Sample (MtS) 4ePrime (http://www.pstnet.com/eprime.cfm) Human-readable log file, parsed and scores computed using a custom Python script, ‘eprime2redcap ’.",OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
All custom scripts referenced in this table are available for download at https://www.nitrc.org/frs/?group_id=672.,OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
"Finally , all CSV ﬁles are imported into REDCap using the PyCap library (http://sburns.org/PyCap/), which provides a convenient wrapper forREDCap ’s API.",OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
WebCNP data retrieval The W ebCNP system (https://webcnp.med.upenn.edu/) stores all test scores and does not require the asynchronous laptop datatransmission procedure.,Non-OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
W ewere able to automate this process by ‘driving ’a Firefox web browser using the Selenium plug-in (http://seleniumhq.org/) andthe ‘selenium ’Python package (https://pypi.python.org/pypi/ selenium).,OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
Our custom scripts for W ebCNP data retrieval and REDCap import are avail- able for download at https://www.nitrc.org/frs/?group_id=672.,OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
"REDCap(Research Electronic Data Capture) 6is a secure, web-based application designed to support data capture for research studies, providing: (1) an intuitive interface for validated data entry; (2) audit trails for tracking data manipulation and exportprocedures; (3) automated export procedures for seamless data downloads tocommon statistical packages; and (4) procedures for importing data from external sources.The N-CANDA Software Collection and operating manuals are available from http://nitrc.org/projects/ncanda-datacore/ Contributors TR designed the overall data management system architecture, implemented the server infrastructure, oversaw system integration, and wrote thisarticle.",OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Hesselbrock M, Easton C, Bucholz KK, et al .",Non-OADS,/arxiv_data1/oa_pdf/97/13/amiajnl-2013-002367.PMC4078281.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Friedman CP, Wong AK, Blumenthal D. Achieving a Nationwide Learning Health System.",Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
"The National Academies Press, 2007. http://www.nap.",Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
2011. http://www.healthit.gov/sites/default/ ﬁles/utility/ ﬁnal-federal-health-it-strategic-plan-0911.pdf 4 Fridsma D. Join Query Health in Developing National Standards for Population Queries.,OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
"Sep 23, 2011. http://www.healthit.gov/buzz-blog/from-the-onc-desk/queryhealth/ (accessed 14 Mar 2012).",Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
http://mehi.masstech.,Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
https://www.nihcollaboratory.,Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
http://www.popmednet.org/ (accessed 7 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
Standards and Interoperability Framework http://code.google.com/p/query-health/source/browse 18 PopHealth Initiative.,OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
http://www.healthcare-informatics.com/article/ asking-population-healths-unanswered-questions (accessed 8 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
Health Data Manag 2012. http://www.healthdatamanagement.com/news/ query-health-distributed-queries-data-analytics-analysis-44013-1.html (accessed 10Jan 2014).,OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
"Arlington, VA: ONC HIT Policy Committee Meaningful Use Workgroup and Certiﬁcation and Adoption Workgroup, 2013. http://www.healthit.gov/sites/default/ ﬁles/archive/FACA%20Hearings/2013-02-13%20Policy%3A%20Meaningful%20Use %20and%20Certi ﬁcation%20%26%20Adoption%20WGs,%20Clinical% 20Documentation%20Hearing/buckhitpolicytestimony20130206.pdf 27 Elmore R. Quality Measures Workgroup Clinical Quality Public Hearing.",Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
"Sep 4, 2012. https://federalregister.gov/a/2012-20982 (accessed 27 Feb 2013).32 Centers for Medicare and Medicaid Services.",OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
2012 Dec. http://www.cms.gov/Regulations-and-Guidance/ Legislation/EHRIncentivePrograms/Electronic_Reporting_Spec.html 33 National Quality Forum (NQF).,Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
http://www.qualityforum.org/News_And_Resources/Report_to_Congress/Report_to_Congress.,Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
http://journals.lww.com/lww-medicalcare/Fulltext/2010/06001/Distributed_Health_ Data_Networks__A_Practical_and.9.aspx 38 Patient Centered Outcomes Research Institute.,Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
https://www.i2b2.org/ (accessed 7 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
http://pcornet.org/clinical-data-research-networks/cdrn1-harvard-university-scihls/ (accessed 7 Jan 2014).,OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
https://github.com/hquery (accessed 3 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/9c/9b/amiajnl-2014-002707.PMC4078284.pdf
"Correspondence to Dr Kenneth D Mandl, Boston Children ’s Hospital, 300 Longwood Avenue, Boston,MA 02115, USA;kenneth_mandl@harvard.edu Received 18 February 2014 Accepted 8 March 2014Published Online First12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002758▸http://dx.doi.org/10.1136/ amiajnl-2014-002764 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002744▸http://dx.doi.org/10.1136/ amiajnl-2014-002746 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002743▸http://dx.doi.org/10.1136/ amiajnl-2014-002827 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002740▸http://dx.doi.org/10.1136/ amiajnl-2014-002751 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002745▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: Mandl KD, Kohane IS, McFadden D, et al.J Am Med Inform Assoc 2014; 21:615–620.ABSTRACT We describe the architecture of the Patient CenteredOutcomes Research Institute (PCORI) funded ScalableCollaborative Infrastructure for a Learning HealthcareSystem (SCILHS, http://www.SCILHS.org) clinical dataresearch network, which leverages the $48 billion dollarfederal investment in health information technology (IT)to enable a queryable semantic data model across10 health systems covering more than 8 million patients,plugging universally into the point of care, generatingevidence and discovery, and thereby enabling clinicianand patient participation in research during the patientencounter.",Non-OADS,/arxiv_data1/oa_pdf/5b/f5/amiajnl-2014-002727.PMC4078286.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Etheredge LM.,Non-OADS,/arxiv_data1/oa_pdf/5b/f5/amiajnl-2014-002727.PMC4078286.pdf
2011. http://deainfo.nci.,Non-OADS,/arxiv_data1/oa_pdf/5b/f5/amiajnl-2014-002727.PMC4078286.pdf
"Presentation at 2012 National SHRINE Conference, 2012. https://cbmi.med.harvard.edu/shrine2012/presentations/shrine_miksad.pdf.",Non-OADS,/arxiv_data1/oa_pdf/5b/f5/amiajnl-2014-002727.PMC4078286.pdf
"Correspondence to Dr Anjum Khurshid, Louisiana Public Health Institute, Suite 1200, 1515 Poydras St,New Orleans, LA 70112, USA;akhurshid@lphi.org Received 21 February 2014 Accepted 10 March 2014Published Online First12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002758▸http://dx.doi.org/10.1136/ amiajnl-2014-002764 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002744▸http://dx.doi.org/10.1136/ amiajnl-2014-002746 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002743▸http://dx.doi.org/10.1136/ amiajnl-2014-002827 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002727▸http://dx.doi.org/10.1136/ amiajnl-2014-002751 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002745▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: Khurshid A, Nauman E, Carton T, et al.",Non-OADS,/arxiv_data1/oa_pdf/20/bc/amiajnl-2014-002740.PMC4078287.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 The National Patient-Centered Clinical Research Network.,Non-OADS,/arxiv_data1/oa_pdf/20/bc/amiajnl-2014-002740.PMC4078287.pdf
http://pcornet.org (accessed Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/20/bc/amiajnl-2014-002740.PMC4078287.pdf
http://www.americashealthrankings.org/la (accessed Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/20/bc/amiajnl-2014-002740.PMC4078287.pdf
http://lsuicon.org (accessed Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/20/bc/amiajnl-2014-002740.PMC4078287.pdf
http://academics.ochsner.org/research.aspx (accessed Mar 2014).,OADS,/arxiv_data1/oa_pdf/20/bc/amiajnl-2014-002740.PMC4078287.pdf
"Correspondence to Dr Michael G. Kahn, Universityof Colorado, Building 500, Mail Stop 563, 13001 East 17th Place Room C1009,Aurora, CO 80045, USA;Michael.Kahn@ucdenver.edu Received 21 February 2014 Accepted 9 March 2014 Published Online First12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002758▸http://dx.doi.org/10.1136/ amiajnl-2014-002764 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002744▸http://dx.doi.org/10.1136/ amiajnl-2014-002746 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002827▸http://dx.doi.org/10.1136/ amiajnl-2014-002740 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002727▸http://dx.doi.org/10.1136/ amiajnl-2014-002751 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002745▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: Forrest CB, Margolis PA, Bailey LC, et al.J Am Med Inform Assoc 2014; 21:602–606.ABSTRACT A learning health system (LHS) integrates research donein routine care settings, structured data capture duringevery encounter, and quality improvement processes torapidly implement advances in new knowledge, all withactive and meaningful patient participation.",Non-OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
"The PEDSnet CDRN is one of 11 CDRNs funded by the Patient Centered Outcomes Research Institute(PCORI) as part of the newly established PCORnet, a national patient-centered clinical research network for conducting clinical effectiveness research (seehttp://www.pcornet.org).",Non-OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
"pediatric terms and their de ﬁnitions to national and inter- national standards bodies, such as the NLM and theInternational Health T erminology Standards DevelopmentOrganization (IHTSDO; http://www.ihtsdo.org), the organiza-tion responsible for the development of SNOMED-CT .",Non-OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
TheNIH PROMIS (http://www.nihpromis.org) measures foradults and children can be accessed using this technology .,Non-OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Van der Lee JH, Mokkink LB, Grootenhuis MA, et al.D eﬁnitions and measurement of chronic health conditions in childhood: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
"National Academies Press, 2007. http://books.google.com/books?hl=en&lr=&id=VWmjvCZOFjoC&oi=fnd&pg=PP1&dq=olsen+aisner+mcginnis+the+learning+healthcare+system&ots=0SX5y0LPkw&sig=TVY43GfL_PfesNz_uZsqs9gTL4Y (accessed 29 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
"Washington, DC: Institute of Medicine, 2013. http://www.iom.edu/ Activities/Quality/VSRT/~/media/Files/Activity%20Files/Quality/VSRT/Data- Harmonization/VSRT-WIB-DataHarmonization.pdf (accessed 29 Jan 2014).",Non-OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
http://www.healthit.gov/policy-researchers- implementers/meaningful-use-regulations (accessed 12 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
2013. http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/ Stage_2.html (accessed 15 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
"Common Data Element (CDE) Resource Portal, 2013. http://www.nlm.nih.gov/cde/ (accessed 16 Feb 2014).",OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
eGEMs (Generating Evidence & Methods to improve patient outcomes);1. doi:http://dx.doi.org/10.13063/2327-9214.1015.http://repository.academyhealth.org/egems/vol1/iss1/12.,Non-OADS,/arxiv_data1/oa_pdf/d2/cc/amiajnl-2014-002743.PMC4078288.pdf
"Correspondence to Dr Jennifer E DeVoe, OCHIN,Inc, 1881 SW Naito Parkway, Portland, OR 97201, USA; devoej@ohsu.edu Received 24 February 2014 Accepted 10 March 2014Published Online First 12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002758▸http://dx.doi.org/10.1136/ amiajnl-2014-002764 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002746▸http://dx.doi.org/10.1136/ amiajnl-2014-002743 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002827▸http://dx.doi.org/10.1136/ amiajnl-2014-002740 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002727▸http://dx.doi.org/10.1136/ amiajnl-2014-002751 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002745▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: DeVoe JE, Gold R, Cottrell E, et al .J Am Med Inform Assoc 2014; 21: 591 –595.ABSTRACT The ADVANCE (Accelerating Data Value Across aNational Community Health Center Network) clinicaldata research network (CDRN) is led by the OCHINCommunity Health Information Network in partnershipwith Health Choice Network and Fenway Health.",Non-OADS,/arxiv_data1/oa_pdf/75/86/amiajnl-2014-002744.PMC4078289.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 DeVoe JE, Gold R, Spofford M, et al .",Non-OADS,/arxiv_data1/oa_pdf/75/86/amiajnl-2014-002744.PMC4078289.pdf
"http://www.healthIT.gov/providers-professionals/rec-highlights 6 DeVoe JE, Tillotson CJ, Lesko SE, et al .",OADS,/arxiv_data1/oa_pdf/75/86/amiajnl-2014-002744.PMC4078289.pdf
http://www.LGBThealtheducation.org 32 The Fenway Institute.,Non-OADS,/arxiv_data1/oa_pdf/75/86/amiajnl-2014-002744.PMC4078289.pdf
http://www.thefenwayinstitute.org 33 CFAR Network of Integrated Clinical Systems.,Non-OADS,/arxiv_data1/oa_pdf/75/86/amiajnl-2014-002744.PMC4078289.pdf
http://www.uab.edu/cnics/ 34 ANSI.,Non-OADS,/arxiv_data1/oa_pdf/75/86/amiajnl-2014-002744.PMC4078289.pdf
"Washington, DC, 2012. http://www.whitehouse.gov/sites/default/ ﬁles/05-01 12_community_health_center_report.pdf (accessed 22 Apr 2014).",Non-OADS,/arxiv_data1/oa_pdf/75/86/amiajnl-2014-002744.PMC4078289.pdf
"Washington, DC, 2010. http://www.hhs.gov/healthcare/facts/timeline/ timeline-text.html (accessed 22 Apr 2014).",Non-OADS,/arxiv_data1/oa_pdf/75/86/amiajnl-2014-002744.PMC4078289.pdf
"edu Received 21 February 2014 Accepted 10 March 2014 Published Online First 12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002758▸http://dx.doi.org/10.1136/ amiajnl-2014-002764 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002744▸http://dx.doi.org/10.1136/ amiajnl-2014-002746 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002743▸http://dx.doi.org/10.1136/ amiajnl-2014-002827 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002740▸http://dx.doi.org/10.1136/ amiajnl-2014-002727 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002751▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: Rosenbloom ST, Harris P, Pulley J, et al.JA m Med Inform Assoc2014; 21:627–632.ABSTRACT The Mid-South Clinical Data Research Network (CDRN)encompasses three large health systems: (1) VanderbiltHealth System (VU) with electronic medical records forover 2 million patients, (2) the Vanderbilt HealthcareAfﬁliated Network (VHAN) which currently includes over 40 hospitals, hundreds of ambulatory practices, and over3 million patients in the Mid-South, and (3) GreenwayMedical Technologies, with access to 24 million patientsnationally.",Non-OADS,/arxiv_data1/oa_pdf/17/d3/amiajnl-2014-002745.PMC4078290.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Guise JM, O ’Haire C, McPheeters M, et al.",Non-OADS,/arxiv_data1/oa_pdf/17/d3/amiajnl-2014-002745.PMC4078290.pdf
"https://www.researchmatch.org/ 22 Harris PA, Scott KW, Lebo L, et al.",OADS,/arxiv_data1/oa_pdf/17/d3/amiajnl-2014-002745.PMC4078290.pdf
"Correspondence to Dr Michael G Kahn, Universityof Colorado, Building 500,Mail Stop 563, 13001 East 17th Place, Room C1009, Aurora, CO 80045, USA;Michael.Kahn@ucdenver.edu Received 21 February 2014 Accepted 10 March 2014 Published Online First12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002758▸http://dx.doi.org/10.1136/ amiajnl-2014-002764 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002744▸http://dx.doi.org/10.1136/ amiajnl-2014-002743 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002827▸http://dx.doi.org/10.1136/ amiajnl-2014-002740 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002727▸http://dx.doi.org/10.1136/ amiajnl-2014-002751 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002745▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: McGlynn EA, Lieu TA, Durham ML, et al.",Non-OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
Distributed data sharing platform Distributed data queries and data exchange across PORTALpartners will be managed using PopMedNet (http://www.popmednet.org) technology ( ﬁgure 3 ).,OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
"Table 2 National/international terminology standards used in the Kaiser Permanente Center for Effectiveness and Safety Research(CESR) common data model Table/clinical domainNational/international coding standards in CESR data model Demographics Race: NIH* Encounters CMS DRGDiagnosis ICD-7-CM, ICD-8-CM, ICD-9-CM, ICD-10-CMProcedures ICD-9, ICD-10, ICD-11, CPT-3, CPT-4, HCPCS-3, HCPCS-4 † Tumor ICD-O-3 ‡, SEER SS1997, SEER SS2000§, Facility Oncology Registry Data Standards¶ Pharmacy dispensingsNDC, Medi-Span GPI**, AHFR Pharmacologic-Therapeutic Classification System †† Medication orders ICD-9, ICD-10 diagnoses associated with medication ordersCensus FIPS/NIST geocoding standards ‡‡ Death ICD-9, ICD-10Laboratory LOINC URLs to less common coding standards are provided as follows: *http://www.whitehouse.gov/omb/fedreg_1997standards†http://www.cms.gov/Regulations-and-Guidance/HIPAA-Administrative-Simplification/ TransactionCodeSetsStands/index.html‡http://www.who.int/classifications/icd/adaptations/oncology/en/ §http://seer.cancer.gov/tools/ssm/¶http://www.facs.org/cancer/coc/programstandards2012.html**http://www.medispan.com/uniform-system-of-classification-cross-reference-file/††http://www.ahfsdruginformation.com/license-pt-classification.aspx ‡‡http://www.nist.gov/itl/fipsinfo.cfm 598 McGlynn EA, et al.J Am Med Inform Assoc 2014; 21:596–601.",Non-OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Kahn MG, Batson D, Schilling LM.",Non-OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
2009. http://www.regulations.gov/contentStreamer?objectId=0900006480e6cd93&disposition=attachment& contentType=pdf (accessed 15 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
http://www.hmoresearchnetwork.,Non-OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
http://www.cqaimh.org/pdf/tool_phq9.pdf (accessed 15 Mar 2014).,OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
"The National Academies Press, 2013. http://www.nap.edu/openbook.php?record_ id=18267 13 Institute of Medicine.",Non-OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
"Washington, DC: Institute of Medicine, 2013. http://www.iom.edu/Activities/Quality/VSRT/~/media/Files/Activity%20Files/Quality/VSRT/ Data-Harmonization/VSRT-WIB-DataHarmonization.pdf (accessed 29 Jan 2014).",Non-OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
http://www.healthit.gov/policy-researchers- implementers/meaningful-use-regulations (accessed 12 Feb 2014).19 Centers for Medicare & Medicaid Services.,OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
2013. http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/ Stage_2.html (accessed 15 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/59/82/amiajnl-2014-002746.PMC4078291.pdf
"Correspondence to Dr Rachael L Fleurence, CERMethods and Infrastructure Program, Patient Centered Outcomes Research Institute(PCORI), 1828L Street, NW,9th Floor, Washington, DC 20036, USA; rﬂeurence@pcori.org, http://www.pcori.org Received 24 February 2014 Revised 31 March 2014 Accepted 8 April 2014Published Online First12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002758 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002764▸http://dx.doi.org/10.1136/ amiajnl-2014-002744 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002746▸http://dx.doi.org/10.1136/ amiajnl-2014-002743 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002827▸http://dx.doi.org/10.1136/ amiajnl-2014-002740 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002727▸http://dx.doi.org/10.1136/ amiajnl-2014-002751 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002745▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: Fleurence RL, Curtis LH, Califf RM, et al.",Non-OADS,/arxiv_data1/oa_pdf/c2/ee/amiajnl-2014-002747.PMC4078292.pdf
"In December 2013, PCORI ’s board of governors funded 11 CDRNs and 18 PPRNs for a period of18 months starting in March 2014 that togetherform PCORnet (http://www.pcornet.org).",Non-OADS,/arxiv_data1/oa_pdf/c2/ee/amiajnl-2014-002747.PMC4078292.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Institute of Medicine (U.S.).,Non-OADS,/arxiv_data1/oa_pdf/c2/ee/amiajnl-2014-002747.PMC4078292.pdf
"2014. https://http://www.nihcollaboratory.org/Pages/default.aspx 8 Selby JV, Krumholz HM, Kuntz RE, et al.",Non-OADS,/arxiv_data1/oa_pdf/c2/ee/amiajnl-2014-002747.PMC4078292.pdf
"Correspondence to Professor Lucila Ohno-Machado,Division of Biomedical Informatics, University of California San Diego, 9500Gilman Drive, MC0728,La Jolla, CA 92093-0728, USA; lohnomachado@ucsd.edu Received 25 February 2014 Revised 3 April 2014Accepted 8 April 2014Published Online First 29 April 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002758▸http://dx.doi.org/10.1136/ amiajnl-2014-002764 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002744▸http://dx.doi.org/10.1136/ amiajnl-2014-002746 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002743▸http://dx.doi.org/10.1136/ amiajnl-2014-002827 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002740▸http://dx.doi.org/10.1136/ amiajnl-2014-002727 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002745▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: Ohno-Machado L, Agha Z, Bell DS, et al.JA m Med Inform Assoc2014; 21:621 –626.ABSTRACT This article describes the patient-centered ScalableNational Network for Effectiveness Research(pSCANNER), which is part of the recently formedPCORnet, a national network composed of learninghealthcare systems and patient-powered researchnetworks funded by the Patient Centered OutcomesResearch Institute (PCORI).",Non-OADS,/arxiv_data1/oa_pdf/d7/fb/amiajnl-2014-002751.PMC4078293.pdf
"V A Informatics and Computing Infrastructure (VINCI; http://www.hsrd.research.va.gov/for_researchers/vinci/) is a major informatics initiativeof the Veterans Health Administration (VHA) thatprovides a secure, central platform for performingresearch and supporting clinical operations activ-ities.",Non-OADS,/arxiv_data1/oa_pdf/d7/fb/amiajnl-2014-002751.PMC4078293.pdf
Scalable National Network for Effectiveness Research (SCANNER; http://scanner.ucsd.edu) wasestablished in late 2010 with Agency for HealthcareResearch and Quality (AHRQ) funds.,Non-OADS,/arxiv_data1/oa_pdf/d7/fb/amiajnl-2014-002751.PMC4078293.pdf
"Members of pSCANNERare active participants in the Data Quality Assessment collabora-tive (http://repository.academyhealth.org/dqc/), and have devel-oped additional tools for quality auditing and assessing validityandﬁtness for use in both research and other secondary uses of population-level data.",OADS,/arxiv_data1/oa_pdf/d7/fb/amiajnl-2014-002751.PMC4078293.pdf
"SCANNER ’s analytic library was seeded with ana- lysis tools used and validated in multiple publications, 26–29and incorporated into the Observational Cohort Event Analysis andNotiﬁcation System (OCEANS) (http://idash.ucsd.edu/dbp- tools#overlay-context=idash-software-tools) and Grid BinaryLogistic Regression (GLORE), 22which include multivariate ana- lysis methods that allow model ﬁtting, causal inference, and hypothesis testing.",OADS,/arxiv_data1/oa_pdf/d7/fb/amiajnl-2014-002751.PMC4078293.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Observational Medical Outcomes Partnership: Common Data Model Speci ﬁcations Version 4.0.,Non-OADS,/arxiv_data1/oa_pdf/d7/fb/amiajnl-2014-002751.PMC4078293.pdf
eGEMs 2013;1. doi: http://dx.doi.org/10.13063/ 2327-9214.1027%5Bpublished Online First: Epub Date.,OADS,/arxiv_data1/oa_pdf/d7/fb/amiajnl-2014-002751.PMC4078293.pdf
"2013. http://www.pcori.org/assets/2013/06/PCORI- Comprehensive-Inventory-Research-Networks-061213.pdf 22 Wu Y, Jiang X, Kim J, et al.",OADS,/arxiv_data1/oa_pdf/d7/fb/amiajnl-2014-002751.PMC4078293.pdf
"Correspondence to Dr Lemuel R Waitman,Division of Medical Informatics, Department of Internal Medicine, University of KansasMedical Center, 3901 RainbowBlvd, Mail Stop 4009, Kansas City, KS 66160, USA; rwaitman@kumc.edu Received 27 February 2014 Accepted 9 March 2014 Published Online First 28 April 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002758▸http://dx.doi.org/10.1136/ amiajnl-2014-002764 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002744▸http://dx.doi.org/10.1136/ amiajnl-2014-002746 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002743▸http://dx.doi.org/10.1136/ amiajnl-2014-002827 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002740▸http://dx.doi.org/10.1136/ amiajnl-2014-002727 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002751▸http://dx.doi.org/10.1136/ amiajnl-2014-002745 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 To cite: Waitman LR, Aaronson LS, Nadkarni PM, et al.J Am Med Inform Assoc 2014; 21:637–641.ABSTRACT The Greater Plains Collaborative (GPC) is composed of10 leading medical centers repurposing the researchprograms and informatics infrastructures developedthrough Clinical and Translational Science Awardinitiatives.",Non-OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Murphy SN, Weber G, Mendis M, et al.",Non-OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
http://www.r-project.org/ (accessed 25 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
http://www.healthit.,Non-OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
https://www.uhc.edu/11536.htm (accessed 25 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
http://www.nlm.nih.gov/research/umls/ rxnorm/ (accessed 25 Sep 2013).,OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
SNOMED CT. http://www.ihtsdo.org/snomed-ct/snomed-ct0/ (accessed 25 Sep 2013).,OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
http://www.cdc.gov/ nchs/icd.htm (accessed 25 Sep 2013).,OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
http://www.cdc.gov/vaccines/programs/iis/code-sets.html and http://www.cdc.gov/vaccines/programs/iis/code-sets.html (accessed 25 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx (accessed 25 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
http://www.who.int/classi ﬁcations/icd/adaptations/oncology/en/ (accessed 25 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
https://informatics.kumc.edu/ work/wiki/UHCSource (accessed 25 Sep 2013).,OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
https://informatics.kumc.edu/ work/browser/heron_load/uhc_i2b2_transform.sql (accessed 25 Sep 2013).,OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
https://informatics.kumc.,Non-OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
https://informatics.kumc.edu/ work/browser/heron_load/naaccr_txform.sql (accessed 25 Sep 2013).,OADS,/arxiv_data1/oa_pdf/95/17/amiajnl-2014-002756.PMC4078294.pdf
"To viewplease visit the journal online(http://dx.doi.org/10.1136/ amiajnl-2014-002758) Patient-Centered Outcomes Research Institute, Washington,DC, USA Correspondence to Sarah Daugherty, 1828L Street, NW, Suite 900, Washington DC, 20036, USA;sdaugherty@pcori.org Received 26 February 2014 Accepted 10 March 2014 Published Online First12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002764▸http://dx.doi.org/10.1136/ amiajnl-2014-002744 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002746▸http://dx.doi.org/10.1136/ amiajnl-2014-002743 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002827▸http://dx.doi.org/10.1136/ amiajnl-2014-002740 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002727▸http://dx.doi.org/10.1136/ amiajnl-2014-002751 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002745▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: PCORnet PPRN Consortium, Daugherty SE, Wahba S, et al.J Am Med Inform Assoc 2014; 21: 583–586.ABSTRACT The Patient-Centered Outcomes Research Institute(PCORI) recently launched PCORnet to establish a singleinter-operable multicenter data research network thatwill support observational research and randomizedclinical trials.",Non-OADS,/arxiv_data1/oa_pdf/65/58/amiajnl-2014-002758.PMC4078295.pdf
The 18PPRN abstracts are available at http://pcornet.org/patient-powered-research-networks/.,Non-OADS,/arxiv_data1/oa_pdf/65/58/amiajnl-2014-002758.PMC4078295.pdf
*Abstracts for each PPRN can be found in the online JAMIA supplement for this manuscript or at http://pcornet.org/patient-powered-research-networks/.,Non-OADS,/arxiv_data1/oa_pdf/65/58/amiajnl-2014-002758.PMC4078295.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Washington AE, Lipstein SH.",Non-OADS,/arxiv_data1/oa_pdf/65/58/amiajnl-2014-002758.PMC4078295.pdf
"Correspondence to Dr Waqas Amin, Departmentof Biomedical Informatics,University of Pittsburgh, 5607 Baum Boulevard # 437-G, Pittsburgh,PA 15206-3701, USA;waa8@pitt.edu Received 27 February 2014 Revised 19 March 2014Accepted 25 March 2014Published Online First 12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002758▸http://dx.doi.org/10.1136/ amiajnl-2014-002764 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002744▸http://dx.doi.org/10.1136/ amiajnl-2014-002746 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002743▸http://dx.doi.org/10.1136/ amiajnl-2014-002827 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002740▸http://dx.doi.org/10.1136/ amiajnl-2014-002727 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002751▸http://dx.doi.org/10.1136/ amiajnl-2014-002745 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: Amin W, Tsui F (R), Borromeo C, et al .JA m Med Inform Assoc2014; 21:633–636.ABSTRACT The PaTH (University of Pittsburgh/UPMC, Penn StateCollege of Medicine, Temple University Hospital, andJohns Hopkins University) clinical data research networkinitiative is a collaborative effort among four academichealth centers in the Mid-Atlantic region.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/amiajnl-2014-002759.PMC4078296.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 PCORnet: The National Patient-Centered Clinical Research Network.,Non-OADS,/arxiv_data1/oa_pdf/f0/d1/amiajnl-2014-002759.PMC4078296.pdf
[cited 03/17/ 2014]; http://www.pcori.org/funding-opportunities/pcornet-national-patient- centered-clinical-research-network/ 2 Spackman K. SNOMED CT Editorial Guide .,Non-OADS,/arxiv_data1/oa_pdf/f0/d1/amiajnl-2014-002759.PMC4078296.pdf
"Correspondence to Rainu Kaushal, 425 East 61st Street, Suite 301, New York, NY 10065, USA;rak2007@med.cornell.edu Received 28 February 2014 Revised 15 March 2014 Accepted 25 March 2014 Published Online First12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864▸http://dx.doi.org/10.1136/ amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002758▸http://dx.doi.org/10.1136/ amiajnl-2014-002744 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002746▸http://dx.doi.org/10.1136/ amiajnl-2014-002743 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002827▸http://dx.doi.org/10.1136/ amiajnl-2014-002740 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002727▸http://dx.doi.org/10.1136/ amiajnl-2014-002751 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002745▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: Kaushal R, Hripcsak G, Ascheim DD, et al .J Am Med Inform Assoc 2014; 21:587 –590.ABSTRACT The New York City Clinical Data Research Network(NYC-CDRN), funded by the Patient-Centered OutcomesResearch Institute (PCORI), brings together 22organizations including seven independent healthsystems to enable patient-centered clinical research,support a national network, and facilitate learninghealthcare systems.",Non-OADS,/arxiv_data1/oa_pdf/12/7f/amiajnl-2014-002764.PMC4078297.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Onyile A, Vaidya SR, Kuperman G, et al .",Non-OADS,/arxiv_data1/oa_pdf/12/7f/amiajnl-2014-002764.PMC4078297.pdf
"https://www.health.ny.gov/ statistics/sparcs/operations/overview.htm 590 Kaushal R, et al .J Am Med Inform Assoc 2014; 21:587 –590.",OADS,/arxiv_data1/oa_pdf/12/7f/amiajnl-2014-002764.PMC4078297.pdf
"Correspondence to Dr Abel N Kho, Division of General Internal Medicine,Northwestern University, 750 NLake Shore Drive, 10th Floor, Chicago, IL 60611, USA; Abel.kho@nmff.org Received 25 March 2014 Revised 4 April 2014 Accepted 8 April 2014 Published Online First12 May 2014 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002864 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002747▸http://dx.doi.org/10.1136/ amiajnl-2014-002758 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002764▸http://dx.doi.org/10.1136/ amiajnl-2014-002744 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002746▸http://dx.doi.org/10.1136/ amiajnl-2014-002743 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002827▸http://dx.doi.org/10.1136/ amiajnl-2014-002740 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002727▸http://dx.doi.org/10.1136/ amiajnl-2014-002751 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002745▸http://dx.doi.org/10.1136/ amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/ amiajnl-2014-002756 To cite: Kho AN, Hynes DM, Goel S, et al.",Non-OADS,/arxiv_data1/oa_pdf/d1/c0/amiajnl-2014-002827.PMC4078298.pdf
"SUCCESSFUL HISTORY OF DATA EXCHANGE The majority of CAPriCORN sites exchange data with theUniversity HealthSystem Consortium (UHC), an alliance of 120academic medical centers and 301 of their af ﬁliated hospitals representing the nation ’s leading academic medical centers (http://www.uhc.edu).",OADS,/arxiv_data1/oa_pdf/d1/c0/amiajnl-2014-002827.PMC4078298.pdf
"4With seed funding through the Otho S. A. Sprague Memorial Institute, a portion of the deidenti ﬁed aggregated health data are shared through a public-facingwebsite (http://www.chicagohealthatlas.org) hosted by CCT .",Non-OADS,/arxiv_data1/oa_pdf/d1/c0/amiajnl-2014-002827.PMC4078298.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 National Center for Health Statistics.,Non-OADS,/arxiv_data1/oa_pdf/d1/c0/amiajnl-2014-002827.PMC4078298.pdf
http://www.cdc.gov/nchs/icd/icd9cm.htm (accessed 20 Sep 2013).,OADS,/arxiv_data1/oa_pdf/d1/c0/amiajnl-2014-002827.PMC4078298.pdf
http://www.ama-assn.,Non-OADS,/arxiv_data1/oa_pdf/d1/c0/amiajnl-2014-002827.PMC4078298.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ To cite Collins FS, Hudson KL, Briggs JP, et al .JA m Med Inform Assoc 2014; 21:576–577.",Non-OADS,/arxiv_data1/oa_pdf/49/64/amiajnl-2014-002864.PMC4078299.pdf
Accepted 8 April 2014Published Online First 12 May 2014 ▸http://dx.doi.org/10.1136/amiajnl-2014-002747 ▸http://dx.doi.org/10.1136/amiajnl-2014-002758 ▸http://dx.doi.org/10.1136/amiajnl-2014-002764 ▸http://dx.doi.org/10.1136/amiajnl-2014-002744 ▸http://dx.doi.org/10.1136/amiajnl-2014-002746 ▸http://dx.doi.org/10.1136/amiajnl-2014-002743 ▸http://dx.doi.org/10.1136/amiajnl-2014-002827 ▸http://dx.doi.org/10.1136/amiajnl-2014-002740 ▸http://dx.doi.org/10.1136/amiajnl-2014-002727 ▸http://dx.doi.org/10.1136/amiajnl-2014-002751 ▸http://dx.doi.org/10.1136/amiajnl-2014-002745 ▸http://dx.doi.org/10.1136/amiajnl-2014-002759 ▸http://dx.doi.org/10.1136/amiajnl-2014-002756 J Am Med Inform Assoc 2014; 21:576–577.,Non-OADS,/arxiv_data1/oa_pdf/49/64/amiajnl-2014-002864.PMC4078299.pdf
6 http://www.pcori.org/assets/2013/11/PCORI- Methodology-Report.pdf (accessed Apr 2014).,OADS,/arxiv_data1/oa_pdf/49/64/amiajnl-2014-002864.PMC4078299.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cd/71/srep05536.PMC4078301.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5536 | DOI: 10.1038/srep05536 6",Non-OADS,/arxiv_data1/oa_pdf/cd/71/srep05536.PMC4078301.pdf
http://arxiv.org/abs/1310.0674.,Non-OADS,/arxiv_data1/oa_pdf/6f/cd/srep05530.PMC4078302.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5530 | DOI: 10.1038/srep05530 5",Non-OADS,/arxiv_data1/oa_pdf/6f/cd/srep05530.PMC4078302.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b4/51/srep05543.PMC4078303.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7a/07/srep05539.PMC4078304.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5539 | DOI: 10.1038/srep05539 7",Non-OADS,/arxiv_data1/oa_pdf/7a/07/srep05539.PMC4078304.pdf
The genome-wide methylation status of all these mutants can be accessed at http://genomes.mcdb.,OADS,/arxiv_data1/oa_pdf/d3/c3/srep05540.PMC4078305.pdf
Acknowledgments We thank Ingo Hoffman for his kind gift of ddm1 seeds and the Pellegrini and Jacobsen labs for making available bisulfite genomic sequencing data at http://genomes.mcdb.ucla.edu/ AthBSseq.,Non-OADS,/arxiv_data1/oa_pdf/d3/c3/srep05540.PMC4078305.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d3/c3/srep05540.PMC4078305.pdf
Animal housing and handling werecarried out in accordance with the US National Institute of Health (NIH) Guide for the Care and Use of Laboratory Animals published by the US National Academy of Sciences (http://oacu.od.nih.gov/regs/index.htm).,Non-OADS,/arxiv_data1/oa_pdf/8d/8a/srep05531.PMC4078306.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/72/54/srep05526.PMC4078307.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5526 | DOI: 10.1038/srep05526 11",Non-OADS,/arxiv_data1/oa_pdf/72/54/srep05526.PMC4078307.pdf
"Mutagenesis and mutant isolation .<67,500 ago1-52 seeds (1 g) were sent to a commercial supplier, Lehle Seeds (http://www.arabidopsis.com), where they were mutagenised by immersion in a solution of 0.23% (v/v) EMS for 12 hours at 25 uC, stratified for 7 days, and then sown in pots.",Non-OADS,/arxiv_data1/oa_pdf/1c/d2/srep05533.PMC4078309.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1c/d2/srep05533.PMC4078309.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5533 | DOI: 10.1038/srep05533 8",Non-OADS,/arxiv_data1/oa_pdf/1c/d2/srep05533.PMC4078309.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4c/b4/srep05537.PMC4078311.pdf
cThe GenBank accession numbers (http://www.ncbi.nlm.nih.gov/genbank/) of tetherins are listed.,OADS,/arxiv_data1/oa_pdf/72/43/srep05529.PMC4078312.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/72/43/srep05529.PMC4078312.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5529 | DOI: 10.1038/srep05529 8",Non-OADS,/arxiv_data1/oa_pdf/72/43/srep05529.PMC4078312.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3b/e4/srep05542.PMC4078315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5542 | DOI: 10.1038/srep05542 6",Non-OADS,/arxiv_data1/oa_pdf/3b/e4/srep05542.PMC4078315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5544 | DOI: 10.1038/srep05544 9",Non-OADS,/arxiv_data1/oa_pdf/50/72/srep05544.PMC4078317.pdf
Available from: http://www.pharmacognosy.,Non-OADS,/arxiv_data1/oa_pdf/11/47/PM-10-441.PMC4078324.pdf
Available from: http://www.courage‑khazaka.,Non-OADS,/arxiv_data1/oa_pdf/90/e2/PM-10-392.PMC4078333.pdf
Available from: http://www.courage‑khazaka.com/index.,Non-OADS,/arxiv_data1/oa_pdf/90/e2/PM-10-392.PMC4078333.pdf
Available from: http://www.courage‑khazaka.,Non-OADS,/arxiv_data1/oa_pdf/90/e2/PM-10-392.PMC4078333.pdf
Available from: http://www.courage‑khazaka.,Non-OADS,/arxiv_data1/oa_pdf/90/e2/PM-10-392.PMC4078333.pdf
Available from: http://www.stat.cmu.edu/_ hseltman/309/Book/Book.pdf [Last accessed on 2013 Jan 16].,Non-OADS,/arxiv_data1/oa_pdf/90/e2/PM-10-392.PMC4078333.pdf
Available from: http://postharvest.tfrec.,Non-OADS,/arxiv_data1/oa_pdf/ed/30/PM-10-225.PMC4078343.pdf
A vailable  from: http://www.who.int/gho/publications/world_health_statistics/2012/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/4c/52/JRMS-19-26.PMC4078377.pdf
Available from: http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bc/dd/JRMS-19-17.PMC4078381.pdf
Available from: http://www.srga.org/eucastwt/MICTAB/MIC miscellaneous.html.,Non-OADS,/arxiv_data1/oa_pdf/86/9a/JRMS-19-67.PMC4078383.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: R.A.M.,Non-OADS,/arxiv_data1/oa_pdf/8c/dc/ncomms5106.PMC4078410.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Singh, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/8c/dc/ncomms5106.PMC4078410.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)IBP induces epithelial-to-mesenchymal transition Z Zhang et al 3382 Oncogene (2014) 3374 – 3382 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/1e/5d/onc2013337a.PMC4078416.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/29/133264 Journal of Clinical Imaging Science www.clinicalimagingscience.orgFor entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor‑in‑Chief: Vikram S. Dogra, MD  Department of Imaging Sciences, University of  Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format",Non-OADS,/arxiv_data1/oa_pdf/0b/9c/JCIS-4-29.PMC4078418.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/25/133257ORIGINAL ARTICLE Received : 09‑03‑2014 Accepted : 08‑04‑2014 Published : 27‑05‑2014,Non-OADS,/arxiv_data1/oa_pdf/2b/43/JCIS-4-25.PMC4078419.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/26/133259Address for correspondence:    Dr. Santosh Kumar,   Department of Urology, Postgraduate  Institute of Medical Education and  Research, Chandigarh ‑ 160 012, India.",Non-OADS,/arxiv_data1/oa_pdf/d3/6f/JCIS-4-26.PMC4078420.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/30/133265CASE REPORT,Non-OADS,/arxiv_data1/oa_pdf/a5/b7/JCIS-4-30.PMC4078421.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/27/133261CASE REPORT Address for correspondence:    Dr. Hamed Akhavizadegan,   Department of Urology, Baharloo  hospital, Behdari Street, Rahahan square,  Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/18/c7/JCIS-4-27.PMC4078422.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/e9/srep05545.PMC4078435.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Intraoperative magnetic resonance imaging versus standard  neuronavigation for the neurosurgical treatment of glioblastoma:  A randomized controlled trial Pieter L. Kubben1, Felix Scholtes2, Olaf E.M.G.",Non-OADS,/arxiv_data1/oa_pdf/0a/cc/SNI-5-70.PMC4078446.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/70/132572 Copyright: © 2014 Kubben LP .,Non-OADS,/arxiv_data1/oa_pdf/0a/cc/SNI-5-70.PMC4078446.pdf
"Surgical Neurology International 2014, 5:70  http://www.surgicalneurologyint.com/content/5/1/70INTRODUCTION Glioblastoma is an infiltrating malignant brain tumor.",Non-OADS,/arxiv_data1/oa_pdf/0a/cc/SNI-5-70.PMC4078446.pdf
"Surgical Neurology International 2014, 5:70  http://www.surgicalneurologyint.com/content/5/1/70performed using OsiriX software (Pixmeo SARL, Bernex,  Switzerland) on Mac OS X using a Wacom Bamboo pen  mouse for contour drawing.",Non-OADS,/arxiv_data1/oa_pdf/0a/cc/SNI-5-70.PMC4078446.pdf
This software is provided by the Trans  European Network (http://www.tenalea.com/) and  maintenance for The Netherlands is performed by the  Netherlands Cancer Institute (http://www.nki.nl/).,Non-OADS,/arxiv_data1/oa_pdf/0a/cc/SNI-5-70.PMC4078446.pdf
"Surgical Neurology International 2014, 5:70  http://www.surgicalneurologyint.com/content/5/1/70with an interquartile range of 3.5-33.5%.",Non-OADS,/arxiv_data1/oa_pdf/0a/cc/SNI-5-70.PMC4078446.pdf
"Surgical Neurology International 2014, 5:70  http://www.surgicalneurologyint.com/content/5/1/70using iMRI.",Non-OADS,/arxiv_data1/oa_pdf/0a/cc/SNI-5-70.PMC4078446.pdf
"Surgical Neurology International 2014, 5:70  http://www.surgicalneurologyint.com/content/5/1/70resection should be seen in the context of a minimal  difference in postoperative tumor volume between  both treatment groups.",Non-OADS,/arxiv_data1/oa_pdf/0a/cc/SNI-5-70.PMC4078446.pdf
"Surgical Neurology International 2014, 5:70  http://www.surgicalneurologyint.com/content/5/1/70cannot be tested due to the small sample size aggravated  by missing data.",Non-OADS,/arxiv_data1/oa_pdf/0a/cc/SNI-5-70.PMC4078446.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Medullary schistosomiasis Lia Pappamikail, Paulo Fernandes, Casimiro Gonçalves Department of Neurosurgery, Centro Hospitalar de Lisboa Central EPE, Lisboa, Portugal E‑mail: *Lia Pappamikail ‑ Pappamikail@gmail.com; Paulo Fernandes ‑ Paulopbf@sapo.pt; Casimiro Gonçalves ‑ j.casimiro@iol.pt   *Corresponding author Received: 01 January 14  Accepted: 27 March 14  Published: 09 May 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.132235  Quick Response Code: Abstract Background: Schistosomal infestation of the central nervous system is a rare  cause of cord compression, although a predominant one in endemic areas.",Non-OADS,/arxiv_data1/oa_pdf/d9/1c/SNI-5-66.PMC4078447.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/66/132235 Copyright: © 2014 Pappamikail L. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d9/1c/SNI-5-66.PMC4078447.pdf
"Surgical Neurology International 2014, 5:66  http://www.surgicalneurologyint.com/content/5/1/66hypersignal as well as heterogeneous enhancement after  intravenous injection of gadolinium, with a granular  pattern (disruption of the blood‑brain barrier) [Figure 1].",Non-OADS,/arxiv_data1/oa_pdf/d9/1c/SNI-5-66.PMC4078447.pdf
"Surgical Neurology International 2014, 5:66  http://www.surgicalneurologyint.com/content/5/1/66swim and penetrate the skin of human host.",Non-OADS,/arxiv_data1/oa_pdf/d9/1c/SNI-5-66.PMC4078447.pdf
"Surgical Neurology International 2014, 5:66  http://www.surgicalneurologyint.com/content/5/1/66definitive consensual therapy for neuroschistosomiasis,  consistently, the association of antischistosomal drugs and  steroids produces speedy recovery of motor and sensory  deficits, as well as sphincter control.",Non-OADS,/arxiv_data1/oa_pdf/d9/1c/SNI-5-66.PMC4078447.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Retrospective study of Heparin Administration for Ischemic  Stroke when there is an IV‑tPA Contraindication Zakaria Hakma, Douglas L. Stofko, Mandy Jo Binning, Kenneth Liebman, Erol Veznedaroglu Department of Neurosurgery, Stroke and Cerebrovascular Center of New Jersey at Capital Health, Two Capital Way, Suite 456, Pennington, NJ 08534, USA E‑mail: *Douglas L. Stofko ‑ douglas.stofko@gmail.com; Zakaria Hakma ‑ zhakma@mac; Mandy Jo Binning ‑ mbinning@capitalhealth.org;   Kenneth Liebman ‑ kliebman@capitalhealth.org; Erol Veznedaroglu ‑ veznedaroglu@yahoo.com   *Corresponding author Received: 14 November 13   Accepted: 11 March 14   Published: 06 May 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.132032  Quick Response Code: Abstract Background:  The majority of patients presenting with an ischemic stroke arrive after  the 3-4.5 h time window allowed for intravenous tissue plasminogen activator (IV  tPA) administration.",Non-OADS,/arxiv_data1/oa_pdf/cb/f1/SNI-5-62.PMC4078448.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/62/132032 Copyright: © 2014 Stofko DL.,Non-OADS,/arxiv_data1/oa_pdf/cb/f1/SNI-5-62.PMC4078448.pdf
"Surgical Neurology International 2014, 5:62  http://www.surgicalneurologyint.com/content/5/1/62INTRODUCTION Acute ischemic stroke is a common problem that carries  a significant risk of mortality and morbidity.",Non-OADS,/arxiv_data1/oa_pdf/cb/f1/SNI-5-62.PMC4078448.pdf
"Surgical Neurology International 2014, 5:62  http://www.surgicalneurologyint.com/content/5/1/62computed tomography (CT) prior to starting therapy.",Non-OADS,/arxiv_data1/oa_pdf/cb/f1/SNI-5-62.PMC4078448.pdf
"Surgical Neurology International 2014, 5:62  http://www.surgicalneurologyint.com/content/5/1/62stroke (30%), carotid territory stroke (31%), and multiple  transient ischemic attacks (47%).",Non-OADS,/arxiv_data1/oa_pdf/cb/f1/SNI-5-62.PMC4078448.pdf
"Surgical Neurology International 2014, 5:62  http://www.surgicalneurologyint.com/content/5/1/62thrombosed basilar aneurysm that was causing an embolic  stroke and the other a pontine hemorrhagic conversion.",Non-OADS,/arxiv_data1/oa_pdf/cb/f1/SNI-5-62.PMC4078448.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor Delayed detection versus delayed occurrence of contralateral  hematoma Bhavanam Hanuma Srinivas, Alugolu Rajesh Department of Neurosurgery, Nizam’s Institute of Medical Sciences, Punjagutta, Hyderabad, Andhra Pradesh, India E‑mail:  Bhavanam Hanuma Srinivas ‑ dr.hanuma9@gmail.com; *Alugolu Rajesh ‑ drarajesh1306@gmail.com   *Corresponding author Received: 09 January 14  Accepted: 02 April 14  Published: 09 May 14 Dear Sir, Intraoperative or immediate development of contralateral  hematoma, following decompressive craniectomy, with  or without a coexisting fracture/hematoma, is a well  documented entity in the literature.",Non-OADS,/arxiv_data1/oa_pdf/0f/e2/SNI-5-67.PMC4078449.pdf
Available FREE in open access from:  http://www.surgicalneurologyint.com/text.asp?2014/5/1/67/132237 Copyright:  © 2012 Srinivas BH.,Non-OADS,/arxiv_data1/oa_pdf/0f/e2/SNI-5-67.PMC4078449.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Effectiveness of zigzag Incision and 1.5‑Layer method for  frontotemporal craniotomy Noriaki Minami, Toshikazu Kimura1, Takehiro Uda2, Chikayuki Ochiai1, Eiji Kohmura, Akio Morita3 Department of Neurosurgery, Kobe University Graduate School of Medicine, Kusunoki-cho, 7-5-2, Chuo-ku, Kobe, 1Department of Neurosurgery, NTT Medical Center  T okyo, T okyo, 2Department of Neurosurgery, Osaka City University Graduate School of Medicine, Osaka, 3Department of Neurosurgery, Nippon Medical School, T okyo, Japan E-mail: *Noriaki Minami  - nminami@med.kobe -u.ac.jp; T oshikazu Kimura  - tkim.tky.umin@gmail.com; Takehiro Uda - uda_takehiro@hotmail.com;   Chikayuki Ochia - ochiai@east.ntt.co.jp; Eiji Kohmura  - ekohmura@med.kobe -u.ac.jp; Akio Morita - amor-tky@umin.ac.jp   *Corresponding Author Received: 10  December 13   Accepted:  20  March 14   Published:  15 May 14 Abstract Background: In this era of minimally invasive treatment, it is important to make  operative scars as inconspicuous as possible, and there is a great deal of room for improvement in daily practice.",Non-OADS,/arxiv_data1/oa_pdf/cb/2e/SNI-5-69.PMC4078450.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/69/132562 Copyright: © 2014 Minami N.  This is an open -access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/cb/2e/SNI-5-69.PMC4078450.pdf
"Surgical Neurology International 2014, 5:69  http://www.surgicalneurologyint.com/content/5/1/69The zigzag coronal incision has been reported  for this purpose, mainly in the field of plastic  surgery.",Non-OADS,/arxiv_data1/oa_pdf/cb/2e/SNI-5-69.PMC4078450.pdf
"Surgical Neurology International 2014, 5:69  http://www.surgicalneurologyint.com/content/5/1/69reflects VT , SF , RE, and MH.",Non-OADS,/arxiv_data1/oa_pdf/cb/2e/SNI-5-69.PMC4078450.pdf
"Surgical Neurology International 2014, 5:69  http://www.surgicalneurologyint.com/content/5/1/69do not leave scarring of the skin, which contributes  largely to patients’ preference for endovascular surgery,  although radiation‑induced permanent alopecia due  to endovascular treatment occurs in a considerable  proportion of cases.",Non-OADS,/arxiv_data1/oa_pdf/cb/2e/SNI-5-69.PMC4078450.pdf
"Surgical Neurology International 2014, 5:69  http://www.surgicalneurologyint.com/content/5/1/69is a practical, reliable, and valid measure of physical and  MH.",Non-OADS,/arxiv_data1/oa_pdf/cb/2e/SNI-5-69.PMC4078450.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Intraarterial vasodilator therapy immediately rescued pure cortical  deafness due to bilateral cerebral vasospasm Keizoh Asakuno, Atsushi Ishida Department of Neurosurgery, Moriyama Memorial Hospital, T okyo, Japan E‑mail:  Keizoh Asakuno ‑ bellamusicax@gmail.com; *Atsushi Ishida ‑ v2danyon@gmail.com   *Corresponding author Received:  01 March 14  Accepted: 01 April 14  Published: 06 May 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.132031  Quick Response Code: Abstract Background:  Cortical deafness is a rare symptom that is associated with bilateral  lesions of the auditory cortex.",Non-OADS,/arxiv_data1/oa_pdf/9d/19/SNI-5-61.PMC4078451.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/61/132031 Copyright: © 2014 Asakuno K. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/9d/19/SNI-5-61.PMC4078451.pdf
"Surgical Neurology International 2014, 5:61  http://www.surgicalneurologyint.com/content/5/1/61the ischemic lesions in both temporal lobes with the  aid of perfusion‑weighted (PW) magnetic resonance  imaging (MRI).",Non-OADS,/arxiv_data1/oa_pdf/9d/19/SNI-5-61.PMC4078451.pdf
"Surgical Neurology International 2014, 5:61  http://www.surgicalneurologyint.com/content/5/1/61total 20 mg).",Non-OADS,/arxiv_data1/oa_pdf/9d/19/SNI-5-61.PMC4078451.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Acanthamoeba  encephalitis: A  Case Report and Review of Therapy A. Zamora1, H. Henderson1, E. Swiatlo1,2 1Department of Medicine, University of Mississippi Medical Center, 2G.V .",Non-OADS,/arxiv_data1/oa_pdf/ba/34/SNI-5-68.PMC4078452.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/68/132239 Copyright: © 2014 Zamora L.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/ba/34/SNI-5-68.PMC4078452.pdf
"Surgical Neurology International 2014, 5:68  http://www.surgicalneurologyint.com/content/5/1/68DISCUSSION Granulomatous amoebic encephalitis (GAE) is an  infection of the central nervous system with a mortality  rate over 50% and is increasingly recognized as an  opportunistic infection of immunocompromised hosts.",Non-OADS,/arxiv_data1/oa_pdf/ba/34/SNI-5-68.PMC4078452.pdf
"Surgical Neurology International 2014, 5:68  http://www.surgicalneurologyint.com/content/5/1/68and low glucose, however, amoebae are frequently seen  by any staining or microscopic technique.",Non-OADS,/arxiv_data1/oa_pdf/ba/34/SNI-5-68.PMC4078452.pdf
"Surgical Neurology International 2014, 5:68  http://www.surgicalneurologyint.com/content/5/1/68REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/ba/34/SNI-5-68.PMC4078452.pdf
"Surgical Neurology International 2014, 5:68  http://www.surgicalneurologyint.com/content/5/1/68lymphocytic pleocytosis.",Non-OADS,/arxiv_data1/oa_pdf/ba/34/SNI-5-68.PMC4078452.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial Epilepsy needs to be talked about, who wants to go first?",Non-OADS,/arxiv_data1/oa_pdf/66/9f/SNI-5-65.PMC4078453.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/65/132140 Copyright: © 2014 Gillie  AM.,Non-OADS,/arxiv_data1/oa_pdf/66/9f/SNI-5-65.PMC4078453.pdf
"Surgical Neurology International 2014, 5:65  http://www.surgicalneurologyint.com/content/5/1/65Tegretol and Topomax were two of the meds I would  be on for the next 11 years.",Non-OADS,/arxiv_data1/oa_pdf/66/9f/SNI-5-65.PMC4078453.pdf
"Surgical Neurology International 2014, 5:65  http://www.surgicalneurologyint.com/content/5/1/65I think I recall counting to 3 and from there I remember  waking up late that evening in the ICU.",Non-OADS,/arxiv_data1/oa_pdf/66/9f/SNI-5-65.PMC4078453.pdf
"Surgical Neurology International 2014, 5:65  http://www.surgicalneurologyint.com/content/5/1/65point of view helps others understand, I know it would  had helped me.",Non-OADS,/arxiv_data1/oa_pdf/66/9f/SNI-5-65.PMC4078453.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comReview Article Glioblastoma multiforme: State of the art and future therapeutics Taylor A. Wilson, Matthias A. Karajannis1, David H. Harter Department of Neurosurgery, 1 Department of Pediatrics, Division of Oncology, New York University School of Medicine, NY , USA  E‑mail:  Taylor A. Wilson ‑ Taylor.Wilson5@gmail.com; Matthias A. Karajannis ‑ Matthias.Karajannis@nyumc.org; *David H. Harter ‑ David.Harter@nyumc.org   *Corresponding author Received: 27 October 13  Accepted: 13 March 14  Published: 08 May 14 Abstract Background:  Glioblastoma multiforme (GBM) is the most common and lethal  primary malignancy of the central nervous system (CNS).",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/64/132138 Copyright: © 2014 Wilson TA.,Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64Unlike the bulk of the rapidly dividing tumor cells, GSCs  are thought to be relatively quiescent, rendering them  resistant to conventional chemo‑ and radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64pattern of gene expression, whereas primary GBM are a  more heterogeneous group with a diverse array genetic  mutations and aberrant gene expression profiles.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64benefit of TMZ in combination with RT , establishing  the so‑called ""Stupp regimen"" standard of care for GBM  treatment.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64downstream signaling pathways.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64outcomes by reducing angiogenesis, decreasing growth  of tumor cells expressing VEGF , disrupting the  microvasculature of the tumor leading to increased  tumor hypoxia, and increasing tumor cell sensitivity  to RT .",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64the potential for greater efficacy by inhibiting multiple  pathways, but they also have an increased risk of toxicity  from systemic inhibition.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64stimulate an immune response against a specific EGFRvIII  antigen.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64and disadvantages.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64enzyme‑prodrug activating therapy to be successful, the  enzyme transgene must be delivered exclusively into  tumor cells, and its enzymatic activity must be high  enough to kill tumor cells without causing toxicity to  surrounding normal cells or inducing a systemic immune  response.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64for various immunostimulatory agents into tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64to surrounding cells and reduces their transduction  efficiency.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64trial of erlotinib and temozolomide with radiation therapy in the treatment of  newly diagnosed glioblastoma multiforme: North Central Cancer Treatment  Group Study N0177.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/6470.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64116.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64Stevens GH, et al.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64of a recombinant chimeric protein composed of transforming growth  factor (TGF)‑alpha and a mutated form of the Pseudomonas exotoxin termed  PE‑38 (TP‑38) for the treatment of malignant brain tumors.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology International 2014, 5:64  http://www.surgicalneurologyint.com/content/5/1/64Evaluation of E1A double mutant oncolytic adenovectors in anti‑glioma gene  therapy.",Non-OADS,/arxiv_data1/oa_pdf/10/d6/SNI-5-64.PMC4078454.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial Hemicraniectomy in the management of malignant middle  cerebral artery infarction: Lessons from randomized,   controlled trials Dustin Hatefi, Brian Hirshman, Didier Leys1, Jean‑Paul Lejeune1, Lawrence Marshall,   Bob S. Carter, Ekkehard Kasper2, Clark C. Chen Division of Neurosurgery, University of California, San Diego, CA, 1Department of Neurology and Neurosurgery, University of Lille North of France, Lille, France,  2Division of Neurosurgery, Beth Israel Deaconess Medical Center, Boston, MA, USA E‑mail:  Dustin Hatefi ‑ dhatefi@ucsd.edu; Brian Hirshman ‑ bhirshma@ucsd.edu; Didier Leys ‑ didier.leys@univ‑lille2.fr; Jean‑Paul Lejeune ‑ lejeune@chru‑lille.fr;  Lawrence Marshall ‑ lfmarshall@ucsd.edu; Bob S. Carter ‑ bobcarter@ucsd.edu; Ekkehard Kasper ‑ ekasper@bidmc.harvard.edu   *Clark C. Chen ‑ clarkchen@ucsd.edu   *Corresponding author Received: 19 February 14   Accepted: 06 March 14  Published: 15 May 14 BACKGROUND Territorial middle cerebral artery (MCA) infarcts are  among the most devastating forms of ischemic cerebral  disease.",Non-OADS,/arxiv_data1/oa_pdf/d1/c4/SNI-5-72.PMC4078455.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/72/132589 Copyright: © 2014 Hatefi D.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d1/c4/SNI-5-72.PMC4078455.pdf
"Surgical Neurology International 2014, 5:72  http://www.surgicalneurologyint.com/content/5/1/72significant preexisting morbidities were excluded from  this analysis (e.g.",Non-OADS,/arxiv_data1/oa_pdf/d1/c4/SNI-5-72.PMC4078455.pdf
"Surgical Neurology International 2014, 5:72  http://www.surgicalneurologyint.com/content/5/1/72patients in either arm had a mRS<3.",Non-OADS,/arxiv_data1/oa_pdf/d1/c4/SNI-5-72.PMC4078455.pdf
"Surgical Neurology International 2014, 5:72  http://www.surgicalneurologyint.com/content/5/1/72the discovery of antirabies vaccination or of penicillin.",Non-OADS,/arxiv_data1/oa_pdf/d1/c4/SNI-5-72.PMC4078455.pdf
"Surgical Neurology International 2014, 5:72  http://www.surgicalneurologyint.com/content/5/1/722.",Non-OADS,/arxiv_data1/oa_pdf/d1/c4/SNI-5-72.PMC4078455.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/28/133263ABSTRACT Perforation of a duodenal ulcer  (DU) into the retroperitoneal space presenting with  clinical features of acute appendicitis is known as Valentino’s syndrome.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/JCIS-4-28.PMC4078456.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Critical ventriculo‑peritoneal shunt failure due to peritoneal  tuberculosis: Case report and diagnostic suggestions for  abdominal pseudocyst Hajime Takase1,2, Junya Tatezuki2, Naoki Ikegaya1,2, Daisuke Yamamoto2, Mizuki Hashimoto2,  Makoto Takagi2, Yasuhiko Mochimatsu2, Nobutaka Kawahara1 1Departments of Neurosurgery, Graduate School of Medicine, Yokohama City University, 2Yokohama City Minato Red Cross Hospital, Yokohama, Japan E‑mail:  Hajime Takase ‑ htakase@yokohama‑cu.ac.jp; Junya Tatezuki ‑ junnary2@yahoo.co.jp; Naoki Ikegaya ‑ naokigaya0702@hotmail.com;   Daisuke Yamamoto ‑ baystars_saiko@hotmail.com; Mizuki Hashimoto ‑ mizuhash@jcom.home.ne.jp; Makoto Takagi ‑ takagi.nsrg@yokohama.jrc.or.jp;   Yasuhiko Mochimatsu ‑ mochimatsu.nsrg@yokohama.jrc.or.jp; *Nobutaka Kawahara ‑ nkawa@yokohama‑cu.ac.jp   *Corresponding author Received: 03 February 14  Accepted: 30 March 14  Published: 15 May 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.132583  Quick Response Code: Abstract Background:  Tuberculous peritonitis (TBP) is a well‑known complication of  ventriculo‑peritoneal (VP) shunt treatment for hydrocephalus resulting from  tuberculous meningitis (TBM).",Non-OADS,/arxiv_data1/oa_pdf/64/fe/SNI-5-71.PMC4078457.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/71/132583 Copyright: © 2014 Takase H.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/64/fe/SNI-5-71.PMC4078457.pdf
"Surgical Neurology International 2014, 5:71  http://www.surgicalneurologyint.com/content/5/1/71renal failure with hemodialysis, or immunodeficiency  diseases, in developed countries.",Non-OADS,/arxiv_data1/oa_pdf/64/fe/SNI-5-71.PMC4078457.pdf
"Surgical Neurology International 2014, 5:71  http://www.surgicalneurologyint.com/content/5/1/71with an abdominal pseudocyst associated with TBP and  successfully treated by anti- TB agents following insertion  of a ventriculo-pleural shunt  [Figure 3].",Non-OADS,/arxiv_data1/oa_pdf/64/fe/SNI-5-71.PMC4078457.pdf
"Surgical Neurology International 2014, 5:71  http://www.surgicalneurologyint.com/content/5/1/71nervous system.",Non-OADS,/arxiv_data1/oa_pdf/64/fe/SNI-5-71.PMC4078457.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor A typical radiological presentation in a case of choroid plexus  carcinoma Pravin Salunke, Sushanta K. Sahoo, Karthigeyan Madhivanan, B. D. Radotra1 Departments of Neurosurgery, 1Histopathology, PGIMER Chandigarh, India E‑mail: *Pravin Salunke ‑ drpravin_salunke@yahoo.co.uk; Sushanta K. Sahoo ‑ drsushantsahoo@gmail.com;   Karthigeyan Madhivanan ‑ karthigeyanm82@gmail.com; B. D. Radotra ‑ bishanradotra@hotmail.com   *Corresponding author Received: 03 November 13  Accepted: 27 March 14  Published: 07 May 14 Dear Sir, Choroid plexus carcinomas are uncommon intracranial  neoplasms accounting for 15-20% of choroid  plexus tumors.",Non-OADS,/arxiv_data1/oa_pdf/48/d5/SNI-5-63.PMC4078459.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/63/132103 Copyright: © 2014 Salunke P .,Non-OADS,/arxiv_data1/oa_pdf/48/d5/SNI-5-63.PMC4078459.pdf
"Surgical Neurology International 2014, 5:63  http://www.surgicalneurologyint.com/content/5/1/63tumors are heterogeneously hypo-to isointense on T1,  iso-to hyperintense on T2 with heterogenous contrast  enhancement on MRI and shows mild to moderate  diffusion restriction on DWI.",Non-OADS,/arxiv_data1/oa_pdf/48/d5/SNI-5-63.PMC4078459.pdf
"Surgical Neurology International 2014, 5:63  http://www.surgicalneurologyint.com/content/5/1/63enhancing on contrast MRI.",Non-OADS,/arxiv_data1/oa_pdf/48/d5/SNI-5-63.PMC4078459.pdf
"Available from:  http://www.who.int/campaigns/world-health-day/2014/about- diseases/en/index.htm l, accessed on March 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from: http://www.who.int/malaria/ publications/world_malaria_report_2013/en /, accessed on  March 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from: http://www.who.int/ neglected_diseases/diseases/en /, accessed on March 28,  2014.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from: http://www.who.int/ campaigns/world-health-day/2014/event/en /, accessed on  March 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from: http://www.who.int/ lymphatic_filariasis/research/en /, accessed on March 28,  2014.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from: http://www.who.int/ malaria/areas/elimination/overview/en /, accessed on March  28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from: http://www.who.int/malaria/ publications/atoz/gpirm/en /, accessed on March 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from: http://www.who.int/malaria/publications/ atoz/artemisinin_ resistance_containment_2011.pd f, accessed  on March 28, 2014.482  INDIAN J MED RES, APRIL  2014",Non-OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from: http://apps.who.int/iris/bitstream/1066 5/79940/1/9789241505321_ eng.pd f, accessed on March 28,  2014.",OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from: http://www.searo.who.int/entity/worl d- health_day/2014/Aide_memoire_Malaria.pdf,  accessed on  March 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from:  http://www.who.int/tdr/capacity/en/,  accessed on January 4,  2014.",OADS,/arxiv_data1/oa_pdf/6a/28/IJMR-139-481.PMC4078485.pdf
"Available from: http://www.historyofvaccines.org /,  accessed on March 16, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
"Available from: 28.  http://www.pasteurinstituteindia.com/ , accessed on May 30,  2012.",Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
Available from: http://www.unicef.org/wsc/goals.,Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
"Available from: http://www.unicef.org/wsc/ declare.htm#Thechallenge , accessed on May 30, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
"Available from: http://icmr.nic.in/ ethical_guidelines.pdf , accessed on May 30, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
Available 48.  from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
Available from:  http://www.thehindubusinessline.com/news/article3892518.,Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
"Available from: http://www.path.org/news/pr121203- menafrivac.php , accessed on March 20, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
"Available from: http://www.who.int/mediacentre/ news/releases/2012/polio_20120113/en/index.html , accessed  on May 30, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
"Available  from: http://www.cdsco.nic.in/ , accessed on May 30, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
"Available  from: http://www.who.int/immunization_standards/vaccine_ quality/pq_system/en/index.html , accessed on May 30, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
Available from: 68.  http://www.thehindubusinessline.com/news/article3892518.,Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
Available from: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
"Available from: http://pib.nic.in/newsite/ erelease.aspx?relid=99873 , accessed on April 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a3/38/IJMR-139-491.PMC4078488.pdf
"Available from: http://www.who.int/tobacco/surveillance/ gats_india/en/index.html , accessed on April 12, 2012.",Non-OADS,/arxiv_data1/oa_pdf/d2/7e/IJMR-139-523.PMC4078490.pdf
"Available from: http://mohfw.nic.in/ WriteReadData/l892s/911379183TobaccocontroinIndia_10D ec04.pdf , accessed on July 2, 2010.",Non-OADS,/arxiv_data1/oa_pdf/d2/7e/IJMR-139-523.PMC4078490.pdf
Available from : http://www.14wctoh.org/abstract/abs_detail.,OADS,/arxiv_data1/oa_pdf/d2/7e/IJMR-139-523.PMC4078490.pdf
The sample size was calculated by Quanto  software ( http://hydra.usc.edu/gxe ).,OADS,/arxiv_data1/oa_pdf/6d/2a/IJMR-139-572.PMC4078496.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/20/a6/IJMR-139-638.PMC4078505.pdf
Retrieved from: http://www.emedicine.medscape.,OADS,/arxiv_data1/oa_pdf/c4/9d/JRPP-3-34.PMC4078649.pdf
Up‑to‑date  Available from: http://www.uptodate.com/contents/ overview‑of‑postpartum‑hemorrhage.,Non-OADS,/arxiv_data1/oa_pdf/5d/16/JRPP-3-28.PMC4078650.pdf
Available from: http://www.drugs.com/sfx/ oxytocin‑side‑effects.html.,Non-OADS,/arxiv_data1/oa_pdf/5d/16/JRPP-3-28.PMC4078650.pdf
Available from: http://www.uptodate.com/contents/ oxytocin‑drug‑information?source=see_link and,Non-OADS,/arxiv_data1/oa_pdf/5d/16/JRPP-3-28.PMC4078650.pdf
Available from: http://www.medicinenet.com/ oxytocin‑injectable/article.htm.,Non-OADS,/arxiv_data1/oa_pdf/5d/16/JRPP-3-28.PMC4078650.pdf
Available from: http://www.services.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/5d/16/JRPP-3-28.PMC4078650.pdf
"nafldscore.com/) is a validated scoring system that comprises six routinely measured parameters.49 Advanced fibrosis can be reliably excluded (NPV 93%) using the low cut-off score (< −1.455) and diag- nosed with high accuracy (PPV 90%) using the high cut-off score (>0.676).49These results have been vali- dated in other studies.20 50 The FIB-4 score (table 4; http://gihep.com/ calculators/hepatology/fibrosis-4-score/), althoughderived in patients with hepatitis C and HIV coinfec- tion, 51appears to be one of the most useful non- invasive tests for diagnosing advanced fibrosis inNAFLD.",Non-OADS,/arxiv_data1/oa_pdf/b9/51/flgastro-2013-100403.PMC4078666.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/ REFERENCES 1 Armstrong MJ, Houlihan DD, Bentham L, et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/51/flgastro-2013-100403.PMC4078666.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Gilmore A, McKee M. Moving East: how the transnational tobacco industry gained entry to the emerging markets of the former Soviet Union —part I: establishing cigarette imports.",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2011. http://www.pmi.com/eng/tobacco_ regulation/illicit_trade/documents/Project_Star_2010_Results.pdf (accessed 25 July2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"National Audit Of ﬁceOfﬁce NA, 2013. http://www.nao.org.uk/report/ progress-in-tackling-tobacco-smuggling/ (accessed 25 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"International Consortium of Investigative Journalists, 2009. http://www.icij.org/project/tobacco-underground/ ukraines-lost-cigarettes- ﬂood-europe (accessed 25 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"European Union, 2010. http://ec.europa.eu/anti_fraud/documents/cigarette_smug/2010/bat_main_agreement.pdf (accessed 12 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"European Union, 2010. http://ec.europa.eu/anti_fraud/documents/ cigarette_smug/2010_i/agreement_sept_2010.pdf (accessed 12 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"European Union, 2007. http://ec.europa.eu/anti_fraud/documents/cigarette_smug/2007/cooperation_agreement.pdf (accessed 17 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"European Parliament, 2013. http://www.europarl.europa.eu/sides/getAllAnswers.do?reference=E-2013-007681&language=EN (accessed 7 Oct 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
21 August 2012. http://online.wsj.com/news/articles/ SB10000872396390444233104577595221203321922 [Accessed 7 Oct 2013].,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2012. http://www.imperial-tobacco.co.uk/ ﬁles/misc/plain_ packaging_submission.pdf (accessed 25 July 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2012. http://www.jti.com/ ﬁles/ 4013/4149/4323/Packaging_Response.pdf (accessed 25 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2013. http://www.ash.org.uk/APPGillicit2013 (accessed 25 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
UK Standardised Packaging Consultation: Response of British American Tobacco UK Ltd. 2012. http://www.bat.com/group/sites/uk__3mnfen.nsf/vwPagesWebLive/DO8WZC5E/$FILE/medMD8WZC6J.pdf (accessed 25 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
http://www.nonannystate.com.au/ (accessed 25 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2010. http://www.smoke-free.ca/ plain-packaging/documents/industry-responses/PwC_report_-_Illegal_Tobacco_-_ counting_the_cost_of_Australias_black_market_February_2010.pdf (accessed 25Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2011. http://www.bata.com.au/group/ sites/bat_7wykg8.nsf/vwPagesWebLive/DO7WYLJQ/$FILE/medMD8WSDPX.pdf?,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2011. http://phx.corporate-ir.net/External.File?,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"Australia: ASH, 2010. http://www.ashaust.org.au/pdfs/TItacticsGuide.pdf (accessed 25 Jul2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"HM Government, 2011. https://www.gov.uk/government/uploads/system/ uploads/attachment_data/ ﬁle/213757/dh_124960.pdf (accessed 25 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"UK: Cancer Research, 2012. http://www.cancerresearchuk.org/prod_consump/groups/cr_ common/@nre/@new/@pre/documents/generalcontent/smuggling_execsummary.",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"Cancer Council Victoria, 2012. http://www.tobaccoinaustralia.org.au/ (accessed 25 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"PPACTE, 2011. http://www.ppacte.eu/index.php?option=com_docman&task=doc_ download&gid=187&Itemid (accessed 30 Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"WHO, 2003. http://www.who.int/fctc/en/ (accessed 24 Jul 2013).",OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2011. http://customs.hmrc.gov.uk/channelsPortalWebApp/downloadFile?contentID=HMCE_PROD1_031246 (accessed 25 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2010. http://www.hmrc.,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
http://www.lexisnexis.com (accessed Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2012. http://www.pmi.com/eng/tobacco_ regulation/illicit_trade/documents/project%20star%202011%20results.pdf (accessed 25 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"KPMG LLP, 2013. http://www.pmi.com/eng/ media_center/media_kit/Documents/Project_Star_2012_Final_Report.pdf (accessed 20 Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"PPACTE Consortium, 2011. http://www.ppacte.eu/index.php?option=com_docman&task=doc_download&gid=185&Itemid=29 (accessed 25 Jul 2013).",OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"NEMS Market Research, 2011. http://www.illicittobacconorth.org/FileUploads/Illicit_ tobacco_programme_public_opinion_report_2011.pdf (accessed 25 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
http://www.hmrc.gov.uk/statistics/ tax-gaps.htm#3 (accessed 25 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2013. http://www.hmrc.,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
"Philip Morris International, 2013. http://www.pmi.com/eng/media_ center/press_releases/pages/201304170400.aspx (accessed 7 Oct 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
2013. http://www.cancerresearchuk.org/cancer-info/news/archive/ pressrelease/2013-04-17-further-adverts-from-japan-tobacco-international-ruled- misleading (accessed 21 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/4c/tobaccocontrol-2013-051397.PMC4078667.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ tobaccocontrol-2014-051718).,Non-OADS,/arxiv_data1/oa_pdf/b6/7a/tobaccocontrol-2014-051718.PMC4078668.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 U.S. Food and Drug Administration.,Non-OADS,/arxiv_data1/oa_pdf/b6/7a/tobaccocontrol-2014-051718.PMC4078668.pdf
Wall Street J 2013 December 19. http://online.wsj.com/news/articles/ SB10001424052702303773704579268892537996818.,Non-OADS,/arxiv_data1/oa_pdf/b6/7a/tobaccocontrol-2014-051718.PMC4078668.pdf
2013. http://www.businessinsider.com/you-cant-smoke-e-cigarettes-in-planes-2013-2.,Non-OADS,/arxiv_data1/oa_pdf/b6/7a/tobaccocontrol-2014-051718.PMC4078668.pdf
"Reuters 2013 December 11. http://www.reuters.com/article/2013/12/11/ us-usa-ecigarettes-idUSBRE9BA0ZT20131211 57 Smith D, Bansal-Travers M, O ’Connor RJ, et al.",OADS,/arxiv_data1/oa_pdf/b6/7a/tobaccocontrol-2014-051718.PMC4078668.pdf
Funding The study was funded in part by a grant from the Nowetas-Foundation (http://www.nowetas.de).,Non-OADS,/arxiv_data1/oa_pdf/3c/b7/oemed-2014-102172.PMC4078669.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Chesky K, Hanoch MA.",Non-OADS,/arxiv_data1/oa_pdf/3c/b7/oemed-2014-102172.PMC4078669.pdf
Schlüsselverzeichnis für die Angaben zur Tätigkeit in den Meldungen zur Sozialversicherung 2003. http://www.arbeitsagentur.de/zentraler-Content/ A01-Allgemein-Info/A016-Infomanagement/Publikation/pdf/SchluesselverzeichnisSozVers.pdf (accessed 11 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/3c/b7/oemed-2014-102172.PMC4078669.pdf
"Table 3 In silico analysis of long QT genetic variants found in eight victims of SIDS Gene RefSeq accession numbers (transcript and protein) and UniProt numberVariant position (transcript, protein and exon)Bioinformatic programmes Interpretation PolyPhen-2a,*Mutation Assessorb (Functional Impact) I-MUTANT 3.0cPMutdMutPredeSNPs&GOfPANTHERg KCNQ1 NM_000218.2 NP_000209.2P51787c.436G>A p.E146KE2Benign (Scores: 0.250; 0.134) Neutral Disease (RI 6.0) Neutral (RS 0) Pdel: 0.859 Disease (RI 5.0) Pdel: 0.31 Pathogenic (LQTS1) KCNH2 NM_000238.2 NP_000229.1 Q12809c.3140G>T p.R1047L E13Benign (Scores: 0.039; 0.020) Low Disease (RI 2.0) Pathological (RS 8) Pdel: 0.373 Disease (RI 1.0) Pdel: 0.42 Pathogenic (LQTS2) SCN5A NM_198056.2 NP_932173.1Q14524c.1673A>G p.H558RE6Benign (Scores: 0.000; 0.000) Neutral Neutral (RI 6.0) Neutral (RS 6) Pdel: 0.086 Neutral (RI 8.0) Pdel: 0.14 Polymorphism c.2275A>T † p.I759F E15Benign (Scores: 0.003; 0.007) Medium Disease (RI 5.0) Neutral (RS 3) Pdel: 0.878 Disease (RI 7.0) Pdel: 0.54 Pathogenic (LQTS3) c.3578G>A p.R1193QE20Benign (Scores: 0.001; 0.006) Low ‡ Disease (RI 6.0) Pathological (RS 3) Pdel: 0.825 Neutral (RI 4.0) Pdel: 0.28 Uncertain c.4565T>A † p.F1522Y E27Benign (Scores: 0.417; 0.116) Low Neutral (RI 1.0) Neutral (RS 8) Pdel: 0.823 Disease (RI 4.0) – Possibly pathogenic (LQTS3) a. http://genetics.bwh.harvard.edu/pph2/.",Non-OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
